id	sid	tid	token	lemma	pos
aji-135	1	1	_	_	PUNCT
aji-135	2	1	_	_	PUNCT
aji-135	3	1	_	_	PUNCT
aji-135	4	1	_	_	PUNCT
aji-135	5	1	_	_	PUNCT
aji-135	6	1	_	_	PUNCT
aji-135	7	1	_	_	PUNCT
aji-135	8	1	_	_	PUNCT
aji-135	9	1	_	_	PUNCT
aji-135	10	1	_	_	PUNCT
aji-135	11	1	_	_	PUNCT
aji-135	12	1	_	_	PUNCT
aji-135	13	1	_	_	PUNCT
aji-135	14	1	_	_	PUNCT
aji-135	15	1	_	_	PUNCT
aji-135	16	1	_	_	PUNCT
aji-135	17	1	_	_	PUNCT
aji-135	18	1	_	_	PUNCT
aji-135	19	1	_	_	PUNCT
aji-135	20	1	_	_	PUNCT
aji-135	21	1	_	_	PUNCT
aji-135	22	1	_	_	PUNCT
aji-135	23	1	_	_	PUNCT
aji-135	24	1	_	_	PUNCT
aji-135	25	1	_	_	PUNCT
aji-135	26	1	_	_	PUNCT
aji-135	27	1	_	_	PUNCT
aji-135	28	1	_	_	PUNCT
aji-135	29	1	_	_	PUNCT
aji-135	30	1	_	_	PUNCT
aji-135	31	1	_	_	PUNCT
aji-135	32	1	_	_	PUNCT
aji-135	33	1	_	_	PUNCT
aji-135	34	1	_	_	PUNCT
aji-135	35	1	_	_	PUNCT
aji-135	36	1	_	_	PUNCT
aji-135	37	1	_	_	PUNCT
aji-135	38	1	_	_	PUNCT
aji-135	39	1	_	_	PUNCT
aji-135	40	1	_	_	PUNCT
aji-135	41	1	_	_	PUNCT
aji-135	42	1	_	_	PUNCT
aji-135	43	1	_	_	PUNCT
aji-135	44	1	_	_	PUNCT
aji-135	45	1	_	_	PUNCT
aji-135	46	1	_	_	PUNCT
aji-135	47	1	_	_	PUNCT
aji-135	48	1	_	_	PUNCT
aji-135	49	1	_	_	PUNCT
aji-135	50	1	_	_	PUNCT
aji-135	51	1	_	_	PUNCT
aji-135	52	1	_	_	PUNCT
aji-135	53	1	_	_	PUNCT
aji-135	54	1	_	_	PUNCT
aji-135	55	1	_	_	PUNCT
aji-135	56	1	_	_	PUNCT
aji-135	57	1	_	_	PUNCT
aji-135	58	1	_	_	PUNCT
aji-135	59	1	_	_	PUNCT
aji-135	60	1	_	_	PUNCT
aji-135	61	1	_	_	PUNCT
aji-135	62	1	_	_	PUNCT
aji-135	63	1	_	_	PUNCT
aji-135	64	1	_	_	PUNCT
aji-135	65	1	_	_	PUNCT
aji-135	66	1	_	_	PUNCT
aji-135	67	1	_	_	PUNCT
aji-135	68	1	_	_	PUNCT
aji-135	69	1	_	_	PUNCT
aji-135	70	1	_	_	PUNCT
aji-135	71	1	_	_	PUNCT
aji-135	72	1	_	_	PUNCT
aji-135	73	1	_	_	PUNCT
aji-135	74	1	_	_	PUNCT
aji-135	75	1	_	_	PUNCT
aji-135	76	1	_	_	PUNCT
aji-135	77	1	_	_	PUNCT
aji-135	78	1	_	_	PUNCT
aji-135	79	1	_	_	PUNCT
aji-135	80	1	_	_	PUNCT
aji-135	81	1	_	_	PUNCT
aji-135	82	1	_	_	PUNCT
aji-135	83	1	_	_	PUNCT
aji-135	84	1	_	_	PUNCT
aji-135	85	1	_	_	PUNCT
aji-135	86	1	_	_	PUNCT
aji-135	87	1	_	_	PUNCT
aji-135	88	1	_	_	PUNCT
aji-135	89	1	_	_	PUNCT
aji-135	90	1	_	_	PUNCT
aji-135	91	1	_	_	PUNCT
aji-135	92	1	_	_	PUNCT
aji-135	93	1	_	_	PUNCT
aji-135	94	1	_	_	PUNCT
aji-135	95	1	_	_	PUNCT
aji-135	96	1	_	_	PUNCT
aji-135	97	1	_	_	PUNCT
aji-135	98	1	_	_	PUNCT
aji-135	99	1	_	_	PUNCT
aji-135	100	1	_	_	PUNCT
aji-135	101	1	_	_	PUNCT
aji-135	102	1	*	*	PUNCT
aji-135	102	2	corresponding	correspond	VERB
aji-135	102	3	author	author	NOUN
aji-135	102	4	:	:	PUNCT
aji-135	102	5	e	e	NOUN
aji-135	102	6	-	-	NOUN
aji-135	102	7	mail	mail	NOUN
aji-135	102	8	:	:	PUNCT
aji-135	102	9	celso@alergoimuno.med.br	celso@alergoimuno.med.br	ADJ
aji-135	102	10	;	;	PUNCT
aji-135	102	11	cite	cite	VERB
aji-135	102	12	as	as	ADP
aji-135	102	13	:	:	PUNCT
aji-135	102	14	olivier	olivier	PROPN
aji-135	102	15	,	,	PUNCT
aji-135	102	16	celso	celso	PROPN
aji-135	102	17	eduardo	eduardo	PROPN
aji-135	102	18	,	,	PUNCT
aji-135	102	19	daiana	daiana	PROPN
aji-135	102	20	guedes	guedes	PROPN
aji-135	102	21	pinto	pinto	PROPN
aji-135	102	22	,	,	PUNCT
aji-135	102	23	ana	ana	PROPN
aji-135	102	24	paula	paula	PROPN
aji-135	102	25	monezzi	monezzi	PROPN
aji-135	102	26	teixeira	teixeira	PROPN
aji-135	102	27	,	,	PUNCT
aji-135	102	28	jhéssica	jhéssica	PROPN
aji-135	102	29	letícia	letícia	PROPN
aji-135	102	30	santos	santo	VERB
aji-135	102	31	santana	santana	PROPN
aji-135	102	32	,	,	PUNCT
aji-135	102	33	raquel	raquel	NOUN
aji-135	102	34	acácia	acácia	PROPN
aji-135	102	35	pereira	pereira	PROPN
aji-135	102	36	gonçalves	gonçalves	PROPN
aji-135	102	37	santos	santos	PROPN
aji-135	102	38	,	,	PUNCT
aji-135	102	39	and	and	CCONJ
aji-135	102	40	regiane	regiane	VERB
aji-135	102	41	patussi	patussi	PROPN
aji-135	102	42	santos	santos	PROPN
aji-135	102	43	lima	lima	PROPN
aji-135	102	44	.	.	PUNCT
aji-135	102	45	2024	2024	NUM
aji-135	102	46	.	.	PUNCT
aji-135	103	1	“	"	PUNCT
aji-135	103	2	endotyping	endotype	VERB
aji-135	103	3	non	non	ADJ
aji-135	103	4	–	–	PUNCT
aji-135	103	5	ige	ige	ADJ
aji-135	103	6	-	-	PUNCT
aji-135	103	7	mediated	mediate	VERB
aji-135	103	8	immunoreactivity	immunoreactivity	NOUN
aji-135	103	9	to	to	ADP
aji-135	103	10	polyethylene	polyethylene	NOUN
aji-135	103	11	glycol	glycol	NOUN
aji-135	103	12	:	:	PUNCT
aji-135	103	13	implications	implication	NOUN
aji-135	103	14	for	for	ADP
aji-135	103	15	allergic	allergic	ADJ
aji-135	103	16	patients	patient	NOUN
aji-135	103	17	”	"	PUNCT
aji-135	103	18	.	.	PUNCT
aji-135	104	1	asian	asian	ADJ
aji-135	104	2	journal	journal	NOUN
aji-135	104	3	of	of	ADP
aji-135	104	4	immunology	immunology	NOUN
aji-135	104	5	7	7	NUM
aji-135	104	6	(	(	PUNCT
aji-135	104	7	1):100	1):100	NUM
aji-135	104	8	-	-	SYM
aji-135	104	9	111	111	NUM
aji-135	104	10	.	.	PUNCT
aji-135	105	1	https://journalaji.com/index.php/aji/article/view/135	https://journalaji.com/index.php/aji/article/view/135	PROPN
aji-135	105	2	.	.	PUNCT
aji-135	105	3	asian	asian	ADJ
aji-135	105	4	journal	journal	PROPN
aji-135	105	5	of	of	ADP
aji-135	105	6	immunology	immunology	NOUN
aji-135	105	7	volume	volume	NOUN
aji-135	105	8	7	7	NUM
aji-135	105	9	,	,	PUNCT
aji-135	105	10	issue	issue	NOUN
aji-135	105	11	1	1	NUM
aji-135	105	12	,	,	PUNCT
aji-135	105	13	page	page	NOUN
aji-135	105	14	100	100	NUM
aji-135	105	15	-	-	SYM
aji-135	105	16	111	111	NUM
aji-135	105	17	,	,	PUNCT
aji-135	105	18	2024	2024	NUM
aji-135	105	19	;	;	PUNCT
aji-135	105	20	article	article	NOUN
aji-135	105	21	no.aji.119914	no.aji.119914	PROPN
aji-135	105	22	endotyping	endotype	VERB
aji-135	105	23	non	non	ADJ
aji-135	105	24	–	–	PUNCT
aji-135	105	25	ige	ige	ADJ
aji-135	105	26	-	-	PUNCT
aji-135	105	27	mediated	mediate	VERB
aji-135	105	28	immunoreactivity	immunoreactivity	NOUN
aji-135	105	29	to	to	ADP
aji-135	105	30	polyethylene	polyethylene	NOUN
aji-135	105	31	glycol	glycol	NOUN
aji-135	105	32	:	:	PUNCT
aji-135	105	33	implications	implication	NOUN
aji-135	105	34	for	for	ADP
aji-135	105	35	allergic	allergic	ADJ
aji-135	105	36	patients	patient	NOUN
aji-135	105	37	celso	celso	PROPN
aji-135	105	38	eduardo	eduardo	PROPN
aji-135	105	39	olivier	olivier	PROPN
aji-135	105	40	a	a	PROPN
aji-135	105	41	*	*	PROPN
aji-135	105	42	,	,	PUNCT
aji-135	105	43	daiana	daiana	PROPN
aji-135	105	44	guedes	guede	VERB
aji-135	105	45	pinto	pinto	NOUN
aji-135	105	46	a	a	PRON
aji-135	105	47	,	,	PUNCT
aji-135	105	48	ana	ana	PROPN
aji-135	105	49	paula	paula	PROPN
aji-135	105	50	monezzi	monezzi	PROPN
aji-135	105	51	teixeira	teixeira	PROPN
aji-135	105	52	a	a	PROPN
aji-135	105	53	,	,	PUNCT
aji-135	105	54	jhéssica	jhéssica	PROPN
aji-135	105	55	letícia	letícia	PROPN
aji-135	105	56	santos	santo	VERB
aji-135	105	57	santana	santana	PROPN
aji-135	105	58	a	a	PROPN
aji-135	105	59	,	,	PUNCT
aji-135	105	60	raquel	raquel	NOUN
aji-135	105	61	acácia	acácia	PROPN
aji-135	105	62	pereira	pereira	PROPN
aji-135	105	63	gonçalves	gonçalves	PROPN
aji-135	105	64	santos	santos	PROPN
aji-135	105	65	a	a	PRON
aji-135	105	66	and	and	CCONJ
aji-135	105	67	regiane	regiane	VERB
aji-135	105	68	patussi	patussi	PROPN
aji-135	105	69	santos	santos	PROPN
aji-135	105	70	lima	lima	PROPN
aji-135	105	71	b	b	PROPN
aji-135	105	72	a	a	DET
aji-135	105	73	instituto	instituto	PROPN
aji-135	105	74	alergoimuno	alergoimuno	PROPN
aji-135	105	75	de	de	X
aji-135	105	76	americana	americana	PROPN
aji-135	105	77	,	,	PUNCT
aji-135	105	78	brazil	brazil	PROPN
aji-135	105	79	.	.	PUNCT
aji-135	106	1	b	b	PROPN
aji-135	106	2	lavoisier	lavoisier	NOUN
aji-135	106	3	’s	’s	PART
aji-135	106	4	laboratories	laboratory	NOUN
aji-135	106	5	,	,	PUNCT
aji-135	106	6	são	são	PROPN
aji-135	106	7	paulo	paulo	PROPN
aji-135	106	8	,	,	PUNCT
aji-135	106	9	brazil	brazil	PROPN
aji-135	106	10	.	.	PUNCT
aji-135	107	1	authors	author	NOUN
aji-135	107	2	’	’	PART
aji-135	107	3	contributions	contribution	NOUN
aji-135	107	4	this	this	DET
aji-135	107	5	work	work	NOUN
aji-135	107	6	was	be	AUX
aji-135	107	7	carried	carry	VERB
aji-135	107	8	out	out	ADP
aji-135	107	9	in	in	ADP
aji-135	107	10	collaboration	collaboration	NOUN
aji-135	107	11	among	among	ADP
aji-135	107	12	all	all	DET
aji-135	107	13	authors	author	NOUN
aji-135	107	14	.	.	PUNCT
aji-135	108	1	author	author	NOUN
aji-135	108	2	ceo	ceo	NOUN
aji-135	108	3	designed	design	VERB
aji-135	108	4	the	the	DET
aji-135	108	5	study	study	NOUN
aji-135	108	6	,	,	PUNCT
aji-135	108	7	wrote	write	VERB
aji-135	108	8	the	the	DET
aji-135	108	9	protocol	protocol	NOUN
aji-135	108	10	and	and	CCONJ
aji-135	108	11	the	the	DET
aji-135	108	12	manuscript	manuscript	NOUN
aji-135	108	13	’s	’s	PART
aji-135	108	14	first	first	ADJ
aji-135	108	15	draft	draft	NOUN
aji-135	108	16	,	,	PUNCT
aji-135	108	17	and	and	CCONJ
aji-135	108	18	managed	manage	VERB
aji-135	108	19	the	the	DET
aji-135	108	20	literature	literature	NOUN
aji-135	108	21	searches	search	NOUN
aji-135	108	22	.	.	PUNCT
aji-135	109	1	authors	author	NOUN
aji-135	109	2	dgp	dgp	VERB
aji-135	109	3	,	,	PUNCT
aji-135	109	4	apmt	apmt	PROPN
aji-135	109	5	,	,	PUNCT
aji-135	109	6	jlss	jlss	PROPN
aji-135	109	7	and	and	CCONJ
aji-135	109	8	rpsl	rpsl	VERB
aji-135	109	9	performed	perform	VERB
aji-135	109	10	laboratory	laboratory	NOUN
aji-135	109	11	research	research	NOUN
aji-135	109	12	.	.	PUNCT
aji-135	110	1	author	author	NOUN
aji-135	110	2	rapgs	rapgs	PROPN
aji-135	110	3	performed	perform	VERB
aji-135	110	4	cutaneous	cutaneous	ADJ
aji-135	110	5	tests	test	NOUN
aji-135	110	6	.	.	PUNCT
aji-135	111	1	all	all	DET
aji-135	111	2	authors	author	NOUN
aji-135	111	3	read	read	VERB
aji-135	111	4	and	and	CCONJ
aji-135	111	5	approved	approve	VERB
aji-135	111	6	the	the	DET
aji-135	111	7	final	final	ADJ
aji-135	111	8	manuscript	manuscript	NOUN
aji-135	111	9	.	.	PUNCT
aji-135	112	1	article	article	NOUN
aji-135	112	2	information	information	PROPN
aji-135	112	3	doi	doi	PROPN
aji-135	112	4	:	:	PUNCT
aji-135	112	5	https://doi.org/10.9734/aji/2024/v7i1135	https://doi.org/10.9734/aji/2024/v7i1135	PROPN
aji-135	112	6	open	open	ADJ
aji-135	112	7	peer	peer	NOUN
aji-135	112	8	review	review	NOUN
aji-135	112	9	history	history	NOUN
aji-135	112	10	:	:	PUNCT
aji-135	112	11	this	this	DET
aji-135	112	12	journal	journal	NOUN
aji-135	112	13	follows	follow	VERB
aji-135	112	14	the	the	DET
aji-135	112	15	advanced	advance	VERB
aji-135	112	16	open	open	ADJ
aji-135	112	17	peer	peer	NOUN
aji-135	112	18	review	review	NOUN
aji-135	112	19	policy	policy	NOUN
aji-135	112	20	.	.	PUNCT
aji-135	113	1	identity	identity	NOUN
aji-135	113	2	of	of	ADP
aji-135	113	3	the	the	DET
aji-135	113	4	reviewers	reviewer	NOUN
aji-135	113	5	,	,	PUNCT
aji-135	113	6	editor(s	editor(s	NOUN
aji-135	113	7	)	)	PUNCT
aji-135	113	8	and	and	CCONJ
aji-135	113	9	additional	additional	ADJ
aji-135	113	10	reviewers	reviewer	NOUN
aji-135	113	11	,	,	PUNCT
aji-135	113	12	peer	peer	NOUN
aji-135	113	13	review	review	NOUN
aji-135	113	14	comments	comment	NOUN
aji-135	113	15	,	,	PUNCT
aji-135	113	16	different	different	ADJ
aji-135	113	17	versions	version	NOUN
aji-135	113	18	of	of	ADP
aji-135	113	19	the	the	DET
aji-135	113	20	manuscript	manuscript	NOUN
aji-135	113	21	,	,	PUNCT
aji-135	113	22	comments	comment	NOUN
aji-135	113	23	of	of	ADP
aji-135	113	24	the	the	DET
aji-135	113	25	editors	editor	NOUN
aji-135	113	26	,	,	PUNCT
aji-135	113	27	etc	etc	X
aji-135	113	28	are	be	AUX
aji-135	113	29	available	available	ADJ
aji-135	113	30	here	here	ADV
aji-135	113	31	:	:	PUNCT
aji-135	113	32	https://www.sdiarticle5.com/review-history/119914	https://www.sdiarticle5.com/review-history/119914	NOUN
aji-135	113	33	received	receive	VERB
aji-135	113	34	:	:	PUNCT
aji-135	113	35	01/07/2024	01/07/2024	NUM
aji-135	113	36	accepted	accept	VERB
aji-135	113	37	:	:	PUNCT
aji-135	113	38	16/07/2024	16/07/2024	NUM
aji-135	113	39	published	publish	VERB
aji-135	113	40	:	:	PUNCT
aji-135	113	41	17/07/2024	17/07/2024	NUM
aji-135	113	42	original	original	ADJ
aji-135	113	43	research	research	NOUN
aji-135	113	44	article	article	NOUN
aji-135	113	45	https://doi.org/10.9734/aji/2024/v7i1135	https://doi.org/10.9734/aji/2024/v7i1135	PROPN
aji-135	113	46	https://www.sdiarticle5.com/review-history/119914	https://www.sdiarticle5.com/review-history/119914	PROPN
aji-135	113	47	olivier	olivier	X
aji-135	113	48	et	et	PROPN
aji-135	113	49	al	al	PROPN
aji-135	113	50	.	.	PROPN
aji-135	113	51	;	;	PUNCT
aji-135	113	52	asian	asian	PROPN
aji-135	113	53	j.	j.	PROPN
aji-135	113	54	immunol	immunol	PROPN
aji-135	113	55	.	.	PROPN
aji-135	113	56	,	,	PUNCT
aji-135	113	57	vol	vol	NOUN
aji-135	113	58	.	.	PROPN
aji-135	113	59	7	7	NUM
aji-135	113	60	,	,	PUNCT
aji-135	113	61	no	no	INTJ
aji-135	113	62	.	.	NOUN
aji-135	113	63	1	1	NUM
aji-135	113	64	,	,	PUNCT
aji-135	113	65	pp	pp	ADJ
aji-135	113	66	.	.	PUNCT
aji-135	114	1	100	100	NUM
aji-135	114	2	-	-	SYM
aji-135	114	3	111	111	NUM
aji-135	114	4	,	,	PUNCT
aji-135	114	5	2024	2024	NUM
aji-135	114	6	;	;	PUNCT
aji-135	115	1	article	article	NOUN
aji-135	115	2	no.aji.119914	no.aji.119914	PROPN
aji-135	115	3	101	101	NUM
aji-135	115	4	abstract	abstract	ADJ
aji-135	115	5	background	background	NOUN
aji-135	115	6	:	:	PUNCT
aji-135	115	7	several	several	ADJ
aji-135	115	8	publications	publication	NOUN
aji-135	115	9	report	report	VERB
aji-135	115	10	polyethylene	polyethylene	NOUN
aji-135	115	11	glycols	glycol	NOUN
aji-135	115	12	(	(	PUNCT
aji-135	115	13	pegs	peg	NOUN
aji-135	115	14	)	)	PUNCT
aji-135	115	15	and	and	CCONJ
aji-135	115	16	pegylated	pegylate	VERB
aji-135	115	17	therapeutics	therapeutic	NOUN
aji-135	115	18	as	as	ADV
aji-135	115	19	responsible	responsible	ADJ
aji-135	115	20	for	for	ADP
aji-135	115	21	non	non	ADJ
aji-135	115	22	–	–	PUNCT
aji-135	115	23	ige	ige	ADJ
aji-135	115	24	-	-	PUNCT
aji-135	115	25	mediated	mediate	VERB
aji-135	115	26	allergic	allergic	ADJ
aji-135	115	27	reactions	reaction	NOUN
aji-135	115	28	.	.	PUNCT
aji-135	116	1	there	there	PRON
aji-135	116	2	is	be	VERB
aji-135	116	3	no	no	DET
aji-135	116	4	standardized	standardized	ADJ
aji-135	116	5	lab	lab	NOUN
aji-135	116	6	exam	exam	NOUN
aji-135	116	7	that	that	PRON
aji-135	116	8	can	can	AUX
aji-135	116	9	endotype	endotype	VERB
aji-135	116	10	(	(	PUNCT
aji-135	116	11	quantify	quantify	VERB
aji-135	116	12	the	the	DET
aji-135	116	13	participation	participation	NOUN
aji-135	116	14	of	of	ADP
aji-135	116	15	these	these	DET
aji-135	116	16	mechanisms	mechanism	NOUN
aji-135	116	17	inside	inside	ADP
aji-135	116	18	each	each	DET
aji-135	116	19	patient	patient	NOUN
aji-135	116	20	’s	’s	PART
aji-135	116	21	pattern	pattern	NOUN
aji-135	116	22	of	of	ADP
aji-135	116	23	symptoms	symptom	NOUN
aji-135	116	24	)	)	PUNCT
aji-135	116	25	besides	besides	ADV
aji-135	116	26	in	in	ADP
aji-135	116	27	vivo	vivo	ADJ
aji-135	116	28	provocation	provocation	NOUN
aji-135	116	29	tests	test	NOUN
aji-135	116	30	.	.	PUNCT
aji-135	117	1	objective	objective	ADJ
aji-135	117	2	and	and	CCONJ
aji-135	117	3	aim	aim	VERB
aji-135	117	4	:	:	PUNCT
aji-135	117	5	to	to	PART
aji-135	117	6	evaluate	evaluate	VERB
aji-135	117	7	the	the	DET
aji-135	117	8	tube	tube	NOUN
aji-135	117	9	titration	titration	NOUN
aji-135	117	10	of	of	ADP
aji-135	117	11	precipitins	precipitin	NOUN
aji-135	117	12	(	(	PUNCT
aji-135	117	13	ttp	ttp	NOUN
aji-135	117	14	)	)	PUNCT
aji-135	117	15	and	and	CCONJ
aji-135	117	16	the	the	DET
aji-135	117	17	leukocyte	leukocyte	NOUN
aji-135	117	18	adherence	adherence	NOUN
aji-135	117	19	inhibition	inhibition	NOUN
aji-135	117	20	test	test	NOUN
aji-135	117	21	(	(	PUNCT
aji-135	117	22	lait	lait	NOUN
aji-135	117	23	)	)	PUNCT
aji-135	117	24	to	to	PART
aji-135	117	25	discriminate	discriminate	VERB
aji-135	117	26	and	and	CCONJ
aji-135	117	27	endotype	endotype	VERB
aji-135	117	28	non	non	PROPN
aji-135	117	29	–	–	PUNCT
aji-135	117	30	ige	ige	ADJ
aji-135	117	31	-	-	PUNCT
aji-135	117	32	mediated	mediate	VERB
aji-135	117	33	immunoreactivity	immunoreactivity	NOUN
aji-135	117	34	against	against	ADP
aji-135	117	35	a	a	DET
aji-135	117	36	pegs	pegs	NOUN
aji-135	117	37	solution	solution	NOUN
aji-135	117	38	in	in	ADP
aji-135	117	39	patients	patient	NOUN
aji-135	117	40	with	with	ADP
aji-135	117	41	non	non	ADJ
aji-135	117	42	–	–	PUNCT
aji-135	117	43	ige	ige	ADJ
aji-135	117	44	-	-	PUNCT
aji-135	117	45	mediated	mediate	VERB
aji-135	117	46	allergic	allergic	ADJ
aji-135	117	47	phenotypes	phenotype	NOUN
aji-135	117	48	.	.	PUNCT
aji-135	118	1	research	research	NOUN
aji-135	118	2	design	design	NOUN
aji-135	118	3	and	and	CCONJ
aji-135	118	4	research	research	NOUN
aji-135	118	5	protocol	protocol	NOUN
aji-135	118	6	:	:	PUNCT
aji-135	118	7	to	to	PART
aji-135	118	8	retrospectively	retrospectively	ADV
aji-135	118	9	examine	examine	VERB
aji-135	118	10	the	the	DET
aji-135	118	11	medical	medical	ADJ
aji-135	118	12	charts	chart	NOUN
aji-135	118	13	of	of	ADP
aji-135	118	14	two	two	NUM
aji-135	118	15	cohorts	cohort	NOUN
aji-135	118	16	(	(	PUNCT
aji-135	118	17	with	with	ADP
aji-135	118	18	100	100	NUM
aji-135	118	19	patients	patient	NOUN
aji-135	118	20	each	each	PRON
aji-135	118	21	)	)	PUNCT
aji-135	118	22	diagnosed	diagnose	VERB
aji-135	118	23	with	with	ADP
aji-135	118	24	non	non	ADJ
aji-135	118	25	–	–	PUNCT
aji-135	118	26	ige	ige	ADJ
aji-135	118	27	-	-	PUNCT
aji-135	118	28	mediated	mediate	VERB
aji-135	118	29	allergic	allergic	ADJ
aji-135	118	30	rhinitis	rhinitis	NOUN
aji-135	118	31	,	,	PUNCT
aji-135	118	32	allergic	allergic	ADJ
aji-135	118	33	bronchitis	bronchitis	NOUN
aji-135	118	34	,	,	PUNCT
aji-135	118	35	asthma	asthma	NOUN
aji-135	118	36	,	,	PUNCT
aji-135	118	37	allergic	allergic	ADJ
aji-135	118	38	sinus	sinus	NOUN
aji-135	118	39	headache	headache	NOUN
aji-135	118	40	,	,	PUNCT
aji-135	118	41	atopic	atopic	NOUN
aji-135	118	42	dermatitis	dermatitis	NOUN
aji-135	118	43	,	,	PUNCT
aji-135	118	44	and/or	and/or	CCONJ
aji-135	118	45	urticaria	urticaria	NOUN
aji-135	118	46	who	who	PRON
aji-135	118	47	were	be	AUX
aji-135	118	48	investigated	investigate	VERB
aji-135	118	49	with	with	ADP
aji-135	118	50	the	the	DET
aji-135	118	51	help	help	NOUN
aji-135	118	52	of	of	ADP
aji-135	118	53	ttp	ttp	PROPN
aji-135	118	54	or	or	CCONJ
aji-135	118	55	ex	ex	PRON
aji-135	118	56	vivo	vivo	NOUN
aji-135	118	57	challenge	challenge	NOUN
aji-135	118	58	tests	test	NOUN
aji-135	118	59	monitored	monitor	VERB
aji-135	118	60	by	by	ADP
aji-135	118	61	lait	lait	NOUN
aji-135	118	62	against	against	ADP
aji-135	118	63	pegs	peg	NOUN
aji-135	118	64	.	.	PUNCT
aji-135	119	1	methodology	methodology	NOUN
aji-135	119	2	:	:	PUNCT
aji-135	120	1	we	we	PRON
aji-135	120	2	identified	identify	VERB
aji-135	120	3	the	the	DET
aji-135	120	4	registered	register	VERB
aji-135	120	5	results	result	NOUN
aji-135	120	6	of	of	ADP
aji-135	120	7	the	the	DET
aji-135	120	8	semi	semi	ADJ
aji-135	120	9	-	-	ADJ
aji-135	120	10	quantitative	quantitative	ADJ
aji-135	120	11	serum	serum	NOUN
aji-135	120	12	ttp	ttp	NOUN
aji-135	120	13	against	against	ADP
aji-135	120	14	1	1	NUM
aji-135	120	15	mg	mg	NUM
aji-135	120	16	/	/	SYM
aji-135	121	1	ml	ml	NOUN
aji-135	121	2	pegs	peg	NOUN
aji-135	121	3	4000	4000	NUM
aji-135	121	4	solution	solution	NOUN
aji-135	121	5	,	,	PUNCT
aji-135	121	6	which	which	PRON
aji-135	121	7	were	be	AUX
aji-135	121	8	distributed	distribute	VERB
aji-135	121	9	in	in	ADP
aji-135	121	10	ranges	range	NOUN
aji-135	121	11	through	through	ADP
aji-135	121	12	a	a	DET
aji-135	121	13	cascade	cascade	NOUN
aji-135	121	14	distribution	distribution	NOUN
aji-135	121	15	chart	chart	NOUN
aji-135	121	16	to	to	PART
aji-135	121	17	outline	outline	VERB
aji-135	121	18	the	the	DET
aji-135	121	19	variability	variability	NOUN
aji-135	121	20	of	of	ADP
aji-135	121	21	the	the	DET
aji-135	121	22	results	result	NOUN
aji-135	121	23	inside	inside	ADP
aji-135	121	24	the	the	DET
aji-135	121	25	first	first	ADJ
aji-135	121	26	cohort	cohort	NOUN
aji-135	121	27	.	.	PUNCT
aji-135	122	1	the	the	DET
aji-135	122	2	lai	lai	PROPN
aji-135	122	3	done	do	VERB
aji-135	122	4	with	with	ADP
aji-135	122	5	the	the	DET
aji-135	122	6	ex	ex	ADJ
aji-135	122	7	vivo	vivo	NOUN
aji-135	122	8	challenges	challenge	NOUN
aji-135	122	9	with	with	ADP
aji-135	122	10	1	1	NUM
aji-135	122	11	mg	mg	NUM
aji-135	122	12	/	/	SYM
aji-135	122	13	ml	ml	NOUN
aji-135	122	14	pegs	peg	NOUN
aji-135	122	15	4000	4000	NUM
aji-135	122	16	solution	solution	NOUN
aji-135	122	17	were	be	AUX
aji-135	122	18	distributed	distribute	VERB
aji-135	122	19	in	in	ADP
aji-135	122	20	ranges	range	NOUN
aji-135	122	21	through	through	ADP
aji-135	122	22	a	a	DET
aji-135	122	23	cascade	cascade	NOUN
aji-135	122	24	distribution	distribution	NOUN
aji-135	122	25	chart	chart	NOUN
aji-135	122	26	the	the	DET
aji-135	122	27	statistical	statistical	ADJ
aji-135	122	28	characteristics	characteristic	NOUN
aji-135	122	29	of	of	ADP
aji-135	122	30	the	the	DET
aji-135	122	31	two	two	NUM
aji-135	122	32	cohorts	cohort	NOUN
aji-135	122	33	were	be	AUX
aji-135	122	34	calculated	calculate	VERB
aji-135	122	35	.	.	PUNCT
aji-135	123	1	results	result	NOUN
aji-135	123	2	:	:	PUNCT
aji-135	123	3	the	the	DET
aji-135	123	4	ttp	ttp	PROPN
aji-135	123	5	showed	show	VERB
aji-135	123	6	a	a	DET
aji-135	123	7	wide	wide	ADJ
aji-135	123	8	distribution	distribution	NOUN
aji-135	123	9	range	range	NOUN
aji-135	123	10	of	of	ADP
aji-135	123	11	results	result	NOUN
aji-135	123	12	.	.	PUNCT
aji-135	124	1	the	the	DET
aji-135	124	2	mean	mean	NOUN
aji-135	124	3	was	be	AUX
aji-135	124	4	estimated	estimate	VERB
aji-135	124	5	at	at	ADP
aji-135	124	6	1:246	1:246	NUM
aji-135	124	7	;	;	PUNCT
aji-135	124	8	the	the	DET
aji-135	124	9	median	median	NOUN
aji-135	124	10	at	at	ADP
aji-135	124	11	1:192	1:192	NUM
aji-135	124	12	;	;	PUNCT
aji-135	124	13	the	the	DET
aji-135	124	14	standard	standard	ADJ
aji-135	124	15	deviation	deviation	NOUN
aji-135	124	16	at	at	ADP
aji-135	124	17	1:188	1:188	NUM
aji-135	124	18	.	.	PUNCT
aji-135	125	1	the	the	DET
aji-135	125	2	lait	lait	NOUN
aji-135	125	3	showed	show	VERB
aji-135	125	4	a	a	DET
aji-135	125	5	wide	wide	ADJ
aji-135	125	6	distribution	distribution	NOUN
aji-135	125	7	range	range	NOUN
aji-135	125	8	of	of	ADP
aji-135	125	9	results	result	NOUN
aji-135	125	10	.	.	PUNCT
aji-135	126	1	the	the	DET
aji-135	126	2	lai	lai	PROPN
aji-135	126	3	ranged	range	VERB
aji-135	126	4	from	from	ADP
aji-135	126	5	0	0	NUM
aji-135	126	6	%	%	NOUN
aji-135	126	7	to	to	PART
aji-135	126	8	98	98	NUM
aji-135	126	9	%	%	NOUN
aji-135	126	10	.	.	PUNCT
aji-135	127	1	the	the	DET
aji-135	127	2	mean	mean	NOUN
aji-135	127	3	was	be	AUX
aji-135	127	4	41.9	41.9	NUM
aji-135	127	5	%	%	NOUN
aji-135	127	6	;	;	PUNCT
aji-135	127	7	the	the	DET
aji-135	127	8	median	median	NOUN
aji-135	127	9	was	be	AUX
aji-135	127	10	45	45	NUM
aji-135	127	11	%	%	NOUN
aji-135	127	12	;	;	PUNCT
aji-135	127	13	the	the	DET
aji-135	127	14	standard	standard	ADJ
aji-135	127	15	deviation	deviation	NOUN
aji-135	127	16	was	be	AUX
aji-135	127	17	28.5	28.5	NUM
aji-135	127	18	%	%	NOUN
aji-135	127	19	.	.	PUNCT
aji-135	128	1	the	the	DET
aji-135	128	2	cascade	cascade	NOUN
aji-135	128	3	distribution	distribution	NOUN
aji-135	128	4	demonstrates	demonstrate	VERB
aji-135	128	5	a	a	DET
aji-135	128	6	wide	wide	ADJ
aji-135	128	7	range	range	NOUN
aji-135	128	8	of	of	ADP
aji-135	128	9	lai	lai	PROPN
aji-135	128	10	results	result	NOUN
aji-135	128	11	.	.	PUNCT
aji-135	129	1	conclusion	conclusion	NOUN
aji-135	129	2	:	:	PUNCT
aji-135	129	3	some	some	DET
aji-135	129	4	patients	patient	NOUN
aji-135	129	5	showed	show	VERB
aji-135	129	6	any	any	DET
aji-135	129	7	or	or	CCONJ
aji-135	129	8	low	low	ADJ
aji-135	129	9	immunoreactivity	immunoreactivity	NOUN
aji-135	129	10	during	during	ADP
aji-135	129	11	the	the	DET
aji-135	129	12	ex	ex	ADJ
aji-135	129	13	vivo	vivo	NOUN
aji-135	129	14	challenge	challenge	NOUN
aji-135	129	15	test	test	NOUN
aji-135	129	16	,	,	PUNCT
aji-135	129	17	while	while	SCONJ
aji-135	129	18	most	most	ADJ
aji-135	129	19	displayed	display	VERB
aji-135	129	20	moderate	moderate	ADJ
aji-135	129	21	or	or	CCONJ
aji-135	129	22	strong	strong	ADJ
aji-135	129	23	immunoreactivity	immunoreactivity	NOUN
aji-135	129	24	,	,	PUNCT
aji-135	129	25	which	which	PRON
aji-135	129	26	could	could	AUX
aji-135	129	27	reflect	reflect	VERB
aji-135	129	28	the	the	DET
aji-135	129	29	participation	participation	NOUN
aji-135	129	30	of	of	ADP
aji-135	129	31	pegs	peg	NOUN
aji-135	129	32	antibodies	antibodie	VERB
aji-135	129	33	in	in	ADP
aji-135	129	34	a	a	DET
aji-135	129	35	non	non	ADJ
aji-135	129	36	–	–	PUNCT
aji-135	129	37	ige	ige	ADJ
aji-135	129	38	-	-	PUNCT
aji-135	129	39	mediated	mediate	VERB
aji-135	129	40	hypersensitivity	hypersensitivity	NOUN
aji-135	129	41	condition	condition	NOUN
aji-135	129	42	.	.	PUNCT
aji-135	130	1	keywords	keyword	NOUN
aji-135	130	2	:	:	PUNCT
aji-135	130	3	allergy	allergy	NOUN
aji-135	130	4	;	;	PUNCT
aji-135	130	5	asthma	asthma	NOUN
aji-135	130	6	;	;	PUNCT
aji-135	130	7	atopic	atopic	NOUN
aji-135	130	8	dermatitis	dermatitis	NOUN
aji-135	130	9	;	;	PUNCT
aji-135	130	10	bronchitis	bronchitis	NOUN
aji-135	130	11	;	;	PUNCT
aji-135	130	12	covid-19	covid-19	PROPN
aji-135	130	13	vaccination	vaccination	NOUN
aji-135	130	14	;	;	PUNCT
aji-135	130	15	diagnosis	diagnosis	NOUN
aji-135	130	16	;	;	PUNCT
aji-135	130	17	exposome	exposome	NOUN
aji-135	130	18	-	-	PUNCT
aji-135	130	19	wide	wide	ADJ
aji-135	130	20	association	association	NOUN
aji-135	130	21	study	study	NOUN
aji-135	130	22	;	;	PUNCT
aji-135	130	23	endotype	endotype	NOUN
aji-135	130	24	;	;	PUNCT
aji-135	130	25	hypersensitivity	hypersensitivity	NOUN
aji-135	130	26	;	;	PUNCT
aji-135	130	27	leukocyte	leukocyte	ADJ
aji-135	130	28	adherence	adherence	NOUN
aji-135	130	29	inhibition	inhibition	NOUN
aji-135	130	30	test	test	NOUN
aji-135	130	31	;	;	PUNCT
aji-135	130	32	macrogol	macrogol	NOUN
aji-135	130	33	;	;	PUNCT
aji-135	130	34	non	non	ADJ
aji-135	130	35	–	–	PUNCT
aji-135	130	36	ige	ige	ADJ
aji-135	130	37	-	-	PUNCT
aji-135	130	38	mediated	mediate	VERB
aji-135	130	39	immunoreactivity	immunoreactivity	NOUN
aji-135	130	40	;	;	PUNCT
aji-135	130	41	precision	precision	NOUN
aji-135	130	42	medicine	medicine	NOUN
aji-135	130	43	;	;	PUNCT
aji-135	130	44	polyethylene	polyethylene	NOUN
aji-135	130	45	glycol	glycol	NOUN
aji-135	130	46	;	;	PUNCT
aji-135	130	47	e1521	e1521	NOUN
aji-135	130	48	;	;	PUNCT
aji-135	130	49	rhinitis	rhiniti	NOUN
aji-135	130	50	;	;	PUNCT
aji-135	130	51	sinus	sinus	NOUN
aji-135	130	52	headache	headache	NOUN
aji-135	130	53	;	;	PUNCT
aji-135	130	54	urticaria	urticaria	NOUN
aji-135	130	55	.	.	PUNCT
aji-135	131	1	abbreviations	abbreviation	NOUN
aji-135	131	2	lai	lai	NOUN
aji-135	131	3	:	:	PUNCT
aji-135	131	4	leukocyte	leukocyte	NOUN
aji-135	131	5	adherence	adherence	NOUN
aji-135	131	6	inhibition	inhibition	NOUN
aji-135	131	7	lait	lait	NOUN
aji-135	131	8	:	:	PUNCT
aji-135	131	9	leukocyte	leukocyte	ADJ
aji-135	131	10	adherence	adherence	NOUN
aji-135	131	11	inhibition	inhibition	NOUN
aji-135	131	12	test	test	NOUN
aji-135	131	13	ttp	ttp	NOUN
aji-135	131	14	:	:	PUNCT
aji-135	131	15	tube	tube	NOUN
aji-135	131	16	titration	titration	NOUN
aji-135	131	17	of	of	ADP
aji-135	131	18	precipitins	precipitin	NOUN
aji-135	131	19	pegs	peg	NOUN
aji-135	131	20	:	:	PUNCT
aji-135	131	21	polyethylene	polyethylene	NOUN
aji-135	131	22	glycol	glycol	NOUN
aji-135	131	23	polymers	polymer	NOUN
aji-135	131	24	1	1	NUM
aji-135	131	25	.	.	PUNCT
aji-135	131	26	introduction	introduction	NOUN
aji-135	131	27	for	for	ADP
aji-135	131	28	a	a	DET
aji-135	131	29	long	long	ADJ
aji-135	131	30	time	time	NOUN
aji-135	131	31	,	,	PUNCT
aji-135	131	32	petroleum	petroleum	NOUN
aji-135	131	33	-	-	PUNCT
aji-135	131	34	derived	derive	VERB
aji-135	131	35	polymeric	polymeric	ADJ
aji-135	131	36	products	product	NOUN
aji-135	131	37	were	be	AUX
aji-135	131	38	discarded	discard	VERB
aji-135	131	39	as	as	ADP
aji-135	131	40	tars	tar	NOUN
aji-135	131	41	.	.	PUNCT
aji-135	132	1	the	the	DET
aji-135	132	2	first	first	ADJ
aji-135	132	3	polymerized	polymerized	ADJ
aji-135	132	4	structures	structure	NOUN
aji-135	132	5	to	to	PART
aji-135	132	6	be	be	AUX
aji-135	132	7	identified	identify	VERB
aji-135	132	8	from	from	ADP
aji-135	132	9	tars	tar	NOUN
aji-135	132	10	were	be	AUX
aji-135	132	11	the	the	DET
aji-135	132	12	polyethylene	polyethylene	NOUN
aji-135	132	13	glycol	glycol	NOUN
aji-135	132	14	polymers	polymer	NOUN
aji-135	132	15	(	(	PUNCT
aji-135	132	16	pegs	peg	NOUN
aji-135	132	17	)	)	PUNCT
aji-135	132	18	after	after	ADP
aji-135	132	19	continued	continue	VERB
aji-135	132	20	condensation	condensation	NOUN
aji-135	132	21	studies	study	NOUN
aji-135	132	22	in	in	ADP
aji-135	132	23	1860	1860	NUM
aji-135	132	24	[	[	X
aji-135	132	25	1	1	NUM
aji-135	132	26	]	]	PUNCT
aji-135	132	27	.	.	PUNCT
aji-135	133	1	pegs	peg	NOUN
aji-135	133	2	are	be	AUX
aji-135	133	3	polymers	polymer	NOUN
aji-135	133	4	of	of	ADP
aji-135	133	5	parental	parental	ADJ
aji-135	133	6	ether	ether	NOUN
aji-135	133	7	monomers	monomer	NOUN
aji-135	133	8	such	such	ADJ
aji-135	133	9	as	as	ADP
aji-135	133	10	ethylene	ethylene	NOUN
aji-135	133	11	glycol	glycol	NOUN
aji-135	133	12	,	,	PUNCT
aji-135	133	13	ethylene	ethylene	NOUN
aji-135	133	14	oxide	oxide	NOUN
aji-135	133	15	,	,	PUNCT
aji-135	133	16	or	or	CCONJ
aji-135	133	17	oxyethylene	oxyethylene	ADJ
aji-135	133	18	,	,	PUNCT
aji-135	133	19	commonly	commonly	ADV
aji-135	133	20	available	available	ADJ
aji-135	133	21	as	as	ADP
aji-135	133	22	compounds	compound	NOUN
aji-135	133	23	together	together	ADV
aji-135	133	24	with	with	ADP
aji-135	133	25	their	their	PRON
aji-135	133	26	anionic	anionic	ADJ
aji-135	133	27	or	or	CCONJ
aji-135	133	28	nonionic	nonionic	ADJ
aji-135	133	29	derivatives	derivative	NOUN
aji-135	133	30	,	,	PUNCT
aji-135	133	31	in	in	ADP
aji-135	133	32	mixtures	mixture	NOUN
aji-135	133	33	of	of	ADP
aji-135	133	34	different	different	ADJ
aji-135	133	35	chain	chain	NOUN
aji-135	133	36	lengths	length	NOUN
aji-135	133	37	polymers	polymer	NOUN
aji-135	133	38	,	,	PUNCT
aji-135	133	39	indicated	indicate	VERB
aji-135	133	40	by	by	ADP
aji-135	133	41	their	their	PRON
aji-135	133	42	average	average	ADJ
aji-135	133	43	molecular	molecular	ADJ
aji-135	133	44	weight	weight	NOUN
aji-135	133	45	(	(	PUNCT
aji-135	133	46	200	200	NUM
aji-135	133	47	to	to	PART
aji-135	133	48	over	over	ADP
aji-135	133	49	10,000	10,000	NUM
aji-135	133	50	da	da	NOUN
aji-135	133	51	)	)	PUNCT
aji-135	134	1	[	[	X
aji-135	134	2	2	2	NUM
aji-135	134	3	]	]	PUNCT
aji-135	134	4	.	.	PUNCT
aji-135	135	1	pegs	peg	NOUN
aji-135	135	2	are	be	AUX
aji-135	135	3	used	use	VERB
aji-135	135	4	as	as	ADP
aji-135	135	5	solvents	solvent	NOUN
aji-135	135	6	and	and	CCONJ
aji-135	135	7	emulsifying	emulsify	VERB
aji-135	135	8	agents	agent	NOUN
aji-135	135	9	in	in	ADP
aji-135	135	10	processed	process	VERB
aji-135	135	11	food	food	NOUN
aji-135	135	12	,	,	PUNCT
aji-135	135	13	cosmetics	cosmetic	NOUN
aji-135	135	14	,	,	PUNCT
aji-135	135	15	medicines	medicine	NOUN
aji-135	135	16	,	,	PUNCT
aji-135	135	17	cleansing	cleansing	NOUN
aji-135	135	18	,	,	PUNCT
aji-135	135	19	and	and	CCONJ
aji-135	135	20	personal	personal	ADJ
aji-135	135	21	care	care	NOUN
aji-135	135	22	products	product	NOUN
aji-135	135	23	.	.	PUNCT
aji-135	136	1	they	they	PRON
aji-135	136	2	may	may	AUX
aji-135	136	3	also	also	ADV
aji-135	136	4	be	be	AUX
aji-135	136	5	involved	involve	VERB
aji-135	136	6	in	in	ADP
aji-135	136	7	the	the	DET
aji-135	136	8	production	production	NOUN
aji-135	136	9	of	of	ADP
aji-135	136	10	fabrics	fabric	NOUN
aji-135	136	11	,	,	PUNCT
aji-135	136	12	plastics	plastic	NOUN
aji-135	136	13	,	,	PUNCT
aji-135	136	14	resins	resin	NOUN
aji-135	136	15	,	,	PUNCT
aji-135	136	16	papers	paper	NOUN
aji-135	136	17	,	,	PUNCT
aji-135	136	18	ceramics	ceramic	NOUN
aji-135	136	19	,	,	PUNCT
aji-135	136	20	glasses	glass	NOUN
aji-135	136	21	,	,	PUNCT
aji-135	136	22	rubber	rubber	NOUN
aji-135	136	23	,	,	PUNCT
aji-135	136	24	metals	metal	NOUN
aji-135	136	25	,	,	PUNCT
aji-135	136	26	wood	wood	NOUN
aji-135	136	27	preservatives	preservative	NOUN
aji-135	136	28	,	,	PUNCT
aji-135	136	29	et	et	PROPN
aji-135	136	30	cetera	cetera	NOUN
aji-135	137	1	[	[	X
aji-135	137	2	3	3	NUM
aji-135	137	3	]	]	PUNCT
aji-135	137	4	.	.	PUNCT
aji-135	138	1	“	"	PUNCT
aji-135	138	2	chemically	chemically	ADV
aji-135	138	3	designated	designate	VERB
aji-135	138	4	as	as	ADP
aji-135	138	5	alpha	alpha	NOUN
aji-135	138	6	-	-	PUNCT
aji-135	138	7	hydro	hydro	NOUN
aji-135	138	8	-	-	PUNCT
aji-135	138	9	omegahydroxypoly(oxy-1,2	omegahydroxypoly(oxy-1,2	ADJ
aji-135	138	10	-	-	PUNCT
aji-135	138	11	ethanediol	ethanediol	NOUN
aji-135	138	12	)	)	PUNCT
aji-135	138	13	or	or	CCONJ
aji-135	138	14	polyethylene	polyethylene	NOUN
aji-135	138	15	oxides	oxide	NOUN
aji-135	138	16	,	,	PUNCT
aji-135	138	17	pegs	peg	NOUN
aji-135	138	18	are	be	AUX
aji-135	138	19	regulated	regulate	VERB
aji-135	138	20	additives	additive	NOUN
aji-135	138	21	,	,	PUNCT
aji-135	138	22	allowed	allow	VERB
aji-135	138	23	to	to	PART
aji-135	138	24	be	be	AUX
aji-135	138	25	used	use	VERB
aji-135	138	26	as	as	ADP
aji-135	138	27	emulsifiers	emulsifier	NOUN
aji-135	138	28	in	in	ADP
aji-135	138	29	industrialized	industrialize	VERB
aji-135	138	30	food	food	NOUN
aji-135	138	31	and	and	CCONJ
aji-135	138	32	food	food	NOUN
aji-135	138	33	supplements	supplement	NOUN
aji-135	138	34	(	(	PUNCT
aji-135	138	35	e	e	NOUN
aji-135	138	36	1521	1521	NUM
aji-135	138	37	)	)	PUNCT
aji-135	138	38	and	and	CCONJ
aji-135	138	39	as	as	ADP
aji-135	138	40	plasticizers	plasticizer	NOUN
aji-135	138	41	in	in	ADP
aji-135	138	42	film	film	NOUN
aji-135	138	43	coating	coating	NOUN
aji-135	138	44	formulations	formulation	NOUN
aji-135	138	45	for	for	ADP
aji-135	138	46	food	food	NOUN
aji-135	138	47	supplement	supplement	NOUN
aji-135	138	48	tablets	tablet	NOUN
aji-135	138	49	and	and	CCONJ
aji-135	138	50	capsules	capsule	NOUN
aji-135	138	51	”	"	PUNCT
aji-135	139	1	[	[	X
aji-135	139	2	4	4	NUM
aji-135	139	3	]	]	PUNCT
aji-135	139	4	.	.	PUNCT
aji-135	140	1	“	"	PUNCT
aji-135	140	2	pegs	peg	NOUN
aji-135	140	3	are	be	AUX
aji-135	140	4	amphipathic	amphipathic	ADJ
aji-135	140	5	substances	substance	NOUN
aji-135	140	6	soluble	soluble	ADJ
aji-135	140	7	in	in	ADP
aji-135	140	8	water	water	NOUN
aji-135	140	9	and	and	CCONJ
aji-135	140	10	in	in	ADP
aji-135	140	11	many	many	ADJ
aji-135	140	12	organic	organic	ADJ
aji-135	140	13	solvents	solvent	NOUN
aji-135	140	14	,	,	PUNCT
aji-135	140	15	including	include	VERB
aji-135	140	16	aliphatic	aliphatic	ADJ
aji-135	140	17	ketones	ketone	NOUN
aji-135	140	18	,	,	PUNCT
aji-135	140	19	alcohols	alcohol	NOUN
aji-135	140	20	,	,	PUNCT
aji-135	140	21	chloroform	chloroform	NOUN
aji-135	140	22	,	,	PUNCT
aji-135	140	23	glycol	glycol	NOUN
aji-135	140	24	ethers	ether	NOUN
aji-135	140	25	,	,	PUNCT
aji-135	140	26	esters	ester	NOUN
aji-135	140	27	,	,	PUNCT
aji-135	140	28	and	and	CCONJ
aji-135	140	29	aromatic	aromatic	ADJ
aji-135	140	30	hydrocarbons	hydrocarbon	NOUN
aji-135	140	31	.	.	PUNCT
aji-135	141	1	acting	act	VERB
aji-135	141	2	as	as	ADP
aji-135	141	3	emulsifiers	emulsifier	NOUN
aji-135	141	4	,	,	PUNCT
aji-135	141	5	they	they	PRON
aji-135	141	6	prevent	prevent	VERB
aji-135	141	7	the	the	DET
aji-135	141	8	separation	separation	NOUN
aji-135	141	9	of	of	ADP
aji-135	141	10	unstable	unstable	ADJ
aji-135	141	11	water	water	NOUN
aji-135	141	12	/	/	SYM
aji-135	141	13	oil	oil	NOUN
aji-135	141	14	emulsions	emulsion	NOUN
aji-135	141	15	in	in	ADP
aji-135	141	16	industrialized	industrialize	VERB
aji-135	141	17	food	food	NOUN
aji-135	141	18	such	such	ADJ
aji-135	141	19	as	as	ADP
aji-135	141	20	mayonnaise	mayonnaise	NOUN
aji-135	141	21	,	,	PUNCT
aji-135	141	22	dairy	dairy	NOUN
aji-135	141	23	-	-	PUNCT
aji-135	141	24	based	base	VERB
aji-135	141	25	ice	ice	NOUN
aji-135	141	26	cream	cream	NOUN
aji-135	141	27	,	,	PUNCT
aji-135	141	28	frozen	frozen	ADJ
aji-135	141	29	yogurts	yogurt	NOUN
aji-135	141	30	,	,	PUNCT
aji-135	141	31	margarine	margarine	NOUN
aji-135	141	32	,	,	PUNCT
aji-135	141	33	blended	blend	VERB
aji-135	141	34	spreads	spread	NOUN
aji-135	141	35	,	,	PUNCT
aji-135	141	36	cakes	cake	NOUN
aji-135	141	37	,	,	PUNCT
aji-135	141	38	pastries	pastry	NOUN
aji-135	141	39	,	,	PUNCT
aji-135	141	40	and	and	CCONJ
aji-135	141	41	frozen	frozen	ADJ
aji-135	141	42	desserts	dessert	NOUN
aji-135	141	43	”	"	PUNCT
aji-135	141	44	[	[	X
aji-135	141	45	5	5	NUM
aji-135	141	46	]	]	PUNCT
aji-135	141	47	.	.	PUNCT
aji-135	142	1	when	when	SCONJ
aji-135	142	2	used	use	VERB
aji-135	142	3	as	as	ADP
aji-135	142	4	dietary	dietary	ADJ
aji-135	142	5	emulsifiers	emulsifier	NOUN
aji-135	142	6	,	,	PUNCT
aji-135	142	7	pegs	peg	NOUN
aji-135	142	8	may	may	AUX
aji-135	142	9	increase	increase	VERB
aji-135	142	10	intestinal	intestinal	ADJ
aji-135	142	11	permeability	permeability	NOUN
aji-135	142	12	by	by	ADP
aji-135	142	13	interfering	interfere	VERB
aji-135	142	14	with	with	ADP
aji-135	142	15	the	the	DET
aji-135	142	16	physical	physical	ADJ
aji-135	142	17	properties	property	NOUN
aji-135	142	18	of	of	ADP
aji-135	142	19	the	the	DET
aji-135	142	20	mucus	mucus	NOUN
aji-135	142	21	layer	layer	NOUN
aji-135	142	22	,	,	PUNCT
aji-135	142	23	facilitating	facilitate	VERB
aji-135	142	24	the	the	DET
aji-135	142	25	growth	growth	NOUN
aji-135	142	26	of	of	ADP
aji-135	142	27	pro	pro	ADJ
aji-135	142	28	-	-	ADJ
aji-135	142	29	inflammatory	inflammatory	ADJ
aji-135	142	30	intestinal	intestinal	ADJ
aji-135	142	31	microbiota	microbiota	NOUN
aji-135	142	32	and	and	CCONJ
aji-135	142	33	olivier	olivier	NOUN
aji-135	142	34	et	et	PROPN
aji-135	142	35	al	al	PROPN
aji-135	142	36	.	.	PROPN
aji-135	142	37	;	;	PUNCT
aji-135	143	1	asian	asian	PROPN
aji-135	143	2	j.	j.	PROPN
aji-135	143	3	immunol	immunol	PROPN
aji-135	143	4	.	.	PROPN
aji-135	143	5	,	,	PUNCT
aji-135	143	6	vol	vol	NOUN
aji-135	143	7	.	.	PROPN
aji-135	143	8	7	7	NUM
aji-135	143	9	,	,	PUNCT
aji-135	143	10	no	no	INTJ
aji-135	143	11	.	.	NOUN
aji-135	143	12	1	1	NUM
aji-135	143	13	,	,	PUNCT
aji-135	143	14	pp	pp	ADJ
aji-135	143	15	.	.	PUNCT
aji-135	143	16	100	100	NUM
aji-135	143	17	-	-	SYM
aji-135	143	18	111	111	NUM
aji-135	143	19	,	,	PUNCT
aji-135	143	20	2024	2024	NUM
aji-135	143	21	;	;	PUNCT
aji-135	143	22	article	article	NOUN
aji-135	143	23	no.aji.119914	no.aji.119914	PROPN
aji-135	143	24	102	102	NUM
aji-135	143	25	contributing	contribute	VERB
aji-135	143	26	to	to	ADP
aji-135	143	27	the	the	DET
aji-135	143	28	impairment	impairment	NOUN
aji-135	143	29	of	of	ADP
aji-135	143	30	inflammatory	inflammatory	ADJ
aji-135	143	31	intestinal	intestinal	ADJ
aji-135	143	32	diseases	disease	NOUN
aji-135	143	33	and	and	CCONJ
aji-135	143	34	food	food	NOUN
aji-135	143	35	allergies	allergy	NOUN
aji-135	143	36	[	[	X
aji-135	143	37	6,7	6,7	NUM
aji-135	143	38	]	]	PUNCT
aji-135	143	39	.	.	PUNCT
aji-135	144	1	pegs	peg	NOUN
aji-135	144	2	(	(	PUNCT
aji-135	144	3	also	also	ADV
aji-135	144	4	designated	designate	VERB
aji-135	144	5	as	as	ADP
aji-135	144	6	macrogol	macrogol	NOUN
aji-135	144	7	in	in	ADP
aji-135	144	8	pharmacy	pharmacy	NOUN
aji-135	144	9	)	)	PUNCT
aji-135	144	10	are	be	AUX
aji-135	144	11	used	use	VERB
aji-135	144	12	as	as	ADP
aji-135	144	13	vehicles	vehicle	NOUN
aji-135	144	14	for	for	ADP
aji-135	144	15	drugs	drug	NOUN
aji-135	144	16	and	and	CCONJ
aji-135	144	17	ointment	ointment	NOUN
aji-135	144	18	bases	basis	NOUN
aji-135	144	19	,	,	PUNCT
aji-135	144	20	capsules	capsule	NOUN
aji-135	144	21	,	,	PUNCT
aji-135	144	22	tablet	tablet	NOUN
aji-135	144	23	and	and	CCONJ
aji-135	144	24	pill	pill	NOUN
aji-135	144	25	binders	binder	NOUN
aji-135	144	26	,	,	PUNCT
aji-135	144	27	suppositories	suppository	NOUN
aji-135	144	28	,	,	PUNCT
aji-135	144	29	and	and	CCONJ
aji-135	144	30	liquid	liquid	ADJ
aji-135	144	31	prescriptions	prescription	NOUN
aji-135	144	32	,	,	PUNCT
aji-135	144	33	including	include	VERB
aji-135	144	34	parenteral	parenteral	ADJ
aji-135	144	35	,	,	PUNCT
aji-135	144	36	topical	topical	ADJ
aji-135	144	37	,	,	PUNCT
aji-135	144	38	ophthalmic	ophthalmic	ADJ
aji-135	144	39	,	,	PUNCT
aji-135	144	40	oral	oral	ADJ
aji-135	144	41	,	,	PUNCT
aji-135	144	42	and	and	CCONJ
aji-135	144	43	rectal	rectal	ADJ
aji-135	144	44	preparations	preparation	NOUN
aji-135	144	45	.	.	PUNCT
aji-135	145	1	they	they	PRON
aji-135	145	2	also	also	ADV
aji-135	145	3	prevent	prevent	VERB
aji-135	145	4	protein	protein	NOUN
aji-135	145	5	aggregation	aggregation	NOUN
aji-135	145	6	and	and	CCONJ
aji-135	145	7	inactivation	inactivation	NOUN
aji-135	145	8	of	of	ADP
aji-135	145	9	pharmaceutical	pharmaceutical	ADJ
aji-135	145	10	proteins	protein	NOUN
aji-135	145	11	encapsulated	encapsulate	VERB
aji-135	145	12	in	in	ADP
aji-135	145	13	bioerodible	bioerodible	ADJ
aji-135	145	14	polyester	polyester	NOUN
aji-135	145	15	microspheres	microsphere	NOUN
aji-135	145	16	,	,	PUNCT
aji-135	145	17	acting	act	VERB
aji-135	145	18	as	as	ADP
aji-135	145	19	stabilizers	stabilizer	NOUN
aji-135	145	20	[	[	X
aji-135	145	21	8	8	NUM
aji-135	145	22	]	]	PUNCT
aji-135	145	23	.	.	PUNCT
aji-135	146	1	pegylation	pegylation	NOUN
aji-135	146	2	(	(	PUNCT
aji-135	146	3	or	or	CCONJ
aji-135	146	4	pegylation	pegylation	NOUN
aji-135	146	5	)	)	PUNCT
aji-135	146	6	is	be	AUX
aji-135	146	7	a	a	DET
aji-135	146	8	process	process	NOUN
aji-135	146	9	developed	develop	VERB
aji-135	146	10	in	in	ADP
aji-135	146	11	the	the	DET
aji-135	146	12	1970s	1970	NOUN
aji-135	146	13	to	to	ADP
aji-135	146	14	covalent	covalent	NOUN
aji-135	146	15	or	or	CCONJ
aji-135	146	16	noncovalently	noncovalently	ADV
aji-135	146	17	attach	attach	VERB
aji-135	146	18	peg	peg	NOUN
aji-135	146	19	polymers	polymer	NOUN
aji-135	146	20	to	to	ADP
aji-135	146	21	molecules	molecule	NOUN
aji-135	146	22	,	,	PUNCT
aji-135	146	23	such	such	ADJ
aji-135	146	24	as	as	ADP
aji-135	146	25	drugs	drug	NOUN
aji-135	146	26	,	,	PUNCT
aji-135	146	27	therapeutic	therapeutic	ADJ
aji-135	146	28	proteins	protein	NOUN
aji-135	146	29	,	,	PUNCT
aji-135	146	30	peptides	peptide	NOUN
aji-135	146	31	,	,	PUNCT
aji-135	146	32	antibody	antibody	NOUN
aji-135	146	33	fragments	fragment	NOUN
aji-135	146	34	,	,	PUNCT
aji-135	146	35	and	and	CCONJ
aji-135	146	36	vesicles	vesicle	NOUN
aji-135	146	37	,	,	PUNCT
aji-135	146	38	then	then	ADV
aji-135	146	39	described	describe	VERB
aji-135	146	40	as	as	ADP
aji-135	146	41	“	"	PUNCT
aji-135	146	42	pegylated	pegylate	VERB
aji-135	146	43	”	"	PUNCT
aji-135	147	1	[	[	X
aji-135	147	2	9	9	NUM
aji-135	147	3	]	]	PUNCT
aji-135	147	4	.	.	PUNCT
aji-135	148	1	“	"	PUNCT
aji-135	148	2	pegylation	pegylation	NOUN
aji-135	148	3	changes	change	VERB
aji-135	148	4	the	the	DET
aji-135	148	5	physical	physical	ADJ
aji-135	148	6	and	and	CCONJ
aji-135	148	7	chemical	chemical	NOUN
aji-135	148	8	properties	property	NOUN
aji-135	148	9	of	of	ADP
aji-135	148	10	the	the	DET
aji-135	148	11	biomedical	biomedical	ADJ
aji-135	148	12	molecule	molecule	NOUN
aji-135	148	13	,	,	PUNCT
aji-135	148	14	such	such	ADJ
aji-135	148	15	as	as	ADP
aji-135	148	16	its	its	PRON
aji-135	148	17	conformation	conformation	NOUN
aji-135	148	18	,	,	PUNCT
aji-135	148	19	electrostatic	electrostatic	ADJ
aji-135	148	20	binding	binding	NOUN
aji-135	148	21	,	,	PUNCT
aji-135	148	22	and	and	CCONJ
aji-135	148	23	hydrophobicity	hydrophobicity	NOUN
aji-135	148	24	,	,	PUNCT
aji-135	148	25	resulting	result	VERB
aji-135	148	26	in	in	ADP
aji-135	148	27	an	an	DET
aji-135	148	28	improvement	improvement	NOUN
aji-135	148	29	of	of	ADP
aji-135	148	30	the	the	DET
aji-135	148	31	pharmacokinetic	pharmacokinetic	ADJ
aji-135	148	32	behavior	behavior	NOUN
aji-135	148	33	of	of	ADP
aji-135	148	34	the	the	DET
aji-135	148	35	drug	drug	NOUN
aji-135	148	36	,	,	PUNCT
aji-135	148	37	reducing	reduce	VERB
aji-135	148	38	coalescence	coalescence	NOUN
aji-135	148	39	,	,	PUNCT
aji-135	148	40	degradation	degradation	NOUN
aji-135	148	41	and	and	CCONJ
aji-135	148	42	in	in	ADP
aji-135	148	43	vivo	vivo	ADJ
aji-135	148	44	elimination	elimination	NOUN
aji-135	148	45	of	of	ADP
aji-135	148	46	the	the	DET
aji-135	148	47	active	active	ADJ
aji-135	148	48	pharmacological	pharmacological	ADJ
aji-135	148	49	principles	principle	NOUN
aji-135	148	50	”	"	PUNCT
aji-135	148	51	[	[	X
aji-135	148	52	10	10	NUM
aji-135	148	53	-	-	SYM
aji-135	148	54	12	12	NUM
aji-135	148	55	]	]	PUNCT
aji-135	148	56	.	.	PUNCT
aji-135	149	1	“	"	PUNCT
aji-135	149	2	pegylated	pegylate	VERB
aji-135	149	3	products	product	NOUN
aji-135	149	4	can	can	AUX
aji-135	149	5	induce	induce	VERB
aji-135	149	6	anti	anti	ADJ
aji-135	149	7	-	-	ADJ
aji-135	149	8	peg	peg	ADJ
aji-135	149	9	antibody	antibody	NOUN
aji-135	149	10	production	production	NOUN
aji-135	149	11	associated	associate	VERB
aji-135	149	12	with	with	ADP
aji-135	149	13	type	type	NOUN
aji-135	149	14	iii	iii	NUM
aji-135	149	15	complement	complement	NOUN
aji-135	149	16	-	-	PUNCT
aji-135	149	17	activated	activate	VERB
aji-135	149	18	immunoreactivity	immunoreactivity	NOUN
aji-135	149	19	”	"	PUNCT
aji-135	149	20	[	[	X
aji-135	149	21	13	13	NUM
aji-135	149	22	]	]	PUNCT
aji-135	149	23	.	.	PUNCT
aji-135	150	1	“	"	PUNCT
aji-135	150	2	lower	low	ADJ
aji-135	150	3	molecular	molecular	ADJ
aji-135	150	4	weight	weight	NOUN
aji-135	150	5	pegs	peg	NOUN
aji-135	150	6	are	be	AUX
aji-135	150	7	absorbed	absorb	VERB
aji-135	150	8	by	by	ADP
aji-135	150	9	the	the	DET
aji-135	150	10	digestive	digestive	ADJ
aji-135	150	11	tract	tract	NOUN
aji-135	150	12	and	and	CCONJ
aji-135	150	13	excreted	excrete	VERB
aji-135	150	14	in	in	ADP
aji-135	150	15	the	the	DET
aji-135	150	16	urine	urine	NOUN
aji-135	150	17	;	;	PUNCT
aji-135	150	18	however	however	ADV
aji-135	150	19	,	,	PUNCT
aji-135	150	20	high	high	ADJ
aji-135	150	21	molecular	molecular	ADJ
aji-135	150	22	weight	weight	NOUN
aji-135	150	23	pegs	peg	NOUN
aji-135	150	24	are	be	AUX
aji-135	150	25	not	not	PART
aji-135	150	26	absorbed	absorb	VERB
aji-135	150	27	and	and	CCONJ
aji-135	150	28	form	form	VERB
aji-135	150	29	hydrogen	hydrogen	NOUN
aji-135	150	30	bonds	bond	NOUN
aji-135	150	31	with	with	ADP
aji-135	150	32	water	water	NOUN
aji-135	150	33	in	in	ADP
aji-135	150	34	the	the	DET
aji-135	150	35	gastrointestinal	gastrointestinal	ADJ
aji-135	150	36	tract	tract	NOUN
aji-135	150	37	,	,	PUNCT
aji-135	150	38	where	where	SCONJ
aji-135	150	39	they	they	PRON
aji-135	150	40	hydrate	hydrate	VERB
aji-135	150	41	stools	stool	NOUN
aji-135	150	42	”	"	PUNCT
aji-135	151	1	[	[	X
aji-135	151	2	14	14	NUM
aji-135	151	3	]	]	PUNCT
aji-135	151	4	.	.	PUNCT
aji-135	152	1	long	long	ADJ
aji-135	152	2	-	-	PUNCT
aji-135	152	3	chain	chain	NOUN
aji-135	152	4	pegs	peg	NOUN
aji-135	152	5	are	be	AUX
aji-135	152	6	laxative	laxative	ADJ
aji-135	152	7	medications	medication	NOUN
aji-135	152	8	in	in	ADP
aji-135	152	9	isosmotic	isosmotic	ADJ
aji-135	152	10	balanced	balanced	ADJ
aji-135	152	11	electrolyte	electrolyte	ADJ
aji-135	152	12	preparations	preparation	NOUN
aji-135	152	13	[	[	X
aji-135	152	14	15	15	NUM
aji-135	152	15	]	]	PUNCT
aji-135	152	16	.	.	PUNCT
aji-135	153	1	pegs	peg	NOUN
aji-135	153	2	are	be	AUX
aji-135	153	3	also	also	ADV
aji-135	153	4	used	use	VERB
aji-135	153	5	in	in	ADP
aji-135	153	6	topical	topical	ADJ
aji-135	153	7	dermatological	dermatological	ADJ
aji-135	153	8	preparations	preparation	NOUN
aji-135	153	9	as	as	ADP
aji-135	153	10	penetration	penetration	NOUN
aji-135	153	11	enhancers	enhancer	NOUN
aji-135	153	12	[	[	X
aji-135	153	13	16	16	NUM
aji-135	153	14	]	]	PUNCT
aji-135	153	15	.	.	PUNCT
aji-135	154	1	pegs	peg	NOUN
aji-135	154	2	and	and	CCONJ
aji-135	154	3	their	their	PRON
aji-135	154	4	derivatives	derivative	NOUN
aji-135	154	5	(	(	PUNCT
aji-135	154	6	laureth	laureth	NOUN
aji-135	154	7	,	,	PUNCT
aji-135	154	8	ceteth	ceteth	PROPN
aji-135	154	9	,	,	PUNCT
aji-135	154	10	ceteareth	ceteareth	ADJ
aji-135	154	11	,	,	PUNCT
aji-135	154	12	steareth	steareth	PROPN
aji-135	154	13	,	,	PUNCT
aji-135	154	14	oleth	oleth	PROPN
aji-135	154	15	,	,	PUNCT
aji-135	154	16	laurate	laurate	NOUN
aji-135	154	17	,	,	PUNCT
aji-135	154	18	dilaurate	dilaurate	ADJ
aji-135	154	19	,	,	PUNCT
aji-135	154	20	stearate	stearate	NOUN
aji-135	154	21	,	,	PUNCT
aji-135	154	22	distearate	distearate	NOUN
aji-135	154	23	)	)	PUNCT
aji-135	154	24	do	do	AUX
aji-135	154	25	not	not	PART
aji-135	154	26	readily	readily	ADV
aji-135	154	27	penetrate	penetrate	VERB
aji-135	154	28	intact	intact	ADJ
aji-135	154	29	skin	skin	NOUN
aji-135	154	30	and	and	CCONJ
aji-135	154	31	are	be	AUX
aji-135	154	32	added	add	VERB
aji-135	154	33	to	to	ADP
aji-135	154	34	a	a	DET
aji-135	154	35	great	great	ADJ
aji-135	154	36	variety	variety	NOUN
aji-135	154	37	of	of	ADP
aji-135	154	38	cosmetic	cosmetic	ADJ
aji-135	154	39	applications	application	NOUN
aji-135	154	40	as	as	ADP
aji-135	154	41	surfactants	surfactant	NOUN
aji-135	154	42	,	,	PUNCT
aji-135	154	43	cleansing	cleansing	NOUN
aji-135	154	44	agents	agent	NOUN
aji-135	154	45	,	,	PUNCT
aji-135	154	46	emulsifiers	emulsifier	NOUN
aji-135	154	47	,	,	PUNCT
aji-135	154	48	skin	skin	NOUN
aji-135	154	49	conditioners	conditioner	NOUN
aji-135	154	50	,	,	PUNCT
aji-135	154	51	and	and	CCONJ
aji-135	154	52	humectants	humectant	NOUN
aji-135	154	53	[	[	X
aji-135	154	54	17	17	NUM
aji-135	154	55	]	]	PUNCT
aji-135	154	56	.	.	PUNCT
aji-135	155	1	however	however	ADV
aji-135	155	2	,	,	PUNCT
aji-135	155	3	absorption	absorption	NOUN
aji-135	155	4	through	through	ADP
aji-135	155	5	damaged	damage	VERB
aji-135	155	6	skin	skin	NOUN
aji-135	155	7	of	of	ADP
aji-135	155	8	pegs	peg	NOUN
aji-135	155	9	present	present	ADJ
aji-135	155	10	in	in	ADP
aji-135	155	11	burn	burn	NOUN
aji-135	155	12	creams	cream	NOUN
aji-135	155	13	was	be	AUX
aji-135	155	14	associated	associate	VERB
aji-135	155	15	with	with	ADP
aji-135	155	16	fatal	fatal	ADJ
aji-135	155	17	intoxication	intoxication	NOUN
aji-135	155	18	in	in	ADP
aji-135	155	19	burned	burn	VERB
aji-135	155	20	patients	patient	NOUN
aji-135	155	21	characterized	characterize	VERB
aji-135	155	22	by	by	ADP
aji-135	155	23	acute	acute	ADJ
aji-135	155	24	renal	renal	ADJ
aji-135	155	25	failure	failure	NOUN
aji-135	155	26	and	and	CCONJ
aji-135	155	27	metabolic	metabolic	NOUN
aji-135	155	28	acidosis	acidosis	NOUN
aji-135	155	29	with	with	ADP
aji-135	155	30	increased	increase	VERB
aji-135	155	31	calcium	calcium	NOUN
aji-135	155	32	,	,	PUNCT
aji-135	155	33	anion	anion	NOUN
aji-135	155	34	,	,	PUNCT
aji-135	155	35	and	and	CCONJ
aji-135	155	36	osmolar	osmolar	ADJ
aji-135	155	37	gap	gap	NOUN
aji-135	155	38	[	[	X
aji-135	155	39	18	18	NUM
aji-135	155	40	]	]	PUNCT
aji-135	155	41	.	.	PUNCT
aji-135	156	1	allergic	allergic	ADJ
aji-135	156	2	reactions	reaction	NOUN
aji-135	156	3	due	due	ADP
aji-135	156	4	to	to	ADP
aji-135	156	5	pegs	peg	NOUN
aji-135	156	6	used	use	VERB
aji-135	156	7	as	as	ADP
aji-135	156	8	excipients	excipient	NOUN
aji-135	156	9	have	have	AUX
aji-135	156	10	already	already	ADV
aji-135	156	11	been	be	AUX
aji-135	156	12	reported	report	VERB
aji-135	156	13	[	[	X
aji-135	156	14	19	19	NUM
aji-135	156	15	]	]	PUNCT
aji-135	156	16	.	.	PUNCT
aji-135	157	1	pharmaceutical	pharmaceutical	ADJ
aji-135	157	2	excipients	excipient	NOUN
aji-135	157	3	are	be	AUX
aji-135	157	4	a	a	DET
aji-135	157	5	hidden	hide	VERB
aji-135	157	6	potential	potential	ADJ
aji-135	157	7	cause	cause	NOUN
aji-135	157	8	of	of	ADP
aji-135	157	9	drug	drug	NOUN
aji-135	157	10	and	and	CCONJ
aji-135	157	11	vaccine	vaccine	NOUN
aji-135	157	12	hypersensitivity	hypersensitivity	NOUN
aji-135	157	13	reactions	reaction	NOUN
aji-135	157	14	[	[	X
aji-135	157	15	20	20	NUM
aji-135	157	16	]	]	PUNCT
aji-135	157	17	.	.	PUNCT
aji-135	158	1	allergic	allergic	ADJ
aji-135	158	2	reactions	reaction	NOUN
aji-135	158	3	to	to	ADP
aji-135	158	4	pegs	peg	NOUN
aji-135	158	5	were	be	AUX
aji-135	158	6	put	put	VERB
aji-135	158	7	into	into	ADP
aji-135	158	8	evidence	evidence	NOUN
aji-135	158	9	,	,	PUNCT
aji-135	158	10	particularly	particularly	ADV
aji-135	158	11	after	after	SCONJ
aji-135	158	12	pfizerbiontech	pfizerbiontech	ADJ
aji-135	158	13	®	®	NOUN
aji-135	158	14	and	and	CCONJ
aji-135	158	15	moderna	moderna	PROPN
aji-135	158	16	®	®	PROPN
aji-135	158	17	mrna	mrna	PROPN
aji-135	158	18	covid-19	covid-19	PROPN
aji-135	158	19	vaccines	vaccine	NOUN
aji-135	158	20	were	be	AUX
aji-135	158	21	approved	approve	VERB
aji-135	158	22	for	for	ADP
aji-135	158	23	mass	mass	ADJ
aji-135	158	24	vaccination	vaccination	NOUN
aji-135	159	1	[	[	X
aji-135	159	2	21,22	21,22	X
aji-135	159	3	]	]	X
aji-135	159	4	.	.	PUNCT
aji-135	160	1	endotyping	endotype	VERB
aji-135	160	2	pharmaceutical	pharmaceutical	ADJ
aji-135	160	3	excipient	excipient	NOUN
aji-135	160	4	immunoreactivity	immunoreactivity	PROPN
aji-135	160	5	has	have	AUX
aji-135	160	6	become	become	VERB
aji-135	160	7	a	a	DET
aji-135	160	8	herculean	herculean	ADJ
aji-135	160	9	task	task	NOUN
aji-135	160	10	due	due	ADP
aji-135	160	11	to	to	ADP
aji-135	160	12	the	the	DET
aji-135	160	13	variety	variety	NOUN
aji-135	160	14	and	and	CCONJ
aji-135	160	15	diversity	diversity	NOUN
aji-135	160	16	of	of	ADP
aji-135	160	17	formulations	formulation	NOUN
aji-135	160	18	,	,	PUNCT
aji-135	160	19	mainly	mainly	ADV
aji-135	160	20	after	after	ADP
aji-135	160	21	the	the	DET
aji-135	160	22	appearance	appearance	NOUN
aji-135	160	23	of	of	ADP
aji-135	160	24	the	the	DET
aji-135	160	25	pegylated	pegylate	VERB
aji-135	160	26	lipid	lipid	NOUN
aji-135	160	27	nanoparticle	nanoparticle	NOUN
aji-135	160	28	vaccines	vaccine	NOUN
aji-135	160	29	[	[	X
aji-135	160	30	23	23	NUM
aji-135	160	31	]	]	PUNCT
aji-135	160	32	.	.	PUNCT
aji-135	161	1	pegs	peg	NOUN
aji-135	161	2	are	be	AUX
aji-135	161	3	the	the	DET
aji-135	161	4	most	most	ADV
aji-135	161	5	popular	popular	ADJ
aji-135	161	6	nanomedicine	nanomedicine	ADJ
aji-135	161	7	components	component	NOUN
aji-135	161	8	due	due	ADP
aji-135	161	9	to	to	ADP
aji-135	161	10	their	their	PRON
aji-135	161	11	chemical	chemical	NOUN
aji-135	161	12	properties	property	NOUN
aji-135	161	13	[	[	X
aji-135	161	14	24	24	NUM
aji-135	161	15	]	]	PUNCT
aji-135	161	16	.	.	PUNCT
aji-135	162	1	the	the	DET
aji-135	162	2	ige	ige	PROPN
aji-135	162	3	-	-	PUNCT
aji-135	162	4	mediated	mediate	VERB
aji-135	162	5	anaphylaxis	anaphylaxis	NOUN
aji-135	162	6	elicited	elicit	VERB
aji-135	162	7	by	by	ADP
aji-135	162	8	pegs	pegs	NOUN
aji-135	162	9	excipients	excipient	NOUN
aji-135	162	10	was	be	AUX
aji-135	162	11	the	the	DET
aji-135	162	12	first	first	ADJ
aji-135	162	13	and	and	CCONJ
aji-135	162	14	easiest	easy	ADJ
aji-135	162	15	endotype	endotype	NOUN
aji-135	162	16	to	to	PART
aji-135	162	17	diagnose	diagnose	VERB
aji-135	162	18	[	[	X
aji-135	162	19	25,26	25,26	NUM
aji-135	162	20	]	]	PUNCT
aji-135	162	21	.	.	PUNCT
aji-135	163	1	skin	skin	NOUN
aji-135	163	2	and	and	CCONJ
aji-135	163	3	basophil	basophil	NOUN
aji-135	163	4	activation	activation	NOUN
aji-135	163	5	tests	test	NOUN
aji-135	163	6	are	be	AUX
aji-135	163	7	the	the	DET
aji-135	163	8	most	most	ADV
aji-135	163	9	available	available	ADJ
aji-135	163	10	assays	assay	NOUN
aji-135	163	11	to	to	PART
aji-135	163	12	identify	identify	VERB
aji-135	163	13	immediate	immediate	ADJ
aji-135	163	14	and/or	and/or	CCONJ
aji-135	163	15	ige	ige	NOUN
aji-135	163	16	-	-	PUNCT
aji-135	163	17	mediate	mediate	ADJ
aji-135	163	18	allergy	allergy	NOUN
aji-135	163	19	to	to	ADP
aji-135	163	20	pegs	pegs	NOUN
aji-135	163	21	[	[	X
aji-135	163	22	27	27	NUM
aji-135	163	23	]	]	PUNCT
aji-135	163	24	.	.	PUNCT
aji-135	164	1	however	however	ADV
aji-135	164	2	,	,	PUNCT
aji-135	164	3	intradermal	intradermal	ADJ
aji-135	164	4	skin	skin	NOUN
aji-135	164	5	tests	test	NOUN
aji-135	164	6	performed	perform	VERB
aji-135	164	7	with	with	ADP
aji-135	164	8	pegs	peg	NOUN
aji-135	164	9	may	may	AUX
aji-135	164	10	produce	produce	VERB
aji-135	164	11	immediate	immediate	ADJ
aji-135	164	12	anaphylactic	anaphylactic	ADJ
aji-135	164	13	reactions	reaction	NOUN
aji-135	164	14	,	,	PUNCT
aji-135	164	15	which	which	PRON
aji-135	164	16	makes	make	VERB
aji-135	164	17	the	the	DET
aji-135	164	18	percutaneous	percutaneous	ADJ
aji-135	164	19	route	route	NOUN
aji-135	164	20	a	a	DET
aji-135	164	21	more	more	ADV
aji-135	164	22	secure	secure	ADJ
aji-135	164	23	way	way	NOUN
aji-135	164	24	to	to	PART
aji-135	164	25	perform	perform	VERB
aji-135	164	26	in	in	ADP
aji-135	164	27	vivo	vivo	ADJ
aji-135	164	28	challenges	challenge	NOUN
aji-135	164	29	[	[	X
aji-135	164	30	28	28	NUM
aji-135	164	31	]	]	PUNCT
aji-135	164	32	.	.	PUNCT
aji-135	165	1	at	at	ADP
aji-135	165	2	our	our	PRON
aji-135	165	3	facilities	facility	NOUN
aji-135	165	4	,	,	PUNCT
aji-135	165	5	we	we	PRON
aji-135	165	6	had	have	AUX
aji-135	165	7	performed	perform	VERB
aji-135	165	8	hundreds	hundred	NOUN
aji-135	165	9	of	of	ADP
aji-135	165	10	skin	skin	NOUN
aji-135	165	11	tests	test	NOUN
aji-135	165	12	with	with	ADP
aji-135	165	13	pegs	peg	NOUN
aji-135	165	14	employing	employ	VERB
aji-135	165	15	the	the	DET
aji-135	165	16	skin	skin	NOUN
aji-135	165	17	scrape	scrape	NOUN
aji-135	165	18	test	test	NOUN
aji-135	165	19	technique	technique	NOUN
aji-135	165	20	with	with	ADP
aji-135	165	21	no	no	DET
aji-135	165	22	systemic	systemic	ADJ
aji-135	165	23	reaction	reaction	NOUN
aji-135	165	24	,	,	PUNCT
aji-135	165	25	despite	despite	SCONJ
aji-135	165	26	dozens	dozen	NOUN
aji-135	165	27	of	of	ADP
aji-135	165	28	positive	positive	ADJ
aji-135	165	29	wheal	wheal	ADJ
aji-135	165	30	-	-	PUNCT
aji-135	165	31	andflare	andflare	NOUN
aji-135	165	32	local	local	ADJ
aji-135	165	33	diagnostic	diagnostic	ADJ
aji-135	165	34	reactions	reaction	NOUN
aji-135	165	35	elicited	elicit	VERB
aji-135	165	36	by	by	ADP
aji-135	165	37	pegs	peg	NOUN
aji-135	165	38	[	[	X
aji-135	165	39	29	29	NUM
aji-135	165	40	]	]	PUNCT
aji-135	165	41	.	.	PUNCT
aji-135	166	1	a	a	DET
aji-135	166	2	dual	dual	ADJ
aji-135	166	3	cytometric	cytometric	ADJ
aji-135	166	4	bead	bead	NOUN
aji-135	166	5	assay	assay	NOUN
aji-135	166	6	(	(	PUNCT
aji-135	166	7	dcba	dcba	NOUN
aji-135	166	8	)	)	PUNCT
aji-135	166	9	was	be	AUX
aji-135	166	10	recently	recently	ADV
aji-135	166	11	described	describe	VERB
aji-135	166	12	for	for	ADP
aji-135	166	13	detecting	detect	VERB
aji-135	166	14	anti	anti	ADJ
aji-135	166	15	-	-	ADJ
aji-135	166	16	peg	peg	ADJ
aji-135	166	17	igg	igg	PROPN
aji-135	166	18	,	,	PUNCT
aji-135	166	19	igm	igm	PROPN
aji-135	166	20	,	,	PUNCT
aji-135	166	21	and	and	CCONJ
aji-135	166	22	ige	ige	PROPN
aji-135	166	23	in	in	ADP
aji-135	166	24	patient	patient	ADJ
aji-135	166	25	sera	sera	NOUN
aji-135	167	1	[	[	X
aji-135	167	2	30	30	NUM
aji-135	167	3	]	]	PUNCT
aji-135	167	4	.	.	PUNCT
aji-135	168	1	besides	besides	SCONJ
aji-135	168	2	the	the	DET
aji-135	168	3	type	type	NOUN
aji-135	168	4	i	i	PRON
aji-135	168	5	ige	ige	NOUN
aji-135	168	6	-	-	PUNCT
aji-135	168	7	mediated	mediate	VERB
aji-135	168	8	hypersensitivity	hypersensitivity	NOUN
aji-135	168	9	reaction	reaction	NOUN
aji-135	168	10	,	,	PUNCT
aji-135	168	11	several	several	ADJ
aji-135	168	12	other	other	ADJ
aji-135	168	13	mechanisms	mechanism	NOUN
aji-135	168	14	have	have	AUX
aji-135	168	15	been	be	AUX
aji-135	168	16	proposed	propose	VERB
aji-135	168	17	,	,	PUNCT
aji-135	168	18	such	such	ADJ
aji-135	168	19	as	as	SCONJ
aji-135	168	20	igg	igg	NOUN
aji-135	168	21	-	-	PUNCT
aji-135	168	22	mediated	mediate	VERB
aji-135	168	23	anaphylaxis	anaphylaxis	ADJ
aji-135	168	24	(	(	PUNCT
aji-135	168	25	complement	complement	NOUN
aji-135	168	26	-	-	PUNCT
aji-135	168	27	related	relate	VERB
aji-135	168	28	or	or	CCONJ
aji-135	168	29	not	not	PART
aji-135	168	30	)	)	PUNCT
aji-135	168	31	and	and	CCONJ
aji-135	168	32	direct	direct	ADJ
aji-135	168	33	mast	mast	NOUN
aji-135	168	34	cell	cell	NOUN
aji-135	168	35	activation	activation	NOUN
aji-135	168	36	[	[	X
aji-135	168	37	31	31	NUM
aji-135	168	38	]	]	PUNCT
aji-135	168	39	.	.	PUNCT
aji-135	169	1	the	the	DET
aji-135	169	2	production	production	NOUN
aji-135	169	3	of	of	ADP
aji-135	169	4	anti	anti	ADJ
aji-135	169	5	-	-	ADJ
aji-135	169	6	poly	poly	ADJ
aji-135	169	7	(	(	PUNCT
aji-135	169	8	ethylene	ethylene	NOUN
aji-135	169	9	glycol	glycol	NOUN
aji-135	169	10	)	)	PUNCT
aji-135	169	11	antibodies	antibodie	VERB
aji-135	169	12	,	,	PUNCT
aji-135	169	13	besides	besides	SCONJ
aji-135	169	14	provoking	provoke	VERB
aji-135	169	15	hypersensitivity	hypersensitivity	NOUN
aji-135	169	16	reactions	reaction	NOUN
aji-135	169	17	,	,	PUNCT
aji-135	169	18	can	can	AUX
aji-135	169	19	also	also	ADV
aji-135	169	20	be	be	AUX
aji-135	169	21	problematic	problematic	ADJ
aji-135	169	22	when	when	SCONJ
aji-135	169	23	a	a	DET
aji-135	169	24	pegylated	pegylated	ADJ
aji-135	169	25	drug	drug	NOUN
aji-135	169	26	is	be	AUX
aji-135	169	27	administered	administer	VERB
aji-135	169	28	,	,	PUNCT
aji-135	169	29	accelerating	accelerate	VERB
aji-135	169	30	drug	drug	NOUN
aji-135	169	31	clearance	clearance	NOUN
aji-135	169	32	and	and	CCONJ
aji-135	169	33	decreasing	decrease	VERB
aji-135	169	34	its	its	PRON
aji-135	169	35	therapeutic	therapeutic	ADJ
aji-135	169	36	efficacy	efficacy	NOUN
aji-135	170	1	[	[	X
aji-135	170	2	32,33	32,33	NUM
aji-135	170	3	]	]	PUNCT
aji-135	170	4	.	.	PUNCT
aji-135	171	1	covid-19	covid-19	PROPN
aji-135	171	2	mrna	mrna	PROPN
aji-135	171	3	vaccination	vaccination	NOUN
aji-135	171	4	is	be	AUX
aji-135	171	5	associated	associate	VERB
aji-135	171	6	with	with	ADP
aji-135	171	7	elevated	elevated	ADJ
aji-135	171	8	levels	level	NOUN
aji-135	171	9	of	of	ADP
aji-135	171	10	vaccine	vaccine	NOUN
aji-135	171	11	-	-	PUNCT
aji-135	171	12	induced	induce	VERB
aji-135	171	13	anti	anti	ADJ
aji-135	171	14	-	-	ADJ
aji-135	171	15	pegs	pegs	ADJ
aji-135	171	16	antibodies	antibody	NOUN
aji-135	171	17	and	and	CCONJ
aji-135	171	18	increased	increase	VERB
aji-135	171	19	systemic	systemic	ADJ
aji-135	171	20	reactogenicity	reactogenicity	NOUN
aji-135	172	1	[	[	X
aji-135	172	2	34	34	NUM
aji-135	172	3	]	]	PUNCT
aji-135	172	4	.	.	PUNCT
aji-135	173	1	pegs	peg	NOUN
aji-135	173	2	excipients	excipient	NOUN
aji-135	173	3	are	be	AUX
aji-135	173	4	also	also	ADV
aji-135	173	5	suspected	suspect	VERB
aji-135	173	6	to	to	PART
aji-135	173	7	elicit	elicit	VERB
aji-135	173	8	life	life	NOUN
aji-135	173	9	-	-	PUNCT
aji-135	173	10	threatening	threaten	VERB
aji-135	173	11	immuneinduced	immuneinduced	ADJ
aji-135	173	12	organ	organ	NOUN
aji-135	173	13	-	-	PUNCT
aji-135	173	14	specific	specific	ADJ
aji-135	173	15	reactions	reaction	NOUN
aji-135	173	16	such	such	ADJ
aji-135	173	17	as	as	ADP
aji-135	173	18	acute	acute	ADJ
aji-135	173	19	pancreatitis	pancreatitis	NOUN
aji-135	173	20	,	,	PUNCT
aji-135	173	21	acute	acute	ADJ
aji-135	173	22	interstitial	interstitial	ADJ
aji-135	173	23	nephritis	nephritis	NOUN
aji-135	173	24	,	,	PUNCT
aji-135	173	25	and	and	CCONJ
aji-135	173	26	liver	liver	NOUN
aji-135	173	27	injury	injury	NOUN
aji-135	173	28	[	[	X
aji-135	173	29	35	35	NUM
aji-135	173	30	]	]	PUNCT
aji-135	173	31	.	.	PUNCT
aji-135	174	1	we	we	PRON
aji-135	174	2	routinely	routinely	ADV
aji-135	174	3	employ	employ	VERB
aji-135	174	4	the	the	DET
aji-135	174	5	leukocyte	leukocyte	NOUN
aji-135	174	6	adherence	adherence	NOUN
aji-135	174	7	inhibition	inhibition	NOUN
aji-135	174	8	test	test	NOUN
aji-135	174	9	(	(	PUNCT
aji-135	174	10	lait	lait	NOUN
aji-135	174	11	)	)	PUNCT
aji-135	174	12	and	and	CCONJ
aji-135	174	13	the	the	DET
aji-135	174	14	tube	tube	NOUN
aji-135	174	15	titration	titration	NOUN
aji-135	174	16	of	of	ADP
aji-135	174	17	precipitins	precipitin	NOUN
aji-135	174	18	(	(	PUNCT
aji-135	174	19	ttp	ttp	X
aji-135	174	20	)	)	PUNCT
aji-135	174	21	in	in	ADP
aji-135	174	22	our	our	PRON
aji-135	174	23	facilities	facility	NOUN
aji-135	174	24	as	as	ADP
aji-135	174	25	a	a	DET
aji-135	174	26	triage	triage	NOUN
aji-135	174	27	to	to	PART
aji-135	174	28	evaluate	evaluate	VERB
aji-135	174	29	non	non	ADJ
aji-135	174	30	–	–	PUNCT
aji-135	174	31	ige	ige	ADJ
aji-135	174	32	-	-	PUNCT
aji-135	174	33	mediated	mediate	VERB
aji-135	174	34	immunoreactivity	immunoreactivity	NOUN
aji-135	174	35	against	against	ADP
aji-135	174	36	suspected	suspect	VERB
aji-135	174	37	allergens	allergen	NOUN
aji-135	174	38	before	before	ADP
aji-135	174	39	the	the	DET
aji-135	174	40	performance	performance	NOUN
aji-135	174	41	of	of	ADP
aji-135	174	42	more	more	ADV
aji-135	174	43	exhaustive	exhaustive	ADJ
aji-135	174	44	in	in	ADP
aji-135	174	45	vivo	vivo	ADJ
aji-135	174	46	provocation	provocation	NOUN
aji-135	174	47	tests	test	NOUN
aji-135	174	48	[	[	X
aji-135	174	49	36	36	NUM
aji-135	174	50	-	-	SYM
aji-135	174	51	42	42	NUM
aji-135	174	52	]	]	PUNCT
aji-135	174	53	.	.	PUNCT
aji-135	175	1	the	the	DET
aji-135	175	2	present	present	ADJ
aji-135	175	3	study	study	NOUN
aji-135	175	4	hypothesizes	hypothesize	VERB
aji-135	175	5	that	that	SCONJ
aji-135	175	6	the	the	DET
aji-135	175	7	lait	lait	NOUN
aji-135	175	8	and	and	CCONJ
aji-135	175	9	the	the	DET
aji-135	175	10	ttp	ttp	PROPN
aji-135	175	11	may	may	AUX
aji-135	175	12	olivier	olivier	VERB
aji-135	175	13	et	et	PROPN
aji-135	175	14	al	al	PROPN
aji-135	175	15	.	.	PROPN
aji-135	175	16	;	;	PUNCT
aji-135	176	1	asian	asian	PROPN
aji-135	176	2	j.	j.	PROPN
aji-135	176	3	immunol	immunol	PROPN
aji-135	176	4	.	.	PROPN
aji-135	176	5	,	,	PUNCT
aji-135	176	6	vol	vol	NOUN
aji-135	176	7	.	.	PROPN
aji-135	176	8	7	7	NUM
aji-135	176	9	,	,	PUNCT
aji-135	176	10	no	no	INTJ
aji-135	176	11	.	.	NOUN
aji-135	176	12	1	1	NUM
aji-135	176	13	,	,	PUNCT
aji-135	176	14	pp	pp	ADJ
aji-135	176	15	.	.	PUNCT
aji-135	176	16	100	100	NUM
aji-135	176	17	-	-	SYM
aji-135	176	18	111	111	NUM
aji-135	176	19	,	,	PUNCT
aji-135	176	20	2024	2024	NUM
aji-135	176	21	;	;	PUNCT
aji-135	176	22	article	article	NOUN
aji-135	176	23	no.aji.119914	no.aji.119914	PROPN
aji-135	176	24	103	103	NUM
aji-135	176	25	differentiate	differentiate	VERB
aji-135	176	26	diverse	diverse	ADJ
aji-135	176	27	endotypes	endotype	NOUN
aji-135	176	28	and	and	CCONJ
aji-135	176	29	degrees	degree	NOUN
aji-135	176	30	of	of	ADP
aji-135	176	31	immunoreactivity	immunoreactivity	NOUN
aji-135	176	32	against	against	ADP
aji-135	176	33	pegs	peg	NOUN
aji-135	176	34	among	among	ADP
aji-135	176	35	patients	patient	NOUN
aji-135	176	36	suffering	suffer	VERB
aji-135	176	37	from	from	ADP
aji-135	176	38	the	the	DET
aji-135	176	39	most	most	ADV
aji-135	176	40	common	common	ADJ
aji-135	176	41	allergic	allergic	ADJ
aji-135	176	42	phenotypes	phenotype	NOUN
aji-135	176	43	.	.	PUNCT
aji-135	177	1	to	to	PART
aji-135	177	2	demonstrate	demonstrate	VERB
aji-135	177	3	diversity	diversity	NOUN
aji-135	177	4	in	in	ADP
aji-135	177	5	immune	immune	ADJ
aji-135	177	6	responses	response	NOUN
aji-135	177	7	and	and	CCONJ
aji-135	177	8	to	to	PART
aji-135	177	9	evaluate	evaluate	VERB
aji-135	177	10	the	the	DET
aji-135	177	11	potential	potential	NOUN
aji-135	177	12	of	of	ADP
aji-135	177	13	the	the	DET
aji-135	177	14	lait	lait	NOUN
aji-135	177	15	and	and	CCONJ
aji-135	177	16	the	the	DET
aji-135	177	17	research	research	NOUN
aji-135	177	18	of	of	ADP
aji-135	177	19	precipitins	precipitin	NOUN
aji-135	177	20	to	to	ADP
aji-135	177	21	endotyping	endotype	VERB
aji-135	177	22	non	non	ADJ
aji-135	177	23	–	–	PUNCT
aji-135	177	24	ige	ige	ADJ
aji-135	177	25	-	-	PUNCT
aji-135	177	26	mediated	mediate	VERB
aji-135	177	27	immunoreactivity	immunoreactivity	NOUN
aji-135	177	28	against	against	ADP
aji-135	177	29	pegs	peg	NOUN
aji-135	177	30	,	,	PUNCT
aji-135	177	31	we	we	PRON
aji-135	177	32	retrospectively	retrospectively	ADV
aji-135	177	33	compiled	compile	VERB
aji-135	177	34	the	the	DET
aji-135	177	35	electronic	electronic	ADJ
aji-135	177	36	medical	medical	ADJ
aji-135	177	37	charts	chart	NOUN
aji-135	177	38	of	of	ADP
aji-135	177	39	patients	patient	NOUN
aji-135	177	40	with	with	ADP
aji-135	177	41	non	non	ADJ
aji-135	177	42	–	–	PUNCT
aji-135	177	43	ige	ige	ADJ
aji-135	177	44	-	-	PUNCT
aji-135	177	45	mediated	mediate	VERB
aji-135	177	46	allergic	allergic	ADJ
aji-135	177	47	rhinitis	rhinitis	NOUN
aji-135	177	48	,	,	PUNCT
aji-135	177	49	allergic	allergic	ADJ
aji-135	177	50	bronchitis	bronchitis	NOUN
aji-135	177	51	,	,	PUNCT
aji-135	177	52	asthma	asthma	NOUN
aji-135	177	53	,	,	PUNCT
aji-135	177	54	sinus	sinus	NOUN
aji-135	177	55	headache	headache	NOUN
aji-135	177	56	,	,	PUNCT
aji-135	177	57	atopic	atopic	NOUN
aji-135	177	58	dermatitis	dermatitis	NOUN
aji-135	177	59	,	,	PUNCT
aji-135	177	60	and/or	and/or	CCONJ
aji-135	177	61	urticaria	urticaria	NOUN
aji-135	177	62	who	who	PRON
aji-135	177	63	were	be	AUX
aji-135	177	64	investigated	investigate	VERB
aji-135	177	65	with	with	ADP
aji-135	177	66	these	these	DET
aji-135	177	67	procedures	procedure	NOUN
aji-135	177	68	into	into	ADP
aji-135	177	69	our	our	PRON
aji-135	177	70	institution	institution	NOUN
aji-135	177	71	.	.	PUNCT
aji-135	178	1	2	2	X
aji-135	178	2	.	.	X
aji-135	178	3	materials	material	NOUN
aji-135	178	4	and	and	CCONJ
aji-135	178	5	methods	method	NOUN
aji-135	178	6	2.1	2.1	NUM
aji-135	178	7	subjects	subject	NOUN
aji-135	178	8	after	after	ADP
aji-135	178	9	receiving	receive	VERB
aji-135	178	10	institutional	institutional	ADJ
aji-135	178	11	review	review	NOUN
aji-135	178	12	board	board	NOUN
aji-135	178	13	approval	approval	NOUN
aji-135	178	14	from	from	ADP
aji-135	178	15	the	the	DET
aji-135	178	16	instituto	instituto	PROPN
aji-135	178	17	alergoimuno	alergoimuno	PROPN
aji-135	178	18	de	de	X
aji-135	178	19	americana	americana	PROPN
aji-135	178	20	(	(	PUNCT
aji-135	178	21	brazil	brazil	PROPN
aji-135	178	22	;	;	PUNCT
aji-135	178	23	05/2024	05/2024	NUM
aji-135	178	24	)	)	PUNCT
aji-135	178	25	,	,	PUNCT
aji-135	178	26	we	we	PRON
aji-135	178	27	reviewed	review	VERB
aji-135	178	28	the	the	DET
aji-135	178	29	electronic	electronic	ADJ
aji-135	178	30	chart	chart	NOUN
aji-135	178	31	of	of	ADP
aji-135	178	32	9.000	9.000	NUM
aji-135	178	33	outpatients	outpatient	NOUN
aji-135	178	34	who	who	PRON
aji-135	178	35	attended	attend	VERB
aji-135	178	36	our	our	PRON
aji-135	178	37	facility	facility	NOUN
aji-135	178	38	from	from	ADP
aji-135	178	39	january	january	PROPN
aji-135	178	40	2018	2018	NUM
aji-135	178	41	to	to	ADP
aji-135	178	42	june	june	PROPN
aji-135	178	43	2024	2024	NUM
aji-135	178	44	.	.	PUNCT
aji-135	179	1	the	the	DET
aji-135	179	2	sample	sample	NOUN
aji-135	179	3	selection	selection	NOUN
aji-135	179	4	was	be	AUX
aji-135	179	5	performed	perform	VERB
aji-135	179	6	by	by	ADP
aji-135	179	7	retrieving	retrieve	VERB
aji-135	179	8	the	the	DET
aji-135	179	9	results	result	NOUN
aji-135	179	10	from	from	ADP
aji-135	179	11	the	the	DET
aji-135	179	12	electronic	electronic	ADJ
aji-135	179	13	sheets	sheet	NOUN
aji-135	179	14	.	.	PUNCT
aji-135	180	1	a	a	DET
aji-135	180	2	cohort	cohort	NOUN
aji-135	180	3	of	of	ADP
aji-135	180	4	100	100	NUM
aji-135	180	5	outside	outside	ADJ
aji-135	180	6	patients	patient	NOUN
aji-135	180	7	had	have	AUX
aji-135	180	8	been	be	AUX
aji-135	180	9	submitted	submit	VERB
aji-135	180	10	to	to	ADP
aji-135	180	11	ttp	ttp	PROPN
aji-135	180	12	with	with	ADP
aji-135	180	13	pegs	peg	NOUN
aji-135	180	14	solution	solution	NOUN
aji-135	180	15	1mg	1mg	NUM
aji-135	180	16	/	/	SYM
aji-135	180	17	ml	ml	X
aji-135	180	18	for	for	ADP
aji-135	180	19	presenting	present	VERB
aji-135	180	20	non	non	ADJ
aji-135	180	21	–	–	PUNCT
aji-135	180	22	ige	ige	ADJ
aji-135	180	23	-	-	PUNCT
aji-135	180	24	mediated	mediate	VERB
aji-135	180	25	allergic	allergic	ADJ
aji-135	180	26	rhinitis	rhinitis	NOUN
aji-135	180	27	,	,	PUNCT
aji-135	180	28	allergic	allergic	ADJ
aji-135	180	29	bronchitis	bronchitis	NOUN
aji-135	180	30	,	,	PUNCT
aji-135	180	31	asthma	asthma	NOUN
aji-135	180	32	,	,	PUNCT
aji-135	180	33	allergic	allergic	ADJ
aji-135	180	34	sinus	sinus	NOUN
aji-135	180	35	headache	headache	NOUN
aji-135	180	36	,	,	PUNCT
aji-135	180	37	atopic	atopic	NOUN
aji-135	180	38	dermatitis	dermatitis	NOUN
aji-135	180	39	,	,	PUNCT
aji-135	180	40	and/or	and/or	CCONJ
aji-135	180	41	urticaria	urticaria	NOUN
aji-135	180	42	.	.	PUNCT
aji-135	181	1	this	this	DET
aji-135	181	2	cohort	cohort	NOUN
aji-135	181	3	counted	count	VERB
aji-135	181	4	31	31	NUM
aji-135	181	5	males	male	NOUN
aji-135	181	6	;	;	PUNCT
aji-135	181	7	mean	mean	VERB
aji-135	181	8	age	age	NOUN
aji-135	181	9	34.8	34.8	NUM
aji-135	181	10	years	year	NOUN
aji-135	181	11	;	;	PUNCT
aji-135	181	12	standard	standard	ADJ
aji-135	181	13	deviation	deviation	NOUN
aji-135	181	14	(	(	PUNCT
aji-135	181	15	sd	sd	NOUN
aji-135	181	16	)	)	PUNCT
aji-135	181	17	21.3	21.3	NUM
aji-135	181	18	years	year	NOUN
aji-135	181	19	;	;	PUNCT
aji-135	181	20	range	range	NOUN
aji-135	181	21	0	0	NUM
aji-135	181	22	to	to	PART
aji-135	181	23	80	80	NUM
aji-135	181	24	years	year	NOUN
aji-135	181	25	;	;	PUNCT
aji-135	181	26	median	median	NOUN
aji-135	181	27	32.5	32.5	NUM
aji-135	181	28	years	year	NOUN
aji-135	181	29	;	;	PUNCT
aji-135	181	30	mode	mode	NOUN
aji-135	181	31	=	=	SYM
aji-135	181	32	28	28	NUM
aji-135	181	33	years	year	NOUN
aji-135	181	34	(	(	PUNCT
aji-135	181	35	appeared	appear	VERB
aji-135	181	36	five	five	NUM
aji-135	181	37	times	time	NOUN
aji-135	181	38	)	)	PUNCT
aji-135	181	39	.	.	PUNCT
aji-135	182	1	a	a	DET
aji-135	182	2	different	different	ADJ
aji-135	182	3	cohort	cohort	NOUN
aji-135	182	4	of	of	ADP
aji-135	182	5	100	100	NUM
aji-135	182	6	outside	outside	ADJ
aji-135	182	7	patients	patient	NOUN
aji-135	182	8	had	have	AUX
aji-135	182	9	been	be	AUX
aji-135	182	10	submitted	submit	VERB
aji-135	182	11	to	to	ADP
aji-135	182	12	an	an	DET
aji-135	182	13	ex	ex	X
aji-135	182	14	vivo	vivo	NOUN
aji-135	182	15	allergen	allergen	NOUN
aji-135	182	16	challenge	challenge	NOUN
aji-135	182	17	test	test	NOUN
aji-135	182	18	with	with	ADP
aji-135	182	19	pegs	peg	NOUN
aji-135	182	20	solution	solution	NOUN
aji-135	182	21	1mg	1mg	NUM
aji-135	182	22	/	/	SYM
aji-135	182	23	ml	ml	VERB
aji-135	182	24	monitored	monitor	VERB
aji-135	182	25	with	with	ADP
aji-135	182	26	lait	lait	NOUN
aji-135	182	27	for	for	ADP
aji-135	182	28	presenting	present	VERB
aji-135	182	29	non	non	ADJ
aji-135	182	30	–	–	PUNCT
aji-135	182	31	ige	ige	ADJ
aji-135	182	32	-	-	PUNCT
aji-135	182	33	mediated	mediate	VERB
aji-135	182	34	allergic	allergic	ADJ
aji-135	182	35	rhinitis	rhinitis	NOUN
aji-135	182	36	,	,	PUNCT
aji-135	182	37	allergic	allergic	ADJ
aji-135	182	38	bronchitis	bronchitis	NOUN
aji-135	182	39	,	,	PUNCT
aji-135	182	40	asthma	asthma	NOUN
aji-135	182	41	,	,	PUNCT
aji-135	182	42	allergic	allergic	ADJ
aji-135	182	43	sinus	sinus	NOUN
aji-135	182	44	headache	headache	NOUN
aji-135	182	45	,	,	PUNCT
aji-135	182	46	atopic	atopic	NOUN
aji-135	182	47	dermatitis	dermatitis	NOUN
aji-135	182	48	,	,	PUNCT
aji-135	182	49	and/or	and/or	CCONJ
aji-135	182	50	urticaria	urticaria	NOUN
aji-135	182	51	.	.	PUNCT
aji-135	183	1	this	this	DET
aji-135	183	2	cohort	cohort	NOUN
aji-135	183	3	counted	count	VERB
aji-135	183	4	27	27	NUM
aji-135	183	5	males	male	NOUN
aji-135	183	6	;	;	PUNCT
aji-135	183	7	mean	mean	VERB
aji-135	183	8	age	age	NOUN
aji-135	183	9	39.9	39.9	NUM
aji-135	183	10	years	year	NOUN
aji-135	183	11	;	;	PUNCT
aji-135	183	12	sd	sd	ADP
aji-135	183	13	20.5	20.5	NUM
aji-135	183	14	years	year	NOUN
aji-135	183	15	;	;	PUNCT
aji-135	183	16	range	range	NOUN
aji-135	183	17	3	3	NUM
aji-135	183	18	to	to	ADP
aji-135	183	19	84	84	NUM
aji-135	183	20	years	year	NOUN
aji-135	183	21	;	;	PUNCT
aji-135	183	22	median	median	NOUN
aji-135	183	23	39.5	39.5	NUM
aji-135	183	24	years	year	NOUN
aji-135	183	25	;	;	PUNCT
aji-135	183	26	modes	mode	NOUN
aji-135	183	27	=	=	SYM
aji-135	183	28	24	24	NUM
aji-135	183	29	and	and	CCONJ
aji-135	183	30	41	41	NUM
aji-135	183	31	years	year	NOUN
aji-135	183	32	(	(	PUNCT
aji-135	183	33	each	each	PRON
aji-135	183	34	appeared	appear	VERB
aji-135	183	35	four	four	NUM
aji-135	183	36	times	time	NOUN
aji-135	183	37	)	)	PUNCT
aji-135	183	38	.	.	PUNCT
aji-135	184	1	this	this	DET
aji-135	184	2	study	study	NOUN
aji-135	184	3	did	do	AUX
aji-135	184	4	not	not	PART
aji-135	184	5	include	include	VERB
aji-135	184	6	patients	patient	NOUN
aji-135	184	7	under	under	ADP
aji-135	184	8	biological	biological	ADJ
aji-135	184	9	and/or	and/or	CCONJ
aji-135	184	10	systemic	systemic	ADJ
aji-135	184	11	anti	anti	ADJ
aji-135	184	12	-	-	ADJ
aji-135	184	13	inflammatory	inflammatory	ADJ
aji-135	184	14	therapy	therapy	NOUN
aji-135	184	15	.	.	PUNCT
aji-135	185	1	these	these	DET
aji-135	185	2	procedures	procedure	NOUN
aji-135	185	3	were	be	AUX
aji-135	185	4	offered	offer	VERB
aji-135	185	5	to	to	ADP
aji-135	185	6	patients	patient	NOUN
aji-135	185	7	with	with	ADP
aji-135	185	8	clinical	clinical	ADJ
aji-135	185	9	suspicion	suspicion	NOUN
aji-135	185	10	of	of	ADP
aji-135	185	11	pegs	peg	NOUN
aji-135	185	12	’	'	PUNCT
aji-135	185	13	hypersensitivity	hypersensitivity	NOUN
aji-135	185	14	who	who	PRON
aji-135	185	15	demonstrated	demonstrate	VERB
aji-135	185	16	a	a	DET
aji-135	185	17	nonreactive	nonreactive	ADJ
aji-135	185	18	or	or	CCONJ
aji-135	185	19	inconclusive	inconclusive	ADJ
aji-135	185	20	allergic	allergic	ADJ
aji-135	185	21	skin	skin	NOUN
aji-135	185	22	scrape	scrape	NOUN
aji-135	185	23	test	test	NOUN
aji-135	185	24	against	against	ADP
aji-135	185	25	pegs	peg	NOUN
aji-135	185	26	’	'	PUNCT
aji-135	185	27	solution	solution	NOUN
aji-135	185	28	[	[	X
aji-135	185	29	29	29	NUM
aji-135	185	30	]	]	PUNCT
aji-135	185	31	.	.	PUNCT
aji-135	186	1	2.2	2.2	NUM
aji-135	186	2	pegs	peg	NOUN
aji-135	186	3	solution	solution	NOUN
aji-135	186	4	the	the	DET
aji-135	186	5	pegs	pegs	NOUN
aji-135	186	6	solution	solution	NOUN
aji-135	186	7	was	be	AUX
aji-135	186	8	prepared	prepare	VERB
aji-135	186	9	with	with	ADP
aji-135	186	10	powdered	powdered	ADJ
aji-135	186	11	peg	peg	NOUN
aji-135	186	12	4000	4000	NUM
aji-135	186	13	(	(	PUNCT
aji-135	186	14	acquired	acquire	VERB
aji-135	186	15	from	from	ADP
aji-135	186	16	acs	acs	PROPN
aji-135	186	17	científica	científica	PROPN
aji-135	186	18	)	)	PUNCT
aji-135	186	19	diluted	dilute	VERB
aji-135	186	20	with	with	ADP
aji-135	186	21	isotonic	isotonic	ADJ
aji-135	186	22	saline	saline	ADJ
aji-135	186	23	solution	solution	NOUN
aji-135	186	24	at	at	ADP
aji-135	186	25	1	1	NUM
aji-135	186	26	mg	mg	NOUN
aji-135	186	27	/	/	SYM
aji-135	186	28	ml	ml	NOUN
aji-135	186	29	to	to	PART
aji-135	186	30	perform	perform	VERB
aji-135	186	31	the	the	DET
aji-135	186	32	allergic	allergic	ADJ
aji-135	186	33	skin	skin	NOUN
aji-135	186	34	scrape	scrape	NOUN
aji-135	186	35	tests	test	NOUN
aji-135	186	36	,	,	PUNCT
aji-135	186	37	ttp	ttp	X
aji-135	186	38	,	,	PUNCT
aji-135	186	39	and	and	CCONJ
aji-135	186	40	lait	lait	NOUN
aji-135	186	41	.	.	PUNCT
aji-135	187	1	2.3	2.3	NUM
aji-135	187	2	ex	ex	X
aji-135	187	3	vivo	vivo	ADJ
aji-135	187	4	investigation	investigation	NOUN
aji-135	187	5	:	:	PUNCT
aji-135	187	6	leukocyte	leukocyte	ADJ
aji-135	187	7	adherence	adherence	NOUN
aji-135	187	8	inhibition	inhibition	NOUN
aji-135	187	9	test	test	NOUN
aji-135	187	10	2.3.1	2.3.1	NUM
aji-135	187	11	procedure	procedure	NOUN
aji-135	187	12	for	for	ADP
aji-135	187	13	allergen	allergen	NOUN
aji-135	187	14	ex	ex	PRON
aji-135	187	15	vivo	vivo	NOUN
aji-135	187	16	challenging	challenge	VERB
aji-135	187	17	we	we	PRON
aji-135	187	18	performed	perform	VERB
aji-135	187	19	the	the	DET
aji-135	187	20	lait	lait	NOUN
aji-135	187	21	as	as	SCONJ
aji-135	187	22	previously	previously	ADV
aji-135	187	23	described	describe	VERB
aji-135	187	24	[	[	PUNCT
aji-135	187	25	43	43	NUM
aji-135	187	26	-	-	SYM
aji-135	187	27	51	51	NUM
aji-135	187	28	]	]	PUNCT
aji-135	187	29	.	.	PUNCT
aji-135	188	1	shortly	shortly	ADV
aji-135	188	2	,	,	PUNCT
aji-135	188	3	each	each	DET
aji-135	188	4	donor	donor	NOUN
aji-135	188	5	’s	’s	PART
aji-135	188	6	fresh	fresh	ADJ
aji-135	188	7	plasma	plasma	NOUN
aji-135	188	8	was	be	AUX
aji-135	188	9	divided	divide	VERB
aji-135	188	10	into	into	ADP
aji-135	188	11	two	two	NUM
aji-135	188	12	parts	part	NOUN
aji-135	188	13	and	and	CCONJ
aji-135	188	14	used	use	VERB
aji-135	188	15	in	in	ADP
aji-135	188	16	paralleled	parallel	VERB
aji-135	188	17	ex	ex	PRON
aji-135	188	18	vivo	vivo	ADJ
aji-135	188	19	challenging	challenge	VERB
aji-135	188	20	tests	test	NOUN
aji-135	188	21	with	with	ADP
aji-135	188	22	pegs	peg	NOUN
aji-135	188	23	solution	solution	NOUN
aji-135	188	24	1	1	NUM
aji-135	188	25	mg	mg	NUM
aji-135	188	26	/	/	SYM
aji-135	188	27	ml	ml	NOUN
aji-135	188	28	and	and	CCONJ
aji-135	188	29	the	the	DET
aji-135	188	30	unchallenged	unchallenged	ADJ
aji-135	188	31	plasma	plasma	NOUN
aji-135	188	32	assay	assay	VERB
aji-135	188	33	.	.	PUNCT
aji-135	189	1	we	we	PRON
aji-135	189	2	collected	collect	VERB
aji-135	189	3	the	the	DET
aji-135	189	4	plasma	plasma	NOUN
aji-135	189	5	with	with	ADP
aji-135	189	6	high	high	ADJ
aji-135	189	7	leukocyte	leukocyte	NOUN
aji-135	189	8	content	content	NOUN
aji-135	189	9	(	(	PUNCT
aji-135	189	10	buffy	buffy	PROPN
aji-135	189	11	coat	coat	PROPN
aji-135	189	12	)	)	PUNCT
aji-135	189	13	from	from	ADP
aji-135	189	14	the	the	DET
aji-135	189	15	heparinized	heparinize	VERB
aji-135	189	16	tube	tube	NOUN
aji-135	189	17	after	after	ADP
aji-135	189	18	one	one	NUM
aji-135	189	19	hour	hour	NOUN
aji-135	189	20	of	of	ADP
aji-135	189	21	sedimentation	sedimentation	NOUN
aji-135	189	22	at	at	ADP
aji-135	189	23	37	37	NUM
aji-135	189	24	°	°	NOUN
aji-135	189	25	c	c	NOUN
aji-135	189	26	.	.	PUNCT
aji-135	190	1	then	then	ADV
aji-135	190	2	we	we	PRON
aji-135	190	3	distributed	distribute	VERB
aji-135	190	4	aliquots	aliquot	NOUN
aji-135	190	5	of	of	ADP
aji-135	190	6	100	100	NUM
aji-135	190	7	μl	μl	ADV
aji-135	190	8	into	into	ADP
aji-135	190	9	eppendorf	eppendorf	PROPN
aji-135	190	10	tubes	tube	NOUN
aji-135	190	11	kept	keep	VERB
aji-135	190	12	under	under	ADP
aji-135	190	13	agitation	agitation	NOUN
aji-135	190	14	for	for	ADP
aji-135	190	15	30	30	NUM
aji-135	190	16	minutes	minute	NOUN
aji-135	190	17	(	(	PUNCT
aji-135	190	18	200	200	NUM
aji-135	190	19	rpm	rpm	NOUN
aji-135	190	20	at	at	ADP
aji-135	190	21	37	37	NUM
aji-135	190	22	°	°	NOUN
aji-135	190	23	c	c	NOUN
aji-135	190	24	)	)	PUNCT
aji-135	190	25	with	with	ADP
aji-135	190	26	pegs	pegs	NOUN
aji-135	190	27	solution	solution	NOUN
aji-135	190	28	(	(	PUNCT
aji-135	190	29	10μl	10μl	ADV
aji-135	190	30	of	of	ADP
aji-135	190	31	a	a	DET
aji-135	190	32	solution	solution	NOUN
aji-135	190	33	with	with	ADP
aji-135	190	34	1mg	1mg	PROPN
aji-135	190	35	/	/	SYM
aji-135	190	36	ml	ml	PROPN
aji-135	190	37	and	and	CCONJ
aji-135	190	38	ph	ph	ADJ
aji-135	190	39	7.5	7.5	NUM
aji-135	190	40	)	)	PUNCT
aji-135	190	41	or	or	CCONJ
aji-135	190	42	without	without	ADP
aji-135	190	43	pegs	pegs	NOUN
aji-135	190	44	solution	solution	NOUN
aji-135	190	45	(	(	PUNCT
aji-135	190	46	when	when	SCONJ
aji-135	190	47	used	use	VERB
aji-135	190	48	as	as	ADP
aji-135	190	49	control	control	NOUN
aji-135	190	50	)	)	PUNCT
aji-135	190	51	.	.	PUNCT
aji-135	191	1	2.3.2	2.3.2	NUM
aji-135	191	2	procedure	procedure	NOUN
aji-135	191	3	for	for	ADP
aji-135	191	4	adherence	adherence	NOUN
aji-135	191	5	assay	assay	VERB
aji-135	191	6	after	after	ADP
aji-135	191	7	incubation	incubation	NOUN
aji-135	191	8	,	,	PUNCT
aji-135	191	9	the	the	DET
aji-135	191	10	plasma	plasma	NOUN
aji-135	191	11	was	be	AUX
aji-135	191	12	allocated	allocate	VERB
aji-135	191	13	into	into	ADP
aji-135	191	14	a	a	DET
aji-135	191	15	standard	standard	ADJ
aji-135	191	16	neubauer	neubauer	PROPN
aji-135	191	17	hemocytometer	hemocytometer	PROPN
aji-135	191	18	counting	counting	PROPN
aji-135	191	19	chamber	chamber	NOUN
aji-135	191	20	with	with	ADP
aji-135	191	21	a	a	DET
aji-135	191	22	plain	plain	ADJ
aji-135	191	23	,	,	PUNCT
aji-135	191	24	non	non	ADJ
aji-135	191	25	-	-	ADJ
aji-135	191	26	metallic	metallic	ADJ
aji-135	191	27	glass	glass	NOUN
aji-135	191	28	surface	surface	NOUN
aji-135	191	29	and	and	CCONJ
aji-135	191	30	left	leave	VERB
aji-135	191	31	to	to	PART
aji-135	191	32	stand	stand	VERB
aji-135	191	33	for	for	ADP
aji-135	191	34	2	2	NUM
aji-135	191	35	hours	hour	NOUN
aji-135	191	36	at	at	ADP
aji-135	191	37	37	37	NUM
aji-135	191	38	°	°	SYM
aji-135	191	39	c	c	NOUN
aji-135	191	40	in	in	ADP
aji-135	191	41	the	the	DET
aji-135	191	42	humidified	humidified	ADJ
aji-135	191	43	atmosphere	atmosphere	NOUN
aji-135	191	44	of	of	ADP
aji-135	191	45	the	the	DET
aji-135	191	46	covered	cover	VERB
aji-135	191	47	water	water	NOUN
aji-135	191	48	bath	bath	NOUN
aji-135	191	49	to	to	PART
aji-135	191	50	allow	allow	VERB
aji-135	191	51	leukocytes	leukocyte	NOUN
aji-135	191	52	to	to	PART
aji-135	191	53	adhere	adhere	VERB
aji-135	191	54	to	to	ADP
aji-135	191	55	the	the	DET
aji-135	191	56	glass	glass	NOUN
aji-135	191	57	.	.	PUNCT
aji-135	192	1	next	next	ADV
aji-135	192	2	,	,	PUNCT
aji-135	192	3	we	we	PRON
aji-135	192	4	counted	count	VERB
aji-135	192	5	the	the	DET
aji-135	192	6	leukocytes	leukocyte	NOUN
aji-135	192	7	,	,	PUNCT
aji-135	192	8	removed	remove	VERB
aji-135	192	9	the	the	DET
aji-135	192	10	coverslip	coverslip	NOUN
aji-135	192	11	,	,	PUNCT
aji-135	192	12	and	and	CCONJ
aji-135	192	13	washed	wash	VERB
aji-135	192	14	the	the	DET
aji-135	192	15	chamber	chamber	NOUN
aji-135	192	16	by	by	ADP
aji-135	192	17	immersion	immersion	NOUN
aji-135	192	18	in	in	ADP
aji-135	192	19	a	a	DET
aji-135	192	20	beaker	beaker	NOUN
aji-135	192	21	with	with	ADP
aji-135	192	22	pbs	pbs	PROPN
aji-135	192	23	at	at	ADP
aji-135	192	24	37	37	NUM
aji-135	192	25	°	°	NOUN
aji-135	192	26	c	c	NOUN
aji-135	192	27	.	.	PUNCT
aji-135	193	1	then	then	ADV
aji-135	193	2	,	,	PUNCT
aji-135	193	3	we	we	PRON
aji-135	193	4	added	add	VERB
aji-135	193	5	a	a	DET
aji-135	193	6	drop	drop	NOUN
aji-135	193	7	of	of	ADP
aji-135	193	8	pbs	pbs	PROPN
aji-135	193	9	to	to	ADP
aji-135	193	10	the	the	DET
aji-135	193	11	hemocytometer	hemocytometer	PROPN
aji-135	193	12	’s	’s	PART
aji-135	193	13	chamber	chamber	PROPN
aji-135	193	14	and	and	CCONJ
aji-135	193	15	allocated	allocate	VERB
aji-135	193	16	a	a	DET
aji-135	193	17	clean	clean	ADJ
aji-135	193	18	coverslip	coverslip	NOUN
aji-135	193	19	over	over	ADP
aji-135	193	20	it	it	PRON
aji-135	193	21	.	.	PUNCT
aji-135	194	1	the	the	DET
aji-135	194	2	remaining	remain	VERB
aji-135	194	3	cells	cell	NOUN
aji-135	194	4	were	be	AUX
aji-135	194	5	counted	count	VERB
aji-135	194	6	in	in	ADP
aji-135	194	7	the	the	DET
aji-135	194	8	same	same	ADJ
aji-135	194	9	squares	square	NOUN
aji-135	194	10	as	as	SCONJ
aji-135	194	11	previously	previously	ADV
aji-135	194	12	examined	examine	VERB
aji-135	194	13	.	.	PUNCT
aji-135	195	1	2.3.3	2.3.3	NUM
aji-135	195	2	procedure	procedure	NOUN
aji-135	195	3	for	for	ADP
aji-135	195	4	calculating	calculate	VERB
aji-135	195	5	the	the	DET
aji-135	195	6	adherence	adherence	NOUN
aji-135	195	7	inhibition	inhibition	NOUN
aji-135	195	8	the	the	DET
aji-135	195	9	percentage	percentage	NOUN
aji-135	195	10	of	of	ADP
aji-135	195	11	leukocyte	leukocyte	NOUN
aji-135	195	12	adherence	adherence	NOUN
aji-135	195	13	(	(	PUNCT
aji-135	195	14	la	la	NOUN
aji-135	195	15	)	)	PUNCT
aji-135	195	16	of	of	ADP
aji-135	195	17	each	each	DET
aji-135	195	18	assay	assay	NOUN
aji-135	195	19	was	be	AUX
aji-135	195	20	estimated	estimate	VERB
aji-135	195	21	as	as	ADP
aji-135	195	22	:	:	PUNCT
aji-135	195	23	(	(	PUNCT
aji-135	195	24	the	the	DET
aji-135	195	25	number	number	NOUN
aji-135	195	26	of	of	ADP
aji-135	195	27	leukocytes	leukocyte	NOUN
aji-135	195	28	observed	observe	VERB
aji-135	195	29	on	on	ADP
aji-135	195	30	the	the	DET
aji-135	195	31	hemocytometry	hemocytometry	PROPN
aji-135	195	32	chamber	chamber	PROPN
aji-135	195	33	after	after	ADP
aji-135	195	34	washing	wash	VERB
aji-135	195	35	divided	divide	VERB
aji-135	195	36	by	by	ADP
aji-135	195	37	the	the	DET
aji-135	195	38	number	number	NOUN
aji-135	195	39	of	of	ADP
aji-135	195	40	leukocytes	leukocyte	NOUN
aji-135	195	41	observed	observe	VERB
aji-135	195	42	on	on	ADP
aji-135	195	43	the	the	DET
aji-135	195	44	hemocytometry	hemocytometry	PROPN
aji-135	195	45	chamber	chamber	PROPN
aji-135	195	46	before	before	ADP
aji-135	195	47	washing	washing	NOUN
aji-135	195	48	)	)	PUNCT
aji-135	195	49	and	and	CCONJ
aji-135	195	50	multiplied	multiply	VERB
aji-135	195	51	by	by	ADP
aji-135	195	52	100	100	NUM
aji-135	195	53	(	(	PUNCT
aji-135	195	54	%	%	NOUN
aji-135	195	55	)	)	PUNCT
aji-135	195	56	.	.	PUNCT
aji-135	196	1	the	the	DET
aji-135	196	2	leukocyte	leukocyte	NOUN
aji-135	196	3	adherence	adherence	NOUN
aji-135	196	4	ratio	ratio	NOUN
aji-135	196	5	(	(	PUNCT
aji-135	196	6	lar	lar	ADJ
aji-135	196	7	)	)	PUNCT
aji-135	196	8	was	be	AUX
aji-135	196	9	estimated	estimate	VERB
aji-135	196	10	based	base	VERB
aji-135	196	11	on	on	ADP
aji-135	196	12	the	the	DET
aji-135	196	13	ratio	ratio	NOUN
aji-135	196	14	between	between	ADP
aji-135	196	15	the	the	DET
aji-135	196	16	la	la	NOUN
aji-135	196	17	from	from	ADP
aji-135	196	18	the	the	DET
aji-135	196	19	antigen	antigen	NOUN
aji-135	196	20	-	-	PUNCT
aji-135	196	21	specific	specific	ADJ
aji-135	196	22	challenged	challenge	VERB
aji-135	196	23	plasma	plasma	NOUN
aji-135	196	24	and	and	CCONJ
aji-135	196	25	the	the	DET
aji-135	196	26	la	la	PROPN
aji-135	196	27	from	from	ADP
aji-135	196	28	the	the	DET
aji-135	196	29	unchallenged	unchallenged	ADJ
aji-135	196	30	control	control	NOUN
aji-135	196	31	plasma	plasma	NOUN
aji-135	196	32	:	:	PUNCT
aji-135	196	33	olivier	olivier	PROPN
aji-135	196	34	et	et	PROPN
aji-135	196	35	al	al	PROPN
aji-135	196	36	.	.	PROPN
aji-135	196	37	;	;	PUNCT
aji-135	197	1	asian	asian	PROPN
aji-135	197	2	j.	j.	PROPN
aji-135	197	3	immunol	immunol	PROPN
aji-135	197	4	.	.	PROPN
aji-135	197	5	,	,	PUNCT
aji-135	197	6	vol	vol	NOUN
aji-135	197	7	.	.	PROPN
aji-135	197	8	7	7	NUM
aji-135	197	9	,	,	PUNCT
aji-135	197	10	no	no	INTJ
aji-135	197	11	.	.	NOUN
aji-135	197	12	1	1	NUM
aji-135	197	13	,	,	PUNCT
aji-135	197	14	pp	pp	ADJ
aji-135	197	15	.	.	PUNCT
aji-135	197	16	100	100	NUM
aji-135	197	17	-	-	SYM
aji-135	197	18	111	111	NUM
aji-135	197	19	,	,	PUNCT
aji-135	197	20	2024	2024	NUM
aji-135	197	21	;	;	PUNCT
aji-135	197	22	article	article	NOUN
aji-135	197	23	no.aji.119914	no.aji.119914	PROPN
aji-135	197	24	104	104	NUM
aji-135	197	25	lar	lar	ADJ
aji-135	197	26	=	=	X
aji-135	197	27	la	la	PROPN
aji-135	197	28	of	of	ADP
aji-135	197	29	the	the	DET
aji-135	197	30	challenged	challenge	VERB
aji-135	197	31	sample	sample	NOUN
aji-135	197	32	divided	divide	VERB
aji-135	197	33	by	by	ADP
aji-135	197	34	la	la	PROPN
aji-135	197	35	of	of	ADP
aji-135	197	36	unchallenged	unchallenged	ADJ
aji-135	197	37	control	control	NOUN
aji-135	197	38	plasma	plasma	NOUN
aji-135	197	39	multiplied	multiply	VERB
aji-135	197	40	by	by	ADP
aji-135	197	41	100	100	NUM
aji-135	197	42	(	(	PUNCT
aji-135	197	43	%	%	NOUN
aji-135	197	44	)	)	PUNCT
aji-135	197	45	.	.	PUNCT
aji-135	198	1	to	to	PART
aji-135	198	2	further	far	ADV
aji-135	198	3	calculate	calculate	VERB
aji-135	198	4	the	the	DET
aji-135	198	5	leukocyte	leukocyte	NOUN
aji-135	198	6	adherence	adherence	NOUN
aji-135	198	7	inhibition	inhibition	NOUN
aji-135	198	8	(	(	PUNCT
aji-135	198	9	lai	lai	PROPN
aji-135	198	10	)	)	PUNCT
aji-135	198	11	,	,	PUNCT
aji-135	198	12	we	we	PRON
aji-135	198	13	subtracted	subtract	VERB
aji-135	198	14	the	the	DET
aji-135	198	15	lar	lar	NOUN
aji-135	198	16	from	from	ADP
aji-135	198	17	100	100	NUM
aji-135	198	18	(	(	PUNCT
aji-135	198	19	%	%	NOUN
aji-135	198	20	)	)	PUNCT
aji-135	198	21	.	.	PUNCT
aji-135	199	1	we	we	PRON
aji-135	199	2	employed	employ	VERB
aji-135	199	3	the	the	DET
aji-135	199	4	lai	lai	PROPN
aji-135	199	5	results	result	NOUN
aji-135	199	6	for	for	ADP
aji-135	199	7	the	the	DET
aji-135	199	8	cascade	cascade	NOUN
aji-135	199	9	distribution	distribution	NOUN
aji-135	199	10	chart	chart	NOUN
aji-135	199	11	and	and	CCONJ
aji-135	199	12	the	the	DET
aji-135	199	13	statistics	statistic	NOUN
aji-135	199	14	calculations	calculation	NOUN
aji-135	199	15	,	,	PUNCT
aji-135	199	16	both	both	PRON
aji-135	199	17	performed	perform	VERB
aji-135	199	18	with	with	ADP
aji-135	199	19	the	the	DET
aji-135	199	20	help	help	NOUN
aji-135	199	21	of	of	ADP
aji-135	199	22	the	the	DET
aji-135	199	23	microsoft	microsoft	PROPN
aji-135	199	24	excel	excel	PROPN
aji-135	199	25	®	®	NOUN
aji-135	199	26	statistical	statistical	ADJ
aji-135	199	27	package	package	NOUN
aji-135	199	28	.	.	PUNCT
aji-135	200	1	2.4	2.4	NUM
aji-135	200	2	in	in	ADP
aji-135	200	3	vitro	vitro	X
aji-135	200	4	investigation	investigation	NOUN
aji-135	200	5	:	:	PUNCT
aji-135	200	6	tube	tube	NOUN
aji-135	200	7	titration	titration	NOUN
aji-135	200	8	of	of	ADP
aji-135	200	9	precipitins	precipitin	NOUN
aji-135	200	10	(	(	PUNCT
aji-135	200	11	ttp	ttp	NOUN
aji-135	200	12	)	)	PUNCT
aji-135	200	13	as	as	SCONJ
aji-135	200	14	previously	previously	ADV
aji-135	200	15	reported	report	VERB
aji-135	200	16	,	,	PUNCT
aji-135	200	17	the	the	DET
aji-135	200	18	semi	semi	ADJ
aji-135	200	19	-	-	ADJ
aji-135	200	20	quantitative	quantitative	ADJ
aji-135	200	21	ttp	ttp	NOUN
aji-135	200	22	against	against	ADP
aji-135	200	23	the	the	DET
aji-135	200	24	pegs	pegs	NOUN
aji-135	200	25	solution	solution	NOUN
aji-135	200	26	was	be	AUX
aji-135	200	27	performed	perform	VERB
aji-135	200	28	in	in	ADP
aji-135	200	29	a	a	DET
aji-135	200	30	transparent	transparent	ADJ
aji-135	200	31	vitreous	vitreous	ADJ
aji-135	200	32	tube	tube	NOUN
aji-135	200	33	[	[	X
aji-135	200	34	52	52	NUM
aji-135	200	35	]	]	PUNCT
aji-135	200	36	.	.	PUNCT
aji-135	201	1	shortly	shortly	ADV
aji-135	201	2	,	,	PUNCT
aji-135	201	3	the	the	DET
aji-135	201	4	patient	patient	NOUN
aji-135	201	5	’s	’s	PART
aji-135	201	6	blood	blood	NOUN
aji-135	201	7	was	be	AUX
aji-135	201	8	collected	collect	VERB
aji-135	201	9	in	in	ADP
aji-135	201	10	a	a	DET
aji-135	201	11	clot	clot	NOUN
aji-135	201	12	-	-	PUNCT
aji-135	201	13	activator	activator	NOUN
aji-135	201	14	collecting	collect	VERB
aji-135	201	15	tube	tube	NOUN
aji-135	201	16	.	.	PUNCT
aji-135	202	1	after	after	ADP
aji-135	202	2	separation	separation	NOUN
aji-135	202	3	,	,	PUNCT
aji-135	202	4	the	the	DET
aji-135	202	5	serum	serum	NOUN
aji-135	202	6	was	be	AUX
aji-135	202	7	centrifugated	centrifugate	VERB
aji-135	202	8	at	at	ADP
aji-135	202	9	2,000	2,000	NUM
aji-135	202	10	rpm	rpm	NOUN
aji-135	202	11	for	for	ADP
aji-135	202	12	10	10	NUM
aji-135	202	13	minutes	minute	NOUN
aji-135	202	14	.	.	PUNCT
aji-135	203	1	the	the	DET
aji-135	203	2	allergen	allergen	NOUN
aji-135	203	3	extracts	extract	NOUN
aji-135	203	4	were	be	AUX
aji-135	203	5	allocated	allocate	VERB
aji-135	203	6	in	in	ADP
aji-135	203	7	sets	set	NOUN
aji-135	203	8	of	of	ADP
aji-135	203	9	eleven	eleven	NUM
aji-135	203	10	glass	glass	NOUN
aji-135	203	11	tubes	tube	NOUN
aji-135	203	12	at	at	ADP
aji-135	203	13	progressive	progressive	ADJ
aji-135	203	14	duplicated	duplicate	VERB
aji-135	203	15	serum	serum	NOUN
aji-135	203	16	dilutions	dilution	NOUN
aji-135	203	17	.	.	PUNCT
aji-135	204	1	the	the	DET
aji-135	204	2	progressive	progressive	ADJ
aji-135	204	3	dilutions	dilution	NOUN
aji-135	204	4	were	be	AUX
aji-135	204	5	combined	combine	VERB
aji-135	204	6	with	with	ADP
aji-135	204	7	the	the	DET
aji-135	204	8	15	15	NUM
aji-135	204	9	μl	μl	NUM
aji-135	204	10	of	of	ADP
aji-135	204	11	the	the	DET
aji-135	204	12	antigen	antigen	NOUN
aji-135	204	13	(	(	PUNCT
aji-135	204	14	pegs	pegs	NOUN
aji-135	204	15	solution	solution	NOUN
aji-135	204	16	1	1	NUM
aji-135	204	17	mg	mg	NUM
aji-135	204	18	/	/	SYM
aji-135	204	19	ml	ml	NOUN
aji-135	204	20	)	)	PUNCT
aji-135	204	21	with	with	ADP
aji-135	204	22	250	250	NUM
aji-135	204	23	μl	μl	ADP
aji-135	204	24	of	of	ADP
aji-135	204	25	the	the	DET
aji-135	204	26	patient	patient	NOUN
aji-135	204	27	’s	’s	PART
aji-135	204	28	serum	serum	NOUN
aji-135	204	29	,	,	PUNCT
aji-135	204	30	progressively	progressively	ADV
aji-135	204	31	diluted	dilute	VERB
aji-135	204	32	into	into	ADP
aji-135	204	33	physiological	physiological	ADJ
aji-135	204	34	saline	saline	NOUN
aji-135	204	35	solution	solution	NOUN
aji-135	204	36	(	(	PUNCT
aji-135	204	37	nacl	nacl	NOUN
aji-135	204	38	0,9	0,9	NUM
aji-135	204	39	%	%	NOUN
aji-135	204	40	)	)	PUNCT
aji-135	204	41	in	in	ADP
aji-135	204	42	the	the	DET
aji-135	204	43	dilution	dilution	NOUN
aji-135	204	44	ratios	ratio	NOUN
aji-135	204	45	of	of	ADP
aji-135	204	46	1:1	1:1	NUM
aji-135	204	47	;	;	PUNCT
aji-135	204	48	1:2	1:2	NUM
aji-135	204	49	;	;	PUNCT
aji-135	204	50	1:4	1:4	NUM
aji-135	204	51	;	;	PUNCT
aji-135	204	52	1:8	1:8	NUM
aji-135	204	53	;	;	PUNCT
aji-135	204	54	1:16	1:16	NUM
aji-135	204	55	;	;	PUNCT
aji-135	204	56	1:32	1:32	NUM
aji-135	204	57	;	;	PUNCT
aji-135	204	58	1:64	1:64	NUM
aji-135	204	59	;	;	PUNCT
aji-135	204	60	1:128	1:128	NUM
aji-135	204	61	;	;	PUNCT
aji-135	204	62	1:256	1:256	NUM
aji-135	204	63	;	;	PUNCT
aji-135	204	64	and	and	CCONJ
aji-135	204	65	1:512	1:512	NUM
aji-135	204	66	.	.	PUNCT
aji-135	205	1	one	one	NUM
aji-135	205	2	tube	tube	NOUN
aji-135	205	3	was	be	AUX
aji-135	205	4	a	a	DET
aji-135	205	5	blank	blank	ADJ
aji-135	205	6	control	control	NOUN
aji-135	205	7	done	do	VERB
aji-135	205	8	with	with	ADP
aji-135	205	9	the	the	DET
aji-135	205	10	water	water	NOUN
aji-135	205	11	and	and	CCONJ
aji-135	205	12	serum	serum	NOUN
aji-135	205	13	to	to	PART
aji-135	205	14	observe	observe	VERB
aji-135	205	15	occasional	occasional	ADJ
aji-135	205	16	spontaneous	spontaneous	ADJ
aji-135	205	17	precipitation	precipitation	NOUN
aji-135	205	18	(	(	PUNCT
aji-135	205	19	sia	sia	PROPN
aji-135	205	20	test	test	NOUN
aji-135	205	21	)	)	PUNCT
aji-135	205	22	.	.	PUNCT
aji-135	206	1	after	after	ADP
aji-135	206	2	24	24	NUM
aji-135	206	3	hours	hour	NOUN
aji-135	206	4	,	,	PUNCT
aji-135	206	5	one	one	NUM
aji-135	206	6	of	of	ADP
aji-135	206	7	us	we	PRON
aji-135	206	8	examined	examine	VERB
aji-135	206	9	the	the	DET
aji-135	206	10	tubes	tube	NOUN
aji-135	206	11	,	,	PUNCT
aji-135	206	12	and	and	CCONJ
aji-135	206	13	the	the	DET
aji-135	206	14	titers	titer	NOUN
aji-135	206	15	(	(	PUNCT
aji-135	206	16	the	the	DET
aji-135	206	17	highest	high	ADJ
aji-135	206	18	dilution	dilution	NOUN
aji-135	206	19	factor	factor	NOUN
aji-135	206	20	that	that	PRON
aji-135	206	21	yields	yield	VERB
aji-135	206	22	a	a	DET
aji-135	206	23	positive	positive	ADJ
aji-135	206	24	visual	visual	ADJ
aji-135	206	25	reading	reading	NOUN
aji-135	206	26	)	)	PUNCT
aji-135	206	27	were	be	AUX
aji-135	206	28	recorded	record	VERB
aji-135	206	29	[	[	X
aji-135	206	30	53	53	NUM
aji-135	206	31	]	]	PUNCT
aji-135	206	32	.	.	PUNCT
aji-135	207	1	3	3	X
aji-135	207	2	.	.	X
aji-135	207	3	results	result	NOUN
aji-135	207	4	as	as	ADP
aji-135	207	5	a	a	DET
aji-135	207	6	retrospective	retrospective	ADJ
aji-135	207	7	survey	survey	NOUN
aji-135	207	8	,	,	PUNCT
aji-135	207	9	there	there	PRON
aji-135	207	10	was	be	VERB
aji-135	207	11	no	no	DET
aji-135	207	12	research	research	NOUN
aji-135	207	13	protocol	protocol	NOUN
aji-135	207	14	;	;	PUNCT
aji-135	207	15	therefore	therefore	ADV
aji-135	207	16	,	,	PUNCT
aji-135	207	17	we	we	PRON
aji-135	207	18	report	report	VERB
aji-135	207	19	the	the	DET
aji-135	207	20	incidental	incidental	ADJ
aji-135	207	21	immune	immune	ADJ
aji-135	207	22	investigation	investigation	NOUN
aji-135	207	23	as	as	SCONJ
aji-135	207	24	registered	register	VERB
aji-135	207	25	in	in	ADP
aji-135	207	26	the	the	DET
aji-135	207	27	digital	digital	ADJ
aji-135	207	28	medical	medical	ADJ
aji-135	207	29	charts	chart	NOUN
aji-135	207	30	.	.	PUNCT
aji-135	208	1	the	the	DET
aji-135	208	2	ttp	ttp	PROPN
aji-135	208	3	showed	show	VERB
aji-135	208	4	a	a	DET
aji-135	208	5	wide	wide	ADJ
aji-135	208	6	distribution	distribution	NOUN
aji-135	208	7	range	range	NOUN
aji-135	208	8	of	of	ADP
aji-135	208	9	results	result	NOUN
aji-135	208	10	.	.	PUNCT
aji-135	209	1	there	there	PRON
aji-135	209	2	were	be	VERB
aji-135	209	3	two	two	NUM
aji-135	209	4	negative	negative	ADJ
aji-135	209	5	results	result	NOUN
aji-135	209	6	.	.	PUNCT
aji-135	210	1	most	most	ADJ
aji-135	210	2	positive	positive	ADJ
aji-135	210	3	results	result	NOUN
aji-135	210	4	concentrated	concentrate	VERB
aji-135	210	5	on	on	ADP
aji-135	210	6	the	the	DET
aji-135	210	7	higher	high	ADJ
aji-135	210	8	dilutions	dilution	NOUN
aji-135	210	9	(	(	PUNCT
aji-135	210	10	fig	fig	NOUN
aji-135	210	11	.	.	PUNCT
aji-135	211	1	1	1	NUM
aji-135	211	2	)	)	PUNCT
aji-135	211	3	.	.	PUNCT
aji-135	212	1	the	the	DET
aji-135	212	2	mean	mean	NOUN
aji-135	212	3	was	be	AUX
aji-135	212	4	estimated	estimate	VERB
aji-135	212	5	at	at	ADP
aji-135	212	6	1:246	1:246	NUM
aji-135	212	7	;	;	PUNCT
aji-135	212	8	the	the	DET
aji-135	212	9	median	median	NOUN
aji-135	212	10	was	be	AUX
aji-135	212	11	1:192	1:192	NUM
aji-135	212	12	;	;	PUNCT
aji-135	212	13	the	the	DET
aji-135	212	14	sd	sd	NOUN
aji-135	212	15	was	be	AUX
aji-135	212	16	estimated	estimate	VERB
aji-135	212	17	at	at	ADP
aji-135	212	18	1:188	1:188	NUM
aji-135	212	19	;	;	PUNCT
aji-135	212	20	the	the	DET
aji-135	212	21	mode	mode	NOUN
aji-135	212	22	was	be	AUX
aji-135	212	23	1:512	1:512	NUM
aji-135	212	24	(	(	PUNCT
aji-135	212	25	appeared	appear	VERB
aji-135	212	26	30	30	NUM
aji-135	212	27	times	time	NOUN
aji-135	212	28	)	)	PUNCT
aji-135	212	29	.	.	PUNCT
aji-135	213	1	all	all	PRON
aji-135	213	2	sia	sia	PROPN
aji-135	213	3	tests	test	NOUN
aji-135	213	4	were	be	AUX
aji-135	213	5	negative	negative	ADJ
aji-135	213	6	.	.	PUNCT
aji-135	214	1	the	the	DET
aji-135	214	2	lait	lait	NOUN
aji-135	214	3	showed	show	VERB
aji-135	214	4	a	a	DET
aji-135	214	5	wide	wide	ADJ
aji-135	214	6	distribution	distribution	NOUN
aji-135	214	7	range	range	NOUN
aji-135	214	8	of	of	ADP
aji-135	214	9	results	result	NOUN
aji-135	214	10	.	.	PUNCT
aji-135	215	1	the	the	DET
aji-135	215	2	lai	lai	PROPN
aji-135	215	3	ranged	range	VERB
aji-135	215	4	from	from	ADP
aji-135	215	5	0	0	NUM
aji-135	215	6	%	%	NOUN
aji-135	215	7	to	to	PART
aji-135	215	8	98	98	NUM
aji-135	215	9	%	%	NOUN
aji-135	215	10	.	.	PUNCT
aji-135	216	1	the	the	DET
aji-135	216	2	mean	mean	NOUN
aji-135	216	3	was	be	AUX
aji-135	216	4	41.9	41.9	NUM
aji-135	216	5	%	%	NOUN
aji-135	216	6	;	;	PUNCT
aji-135	216	7	the	the	DET
aji-135	216	8	median	median	NOUN
aji-135	216	9	was	be	AUX
aji-135	216	10	45	45	NUM
aji-135	216	11	%	%	NOUN
aji-135	216	12	;	;	PUNCT
aji-135	216	13	the	the	DET
aji-135	216	14	sd	sd	NOUN
aji-135	216	15	was	be	AUX
aji-135	216	16	28.5	28.5	NUM
aji-135	216	17	%	%	NOUN
aji-135	216	18	;	;	PUNCT
aji-135	216	19	the	the	DET
aji-135	216	20	mode	mode	NOUN
aji-135	216	21	was	be	AUX
aji-135	216	22	0	0	NUM
aji-135	216	23	%	%	NOUN
aji-135	216	24	(	(	PUNCT
aji-135	216	25	appeared	appear	VERB
aji-135	216	26	seven	seven	NUM
aji-135	216	27	times	time	NOUN
aji-135	216	28	)	)	PUNCT
aji-135	216	29	.	.	PUNCT
aji-135	217	1	the	the	DET
aji-135	217	2	cascade	cascade	NOUN
aji-135	217	3	distribution	distribution	NOUN
aji-135	217	4	demonstrates	demonstrate	VERB
aji-135	217	5	a	a	DET
aji-135	217	6	wide	wide	ADJ
aji-135	217	7	range	range	NOUN
aji-135	217	8	of	of	ADP
aji-135	217	9	distribution	distribution	NOUN
aji-135	217	10	of	of	ADP
aji-135	217	11	lai	lai	PROPN
aji-135	217	12	results	result	NOUN
aji-135	217	13	(	(	PUNCT
aji-135	217	14	fig	fig	NOUN
aji-135	217	15	.	.	PUNCT
aji-135	218	1	2	2	NUM
aji-135	218	2	)	)	PUNCT
aji-135	218	3	.	.	PUNCT
aji-135	219	1	six	six	NUM
aji-135	219	2	patients	patient	NOUN
aji-135	219	3	ignored	ignore	VERB
aji-135	219	4	the	the	DET
aji-135	219	5	presence	presence	NOUN
aji-135	219	6	of	of	ADP
aji-135	219	7	the	the	DET
aji-135	219	8	allergen	allergen	NOUN
aji-135	219	9	on	on	ADP
aji-135	219	10	the	the	DET
aji-135	219	11	plasma	plasma	NOUN
aji-135	219	12	and	and	CCONJ
aji-135	219	13	presented	present	VERB
aji-135	219	14	no	no	DET
aji-135	219	15	inhibition	inhibition	NOUN
aji-135	219	16	of	of	ADP
aji-135	219	17	leukocyte	leukocyte	NOUN
aji-135	219	18	adherence	adherence	NOUN
aji-135	219	19	(	(	PUNCT
aji-135	219	20	lai	lai	NOUN
aji-135	219	21	=	=	PUNCT
aji-135	219	22	0	0	NUM
aji-135	219	23	%	%	NOUN
aji-135	219	24	)	)	PUNCT
aji-135	219	25	after	after	ADP
aji-135	219	26	contact	contact	NOUN
aji-135	219	27	with	with	ADP
aji-135	219	28	the	the	DET
aji-135	219	29	pegs	pegs	NOUN
aji-135	219	30	extract	extract	NOUN
aji-135	219	31	(	(	PUNCT
aji-135	219	32	6	6	NUM
aji-135	219	33	%	%	NOUN
aji-135	219	34	of	of	ADP
aji-135	219	35	the	the	DET
aji-135	219	36	tests	test	NOUN
aji-135	219	37	)	)	PUNCT
aji-135	219	38	.	.	PUNCT
aji-135	220	1	some	some	DET
aji-135	220	2	patients	patient	NOUN
aji-135	220	3	showed	show	VERB
aji-135	220	4	any	any	DET
aji-135	220	5	or	or	CCONJ
aji-135	220	6	low	low	ADJ
aji-135	220	7	immunoreactivity	immunoreactivity	NOUN
aji-135	220	8	during	during	ADP
aji-135	220	9	the	the	DET
aji-135	220	10	ex	ex	ADJ
aji-135	220	11	vivo	vivo	NOUN
aji-135	220	12	challenge	challenge	NOUN
aji-135	220	13	test	test	NOUN
aji-135	220	14	,	,	PUNCT
aji-135	220	15	while	while	SCONJ
aji-135	220	16	most	most	ADJ
aji-135	220	17	displayed	display	VERB
aji-135	220	18	moderate	moderate	ADJ
aji-135	220	19	or	or	CCONJ
aji-135	220	20	strong	strong	ADJ
aji-135	220	21	immunoreactivity	immunoreactivity	NOUN
aji-135	220	22	,	,	PUNCT
aji-135	220	23	which	which	PRON
aji-135	220	24	could	could	AUX
aji-135	220	25	reflect	reflect	VERB
aji-135	220	26	the	the	DET
aji-135	220	27	participation	participation	NOUN
aji-135	220	28	of	of	ADP
aji-135	220	29	pegs	peg	NOUN
aji-135	220	30	antibodies	antibodie	VERB
aji-135	220	31	in	in	ADP
aji-135	220	32	a	a	DET
aji-135	220	33	non	non	ADJ
aji-135	220	34	–	–	PUNCT
aji-135	220	35	ige	ige	ADJ
aji-135	220	36	-	-	PUNCT
aji-135	220	37	mediated	mediate	VERB
aji-135	220	38	hypersensitivity	hypersensitivity	NOUN
aji-135	220	39	condition	condition	NOUN
aji-135	220	40	.	.	PUNCT
aji-135	221	1	fig	fig	NOUN
aji-135	221	2	.	.	PUNCT
aji-135	222	1	1	1	NUM
aji-135	222	2	.	.	X
aji-135	222	3	cascade	cascade	NOUN
aji-135	222	4	distribution	distribution	NOUN
aji-135	222	5	chart	chart	NOUN
aji-135	222	6	of	of	ADP
aji-135	222	7	the	the	DET
aji-135	222	8	tube	tube	NOUN
aji-135	222	9	titration	titration	NOUN
aji-135	222	10	of	of	ADP
aji-135	222	11	precipitins	precipitin	NOUN
aji-135	222	12	(	(	PUNCT
aji-135	222	13	ttp	ttp	X
aji-135	222	14	on	on	ADP
aji-135	222	15	the	the	DET
aji-135	222	16	x	x	ADJ
aji-135	222	17	-	-	ADJ
aji-135	222	18	axis	axis	ADJ
aji-135	222	19	%	%	NOUN
aji-135	222	20	)	)	PUNCT
aji-135	222	21	resulting	result	VERB
aji-135	222	22	from	from	ADP
aji-135	222	23	the	the	DET
aji-135	222	24	pegs	pegs	NOUN
aji-135	222	25	solution	solution	NOUN
aji-135	222	26	against	against	ADP
aji-135	222	27	the	the	DET
aji-135	222	28	serially	serially	ADV
aji-135	222	29	diluted	dilute	VERB
aji-135	222	30	serum	serum	NOUN
aji-135	222	31	of	of	ADP
aji-135	222	32	a	a	DET
aji-135	222	33	cohort	cohort	NOUN
aji-135	222	34	of	of	ADP
aji-135	222	35	100	100	NUM
aji-135	222	36	tests	test	NOUN
aji-135	222	37	/	/	SYM
aji-135	222	38	subjects	subject	NOUN
aji-135	222	39	(	(	PUNCT
aji-135	222	40	y	y	NOUN
aji-135	222	41	-	-	PUNCT
aji-135	222	42	axis	axis	NOUN
aji-135	222	43	)	)	PUNCT
aji-135	222	44	olivier	olivier	NOUN
aji-135	222	45	et	et	PROPN
aji-135	222	46	al	al	PROPN
aji-135	222	47	.	.	PROPN
aji-135	222	48	;	;	PUNCT
aji-135	222	49	asian	asian	PROPN
aji-135	222	50	j.	j.	PROPN
aji-135	222	51	immunol	immunol	PROPN
aji-135	222	52	.	.	PROPN
aji-135	222	53	,	,	PUNCT
aji-135	222	54	vol	vol	NOUN
aji-135	222	55	.	.	PROPN
aji-135	223	1	7	7	NUM
aji-135	223	2	,	,	PUNCT
aji-135	223	3	no	no	INTJ
aji-135	223	4	.	.	NOUN
aji-135	223	5	1	1	NUM
aji-135	223	6	,	,	PUNCT
aji-135	223	7	pp	pp	ADJ
aji-135	223	8	.	.	PUNCT
aji-135	224	1	100	100	NUM
aji-135	224	2	-	-	SYM
aji-135	224	3	111	111	NUM
aji-135	224	4	,	,	PUNCT
aji-135	224	5	2024	2024	NUM
aji-135	224	6	;	;	PUNCT
aji-135	225	1	article	article	NOUN
aji-135	225	2	no.aji.119914	no.aji.119914	PROPN
aji-135	225	3	105	105	NUM
aji-135	225	4	fig	fig	NOUN
aji-135	225	5	.	.	PUNCT
aji-135	226	1	2	2	NUM
aji-135	226	2	.	.	NOUN
aji-135	226	3	cascade	cascade	NOUN
aji-135	226	4	distribution	distribution	NOUN
aji-135	226	5	chart	chart	NOUN
aji-135	226	6	of	of	ADP
aji-135	226	7	the	the	DET
aji-135	226	8	range	range	NOUN
aji-135	226	9	groups	group	NOUN
aji-135	226	10	of	of	ADP
aji-135	226	11	leukocyte	leukocyte	NOUN
aji-135	226	12	adherence	adherence	NOUN
aji-135	226	13	inhibition	inhibition	NOUN
aji-135	226	14	(	(	PUNCT
aji-135	226	15	lai	lai	NOUN
aji-135	226	16	)	)	PUNCT
aji-135	226	17	results	result	NOUN
aji-135	226	18	(	(	PUNCT
aji-135	226	19	x	x	NOUN
aji-135	226	20	-	-	ADJ
aji-135	226	21	axis	axis	ADJ
aji-135	226	22	%	%	NOUN
aji-135	226	23	)	)	PUNCT
aji-135	226	24	of	of	ADP
aji-135	226	25	ex	ex	PRON
aji-135	226	26	vivo	vivo	NOUN
aji-135	226	27	pegs	pegs	NOUN
aji-135	226	28	solution	solution	NOUN
aji-135	226	29	monitored	monitor	VERB
aji-135	226	30	by	by	ADP
aji-135	226	31	the	the	DET
aji-135	226	32	leukocyte	leukocyte	NOUN
aji-135	226	33	adherence	adherence	NOUN
aji-135	226	34	inhibition	inhibition	NOUN
aji-135	226	35	test	test	NOUN
aji-135	226	36	(	(	PUNCT
aji-135	226	37	lait	lait	NOUN
aji-135	226	38	)	)	PUNCT
aji-135	226	39	,	,	PUNCT
aji-135	226	40	according	accord	VERB
aji-135	226	41	to	to	ADP
aji-135	226	42	the	the	DET
aji-135	226	43	respective	respective	ADJ
aji-135	226	44	number	number	NOUN
aji-135	226	45	of	of	ADP
aji-135	226	46	outcomes	outcome	NOUN
aji-135	226	47	over	over	ADP
aji-135	226	48	a	a	DET
aji-135	226	49	cohort	cohort	NOUN
aji-135	226	50	with	with	ADP
aji-135	226	51	100	100	NUM
aji-135	226	52	tests	test	NOUN
aji-135	226	53	/	/	SYM
aji-135	226	54	subjects	subject	NOUN
aji-135	226	55	(	(	PUNCT
aji-135	226	56	y	y	NOUN
aji-135	226	57	-	-	PUNCT
aji-135	226	58	axis	axis	NOUN
aji-135	226	59	)	)	PUNCT
aji-135	226	60	4	4	NUM
aji-135	226	61	.	.	X
aji-135	226	62	discussion	discussion	NOUN
aji-135	226	63	more	more	ADV
aji-135	226	64	and	and	CCONJ
aji-135	226	65	more	more	ADJ
aji-135	226	66	patients	patient	NOUN
aji-135	226	67	are	be	AUX
aji-135	226	68	being	be	AUX
aji-135	226	69	diagnosed	diagnose	VERB
aji-135	226	70	with	with	ADP
aji-135	226	71	peg	peg	NOUN
aji-135	226	72	allergy	allergy	NOUN
aji-135	226	73	as	as	ADP
aji-135	226	74	an	an	DET
aji-135	226	75	increasing	increase	VERB
aji-135	226	76	number	number	NOUN
aji-135	226	77	of	of	ADP
aji-135	226	78	processed	process	VERB
aji-135	226	79	foods	food	NOUN
aji-135	226	80	,	,	PUNCT
aji-135	226	81	cosmetics	cosmetic	NOUN
aji-135	226	82	,	,	PUNCT
aji-135	226	83	household	household	NOUN
aji-135	226	84	products	product	NOUN
aji-135	226	85	,	,	PUNCT
aji-135	226	86	vaccines	vaccine	NOUN
aji-135	226	87	,	,	PUNCT
aji-135	226	88	and	and	CCONJ
aji-135	226	89	medicines	medicine	NOUN
aji-135	226	90	add	add	VERB
aji-135	226	91	peg	peg	NOUN
aji-135	226	92	to	to	ADP
aji-135	226	93	their	their	PRON
aji-135	226	94	composition	composition	NOUN
aji-135	226	95	[	[	X
aji-135	226	96	54	54	NUM
aji-135	226	97	]	]	PUNCT
aji-135	226	98	.	.	PUNCT
aji-135	227	1	the	the	DET
aji-135	227	2	development	development	NOUN
aji-135	227	3	of	of	ADP
aji-135	227	4	new	new	ADJ
aji-135	227	5	pegylated	pegylate	VERB
aji-135	227	6	compounds	compound	NOUN
aji-135	227	7	is	be	AUX
aji-135	227	8	advancing	advance	VERB
aji-135	227	9	,	,	PUNCT
aji-135	227	10	especially	especially	ADV
aji-135	227	11	among	among	ADP
aji-135	227	12	biological	biological	ADJ
aji-135	227	13	immune	immune	ADJ
aji-135	227	14	therapeutics	therapeutic	NOUN
aji-135	227	15	[	[	X
aji-135	227	16	55	55	NUM
aji-135	227	17	]	]	PUNCT
aji-135	227	18	.	.	PUNCT
aji-135	228	1	pegs	peg	NOUN
aji-135	228	2	are	be	AUX
aji-135	228	3	the	the	DET
aji-135	228	4	polymer	polymer	NOUN
aji-135	228	5	of	of	ADP
aji-135	228	6	choice	choice	NOUN
aji-135	228	7	for	for	ADP
aji-135	228	8	the	the	DET
aji-135	228	9	delivery	delivery	NOUN
aji-135	228	10	of	of	ADP
aji-135	228	11	small	small	ADJ
aji-135	228	12	drugs	drug	NOUN
aji-135	228	13	,	,	PUNCT
aji-135	228	14	proteins	protein	NOUN
aji-135	228	15	,	,	PUNCT
aji-135	228	16	oligonucleotides	oligonucleotide	NOUN
aji-135	228	17	,	,	PUNCT
aji-135	228	18	and	and	CCONJ
aji-135	228	19	liposomes	liposome	NOUN
aji-135	228	20	due	due	ADP
aji-135	228	21	to	to	ADP
aji-135	228	22	their	their	PRON
aji-135	228	23	biocompatibility	biocompatibility	NOUN
aji-135	228	24	and	and	CCONJ
aji-135	228	25	ability	ability	NOUN
aji-135	228	26	to	to	PART
aji-135	228	27	improve	improve	VERB
aji-135	228	28	pharmacokinetics	pharmacokinetic	NOUN
aji-135	228	29	;	;	PUNCT
aji-135	228	30	however	however	ADV
aji-135	228	31	,	,	PUNCT
aji-135	228	32	pegs	peg	NOUN
aji-135	228	33	are	be	AUX
aji-135	228	34	a	a	DET
aji-135	228	35	mixture	mixture	NOUN
aji-135	228	36	of	of	ADP
aji-135	228	37	different	different	ADJ
aji-135	228	38	polymers	polymer	NOUN
aji-135	228	39	that	that	PRON
aji-135	228	40	can	can	AUX
aji-135	228	41	stimulate	stimulate	VERB
aji-135	228	42	unwanted	unwanted	ADJ
aji-135	228	43	immunogenic	immunogenic	ADJ
aji-135	228	44	reactions	reaction	NOUN
aji-135	228	45	,	,	PUNCT
aji-135	228	46	leading	lead	VERB
aji-135	228	47	to	to	ADP
aji-135	228	48	efforts	effort	NOUN
aji-135	228	49	to	to	PART
aji-135	228	50	develop	develop	VERB
aji-135	228	51	synthetic	synthetic	ADJ
aji-135	228	52	(	(	PUNCT
aji-135	228	53	monodisperse	monodisperse	NOUN
aji-135	228	54	)	)	PUNCT
aji-135	228	55	more	more	ADJ
aji-135	228	56	uniform	uniform	ADJ
aji-135	228	57	pegs	peg	NOUN
aji-135	228	58	[	[	X
aji-135	228	59	56	56	NUM
aji-135	228	60	]	]	PUNCT
aji-135	228	61	.	.	PUNCT
aji-135	229	1	peg	peg	NOUN
aji-135	229	2	hypersensitivity	hypersensitivity	NOUN
aji-135	229	3	is	be	AUX
aji-135	229	4	associated	associate	VERB
aji-135	229	5	with	with	ADP
aji-135	229	6	medicine	medicine	NOUN
aji-135	229	7	-	-	PUNCT
aji-135	229	8	induced	induce	VERB
aji-135	229	9	anaphylaxis	anaphylaxis	ADJ
aji-135	229	10	,	,	PUNCT
aji-135	229	11	and	and	CCONJ
aji-135	229	12	pegylateddrug	pegylateddrug	NOUN
aji-135	229	13	reactions	reaction	NOUN
aji-135	229	14	should	should	AUX
aji-135	229	15	prompt	prompt	VERB
aji-135	229	16	pegs	pegs	NOUN
aji-135	229	17	hypersensitivity	hypersensitivity	NOUN
aji-135	229	18	investigations	investigation	NOUN
aji-135	229	19	,	,	PUNCT
aji-135	229	20	especially	especially	ADV
aji-135	229	21	by	by	ADP
aji-135	229	22	use	use	NOUN
aji-135	229	23	of	of	ADP
aji-135	229	24	skin	skin	NOUN
aji-135	229	25	allergic	allergic	ADJ
aji-135	229	26	tests	test	NOUN
aji-135	229	27	with	with	ADP
aji-135	229	28	high	high	ADJ
aji-135	229	29	molecular	molecular	ADJ
aji-135	229	30	weight	weight	NOUN
aji-135	229	31	pegs	peg	NOUN
aji-135	229	32	[	[	X
aji-135	229	33	57	57	NUM
aji-135	229	34	]	]	PUNCT
aji-135	229	35	.	.	PUNCT
aji-135	230	1	diagnosing	diagnose	VERB
aji-135	230	2	peg	peg	NOUN
aji-135	230	3	allergy	allergy	NOUN
aji-135	230	4	is	be	AUX
aji-135	230	5	challenging	challenge	VERB
aji-135	230	6	since	since	SCONJ
aji-135	230	7	the	the	DET
aji-135	230	8	traditional	traditional	ADJ
aji-135	230	9	allergy	allergy	NOUN
aji-135	230	10	testing	testing	NOUN
aji-135	230	11	approaches	approach	NOUN
aji-135	230	12	are	be	AUX
aji-135	230	13	insufficient	insufficient	ADJ
aji-135	230	14	to	to	PART
aji-135	230	15	demonstrate	demonstrate	VERB
aji-135	230	16	all	all	DET
aji-135	230	17	kinds	kind	NOUN
aji-135	230	18	of	of	ADP
aji-135	230	19	hypersensitivity	hypersensitivity	NOUN
aji-135	230	20	reactions	reaction	NOUN
aji-135	231	1	[	[	X
aji-135	231	2	58	58	NUM
aji-135	231	3	]	]	PUNCT
aji-135	231	4	.	.	PUNCT
aji-135	232	1	besides	besides	SCONJ
aji-135	232	2	the	the	DET
aji-135	232	3	ige	ige	NOUN
aji-135	232	4	-	-	PUNCT
aji-135	232	5	mediated	mediate	VERB
aji-135	232	6	hypersensitivity	hypersensitivity	NOUN
aji-135	232	7	reaction	reaction	NOUN
aji-135	232	8	,	,	PUNCT
aji-135	232	9	the	the	DET
aji-135	232	10	production	production	NOUN
aji-135	232	11	of	of	ADP
aji-135	232	12	specific	specific	ADJ
aji-135	232	13	igm	igm	NOUN
aji-135	232	14	and	and	CCONJ
aji-135	232	15	igg	igg	PROPN
aji-135	232	16	antibodies	antibodie	VERB
aji-135	232	17	and	and	CCONJ
aji-135	232	18	complement	complement	NOUN
aji-135	232	19	activation	activation	NOUN
aji-135	232	20	were	be	AUX
aji-135	232	21	also	also	ADV
aji-135	232	22	described	describe	VERB
aji-135	232	23	[	[	X
aji-135	232	24	59	59	NUM
aji-135	232	25	]	]	PUNCT
aji-135	232	26	.	.	PUNCT
aji-135	233	1	since	since	SCONJ
aji-135	233	2	a	a	DET
aji-135	233	3	methodology	methodology	NOUN
aji-135	233	4	for	for	ADP
aji-135	233	5	specific	specific	ADJ
aji-135	233	6	-	-	PUNCT
aji-135	233	7	ige	ige	NOUN
aji-135	233	8	research	research	NOUN
aji-135	233	9	has	have	AUX
aji-135	233	10	not	not	PART
aji-135	233	11	yet	yet	ADV
aji-135	233	12	been	be	AUX
aji-135	233	13	described	describe	VERB
aji-135	233	14	,	,	PUNCT
aji-135	233	15	the	the	DET
aji-135	233	16	feasibility	feasibility	NOUN
aji-135	233	17	of	of	ADP
aji-135	233	18	in	in	ADP
aji-135	233	19	vitro	vitro	X
aji-135	233	20	challenge	challenge	NOUN
aji-135	233	21	tests	test	NOUN
aji-135	233	22	,	,	PUNCT
aji-135	233	23	such	such	ADJ
aji-135	233	24	as	as	ADP
aji-135	233	25	the	the	DET
aji-135	233	26	basophil	basophil	NOUN
aji-135	233	27	activation	activation	NOUN
aji-135	233	28	test	test	NOUN
aji-135	233	29	,	,	PUNCT
aji-135	233	30	is	be	AUX
aji-135	233	31	being	be	AUX
aji-135	233	32	studied	study	VERB
aji-135	233	33	[	[	PUNCT
aji-135	233	34	60	60	NUM
aji-135	233	35	]	]	PUNCT
aji-135	233	36	.	.	PUNCT
aji-135	234	1	brand	brand	NOUN
aji-135	234	2	new	new	ADJ
aji-135	234	3	allergic	allergic	ADJ
aji-135	234	4	diagnostic	diagnostic	ADJ
aji-135	234	5	techniques	technique	NOUN
aji-135	234	6	(	(	PUNCT
aji-135	234	7	such	such	ADJ
aji-135	234	8	as	as	ADP
aji-135	234	9	performing	perform	VERB
aji-135	234	10	tests	test	NOUN
aji-135	234	11	with	with	ADP
aji-135	234	12	the	the	DET
aji-135	234	13	help	help	NOUN
aji-135	234	14	of	of	ADP
aji-135	234	15	pegylated	pegylated	ADJ
aji-135	234	16	liposomes	liposome	NOUN
aji-135	234	17	)	)	PUNCT
aji-135	234	18	are	be	AUX
aji-135	234	19	currently	currently	ADV
aji-135	234	20	being	be	AUX
aji-135	234	21	designed	design	VERB
aji-135	234	22	to	to	PART
aji-135	234	23	endotype	endotype	VERB
aji-135	234	24	pegs	peg	NOUN
aji-135	234	25	allergies	allergy	NOUN
aji-135	234	26	[	[	X
aji-135	234	27	61	61	NUM
aji-135	234	28	]	]	PUNCT
aji-135	234	29	.	.	PUNCT
aji-135	235	1	the	the	DET
aji-135	235	2	precise	precise	ADJ
aji-135	235	3	diagnosis	diagnosis	NOUN
aji-135	235	4	of	of	ADP
aji-135	235	5	the	the	DET
aji-135	235	6	phenotypes	phenotype	NOUN
aji-135	235	7	and	and	CCONJ
aji-135	235	8	endotypes	endotype	NOUN
aji-135	235	9	of	of	ADP
aji-135	235	10	hypersensitivities	hypersensitivity	NOUN
aji-135	235	11	to	to	ADP
aji-135	235	12	pegylated	pegylated	ADJ
aji-135	235	13	medications	medication	NOUN
aji-135	235	14	is	be	AUX
aji-135	235	15	paramount	paramount	ADJ
aji-135	235	16	for	for	ADP
aji-135	235	17	prescribing	prescribe	VERB
aji-135	235	18	a	a	DET
aji-135	235	19	successful	successful	ADJ
aji-135	235	20	pegs	pegs	NOUN
aji-135	235	21	desensitization	desensitization	NOUN
aji-135	235	22	[	[	X
aji-135	235	23	62	62	NUM
aji-135	235	24	]	]	PUNCT
aji-135	235	25	.	.	PUNCT
aji-135	236	1	this	this	DET
aji-135	236	2	retrospective	retrospective	ADJ
aji-135	236	3	compilation	compilation	NOUN
aji-135	236	4	of	of	ADP
aji-135	236	5	our	our	PRON
aji-135	236	6	data	datum	NOUN
aji-135	236	7	showed	show	VERB
aji-135	236	8	a	a	DET
aji-135	236	9	large	large	ADJ
aji-135	236	10	distribution	distribution	NOUN
aji-135	236	11	of	of	ADP
aji-135	236	12	results	result	NOUN
aji-135	236	13	when	when	SCONJ
aji-135	236	14	we	we	PRON
aji-135	236	15	ascertained	ascertain	VERB
aji-135	236	16	the	the	DET
aji-135	236	17	results	result	NOUN
aji-135	236	18	of	of	ADP
aji-135	236	19	ttp	ttp	NOUN
aji-135	236	20	and	and	CCONJ
aji-135	236	21	tial	tial	ADJ
aji-135	236	22	to	to	PART
aji-135	236	23	explore	explore	VERB
aji-135	236	24	humoral	humoral	ADJ
aji-135	236	25	and	and	CCONJ
aji-135	236	26	cellular	cellular	ADJ
aji-135	236	27	immunoreactivity	immunoreactivity	NOUN
aji-135	236	28	against	against	ADP
aji-135	236	29	pegs	peg	NOUN
aji-135	236	30	.	.	PUNCT
aji-135	237	1	these	these	DET
aji-135	237	2	immunoassays	immunoassay	NOUN
aji-135	237	3	do	do	AUX
aji-135	237	4	not	not	PART
aji-135	237	5	identify	identify	VERB
aji-135	237	6	the	the	DET
aji-135	237	7	exact	exact	ADJ
aji-135	237	8	mechanisms	mechanism	NOUN
aji-135	237	9	responsible	responsible	ADJ
aji-135	237	10	for	for	ADP
aji-135	237	11	the	the	DET
aji-135	237	12	clinical	clinical	ADJ
aji-135	237	13	condition	condition	NOUN
aji-135	237	14	.	.	PUNCT
aji-135	238	1	instead	instead	ADV
aji-135	238	2	,	,	PUNCT
aji-135	238	3	they	they	PRON
aji-135	238	4	provide	provide	VERB
aji-135	238	5	clues	clue	NOUN
aji-135	238	6	about	about	ADP
aji-135	238	7	sensitization	sensitization	NOUN
aji-135	238	8	and	and	CCONJ
aji-135	238	9	immunoreactivity	immunoreactivity	NOUN
aji-135	238	10	distributed	distribute	VERB
aji-135	238	11	into	into	ADP
aji-135	238	12	an	an	DET
aji-135	238	13	extensive	extensive	ADJ
aji-135	238	14	spectral	spectral	ADJ
aji-135	238	15	range	range	NOUN
aji-135	238	16	between	between	ADP
aji-135	238	17	immune	immune	ADJ
aji-135	238	18	tolerance	tolerance	NOUN
aji-135	238	19	and	and	CCONJ
aji-135	238	20	symptomatic	symptomatic	ADJ
aji-135	238	21	hypersensitivity	hypersensitivity	NOUN
aji-135	238	22	.	.	PUNCT
aji-135	239	1	the	the	DET
aji-135	239	2	semi	semi	ADJ
aji-135	239	3	-	-	ADJ
aji-135	239	4	quantitative	quantitative	ADJ
aji-135	239	5	study	study	NOUN
aji-135	239	6	of	of	ADP
aji-135	239	7	the	the	DET
aji-135	239	8	serological	serological	ADJ
aji-135	239	9	reactions	reaction	NOUN
aji-135	239	10	through	through	ADP
aji-135	239	11	the	the	DET
aji-135	239	12	titration	titration	NOUN
aji-135	239	13	of	of	ADP
aji-135	239	14	precipitins	precipitin	NOUN
aji-135	239	15	was	be	AUX
aji-135	239	16	the	the	DET
aji-135	239	17	most	most	ADV
aji-135	239	18	basic	basic	ADJ
aji-135	239	19	laboratory	laboratory	NOUN
aji-135	239	20	exam	exam	NOUN
aji-135	239	21	upon	upon	SCONJ
aji-135	239	22	which	which	PRON
aji-135	239	23	the	the	DET
aji-135	239	24	fundamentals	fundamental	NOUN
aji-135	239	25	of	of	ADP
aji-135	239	26	immunology	immunology	NOUN
aji-135	239	27	were	be	AUX
aji-135	239	28	constructed	construct	VERB
aji-135	239	29	[	[	PUNCT
aji-135	239	30	63	63	NUM
aji-135	239	31	]	]	PUNCT
aji-135	239	32	.	.	PUNCT
aji-135	240	1	precipitating	precipitate	VERB
aji-135	240	2	antibodies	antibody	NOUN
aji-135	240	3	are	be	AUX
aji-135	240	4	classically	classically	ADV
aji-135	240	5	olivier	olivi	ADJ
aji-135	240	6	et	et	PROPN
aji-135	240	7	al	al	PROPN
aji-135	240	8	.	.	PROPN
aji-135	240	9	;	;	PUNCT
aji-135	241	1	asian	asian	PROPN
aji-135	241	2	j.	j.	PROPN
aji-135	241	3	immunol	immunol	PROPN
aji-135	241	4	.	.	PROPN
aji-135	241	5	,	,	PUNCT
aji-135	241	6	vol	vol	NOUN
aji-135	241	7	.	.	PROPN
aji-135	241	8	7	7	NUM
aji-135	241	9	,	,	PUNCT
aji-135	241	10	no	no	INTJ
aji-135	241	11	.	.	NOUN
aji-135	241	12	1	1	NUM
aji-135	241	13	,	,	PUNCT
aji-135	241	14	pp	pp	ADJ
aji-135	241	15	.	.	PUNCT
aji-135	241	16	100	100	NUM
aji-135	241	17	-	-	SYM
aji-135	241	18	111	111	NUM
aji-135	241	19	,	,	PUNCT
aji-135	241	20	2024	2024	NUM
aji-135	241	21	;	;	PUNCT
aji-135	241	22	article	article	NOUN
aji-135	241	23	no.aji.119914	no.aji.119914	PROPN
aji-135	241	24	106	106	NUM
aji-135	241	25	associated	associate	VERB
aji-135	241	26	with	with	ADP
aji-135	241	27	a	a	DET
aji-135	241	28	robust	robust	ADJ
aji-135	241	29	immune	immune	ADJ
aji-135	241	30	humoral	humoral	ADJ
aji-135	241	31	response	response	NOUN
aji-135	241	32	against	against	ADP
aji-135	241	33	an	an	DET
aji-135	241	34	antigen	antigen	NOUN
aji-135	241	35	or	or	CCONJ
aji-135	241	36	allergen	allergen	VERB
aji-135	241	37	[	[	X
aji-135	241	38	64	64	NUM
aji-135	241	39	]	]	PUNCT
aji-135	241	40	.	.	PUNCT
aji-135	242	1	the	the	DET
aji-135	242	2	lait	lait	NOUN
aji-135	242	3	is	be	AUX
aji-135	242	4	an	an	DET
aji-135	242	5	ex	ex	ADJ
aji-135	242	6	vivo	vivo	NOUN
aji-135	242	7	challenge	challenge	NOUN
aji-135	242	8	test	test	NOUN
aji-135	242	9	performed	perform	VERB
aji-135	242	10	with	with	ADP
aji-135	242	11	a	a	DET
aji-135	242	12	viable	viable	ADJ
aji-135	242	13	leukocyte	leukocyte	NOUN
aji-135	242	14	buffy	buffy	NOUN
aji-135	242	15	coat	coat	NOUN
aji-135	242	16	that	that	PRON
aji-135	242	17	can	can	AUX
aji-135	242	18	theoretically	theoretically	ADV
aji-135	242	19	explore	explore	VERB
aji-135	242	20	most	most	ADV
aji-135	242	21	known	know	VERB
aji-135	242	22	immune	immune	ADJ
aji-135	242	23	pathways	pathway	NOUN
aji-135	242	24	as	as	SCONJ
aji-135	242	25	it	it	PRON
aji-135	242	26	allows	allow	VERB
aji-135	242	27	the	the	DET
aji-135	242	28	interaction	interaction	NOUN
aji-135	242	29	of	of	ADP
aji-135	242	30	all	all	DET
aji-135	242	31	immune	immune	NOUN
aji-135	242	32	-	-	PUNCT
aji-135	242	33	circulating	circulate	VERB
aji-135	242	34	participants	participant	NOUN
aji-135	242	35	with	with	ADP
aji-135	242	36	the	the	DET
aji-135	242	37	allergen	allergen	NOUN
aji-135	242	38	[	[	X
aji-135	242	39	65	65	NUM
aji-135	242	40	]	]	PUNCT
aji-135	242	41	.	.	PUNCT
aji-135	243	1	similarly	similarly	ADV
aji-135	243	2	,	,	PUNCT
aji-135	243	3	with	with	ADP
aji-135	243	4	the	the	DET
aji-135	243	5	ttp	ttp	NOUN
aji-135	243	6	,	,	PUNCT
aji-135	243	7	the	the	DET
aji-135	243	8	lait	lait	NOUN
aji-135	243	9	did	do	AUX
aji-135	243	10	not	not	PART
aji-135	243	11	indicate	indicate	VERB
aji-135	243	12	which	which	PRON
aji-135	243	13	pathways	pathway	NOUN
aji-135	243	14	are	be	AUX
aji-135	243	15	involved	involve	VERB
aji-135	243	16	in	in	ADP
aji-135	243	17	producing	produce	VERB
aji-135	243	18	the	the	DET
aji-135	243	19	immune	immune	ADJ
aji-135	243	20	cellular	cellular	ADJ
aji-135	243	21	response	response	NOUN
aji-135	243	22	demonstrated	demonstrate	VERB
aji-135	243	23	by	by	ADP
aji-135	243	24	the	the	DET
aji-135	243	25	leukocyte	leukocyte	NOUN
aji-135	243	26	adherence	adherence	NOUN
aji-135	243	27	inhibition	inhibition	NOUN
aji-135	243	28	[	[	X
aji-135	243	29	66	66	NUM
aji-135	243	30	-	-	SYM
aji-135	243	31	69	69	NUM
aji-135	243	32	]	]	PUNCT
aji-135	243	33	.	.	PUNCT
aji-135	244	1	ttp	ttp	PROPN
aji-135	244	2	and	and	CCONJ
aji-135	244	3	lait	lait	PROPN
aji-135	244	4	must	must	AUX
aji-135	244	5	be	be	AUX
aji-135	244	6	interpreted	interpret	VERB
aji-135	244	7	as	as	ADP
aji-135	244	8	humoral	humoral	ADJ
aji-135	244	9	and	and	CCONJ
aji-135	244	10	cellular	cellular	ADJ
aji-135	244	11	markers	marker	NOUN
aji-135	244	12	of	of	ADP
aji-135	244	13	the	the	DET
aji-135	244	14	immune	immune	ADJ
aji-135	244	15	response	response	NOUN
aji-135	244	16	after	after	ADP
aji-135	244	17	contact	contact	NOUN
aji-135	244	18	with	with	ADP
aji-135	244	19	a	a	DET
aji-135	244	20	specific	specific	ADJ
aji-135	244	21	antigen	antigen	NOUN
aji-135	244	22	,	,	PUNCT
aji-135	244	23	configuring	configure	VERB
aji-135	244	24	themselves	themselves	PRON
aji-135	244	25	as	as	ADP
aji-135	244	26	techniques	technique	NOUN
aji-135	244	27	to	to	PART
aji-135	244	28	endotype	endotype	VERB
aji-135	244	29	the	the	DET
aji-135	244	30	exposome	exposome	NOUN
aji-135	244	31	phenomenon	phenomenon	NOUN
aji-135	244	32	,	,	PUNCT
aji-135	244	33	as	as	SCONJ
aji-135	244	34	proposed	propose	VERB
aji-135	244	35	by	by	ADP
aji-135	244	36	the	the	DET
aji-135	244	37	exposome	exposome	NOUN
aji-135	244	38	-	-	PUNCT
aji-135	244	39	wide	wide	ADJ
aji-135	244	40	association	association	NOUN
aji-135	244	41	study	study	NOUN
aji-135	244	42	[	[	X
aji-135	244	43	70	70	NUM
aji-135	244	44	]	]	PUNCT
aji-135	244	45	.	.	PUNCT
aji-135	245	1	ttp	ttp	PROPN
aji-135	245	2	and	and	CCONJ
aji-135	245	3	lait	lait	NOUN
aji-135	245	4	are	be	AUX
aji-135	245	5	complementary	complementary	ADJ
aji-135	245	6	triage	triage	NOUN
aji-135	245	7	tests	test	NOUN
aji-135	245	8	used	use	VERB
aji-135	245	9	at	at	ADP
aji-135	245	10	our	our	PRON
aji-135	245	11	facilities	facility	NOUN
aji-135	245	12	to	to	PART
aji-135	245	13	select	select	VERB
aji-135	245	14	worthwhile	worthwhile	ADJ
aji-135	245	15	antigens	antigen	NOUN
aji-135	245	16	to	to	PART
aji-135	245	17	proceed	proceed	VERB
aji-135	245	18	with	with	ADP
aji-135	245	19	more	more	ADV
aji-135	245	20	laborious	laborious	ADJ
aji-135	245	21	in	in	ADP
aji-135	245	22	vivo	vivo	ADJ
aji-135	245	23	provocation	provocation	NOUN
aji-135	245	24	tests	test	NOUN
aji-135	245	25	when	when	SCONJ
aji-135	245	26	the	the	DET
aji-135	245	27	specific	specific	ADJ
aji-135	245	28	ige	ige	NOUN
aji-135	245	29	is	be	AUX
aji-135	245	30	undetectable	undetectable	ADJ
aji-135	245	31	.	.	PUNCT
aji-135	246	1	none	none	NOUN
aji-135	246	2	of	of	ADP
aji-135	246	3	our	our	PRON
aji-135	246	4	patients	patient	NOUN
aji-135	246	5	presented	present	VERB
aji-135	246	6	an	an	DET
aji-135	246	7	exclusive	exclusive	ADJ
aji-135	246	8	reaction	reaction	NOUN
aji-135	246	9	to	to	ADP
aji-135	246	10	pegs	peg	NOUN
aji-135	246	11	.	.	PUNCT
aji-135	247	1	every	every	DET
aji-135	247	2	patient	patient	NOUN
aji-135	247	3	was	be	AUX
aji-135	247	4	simultaneously	simultaneously	ADV
aji-135	247	5	tested	test	VERB
aji-135	247	6	with	with	ADP
aji-135	247	7	several	several	ADJ
aji-135	247	8	chemical	chemical	ADJ
aji-135	247	9	and	and	CCONJ
aji-135	247	10	biological	biological	ADJ
aji-135	247	11	allergens	allergen	NOUN
aji-135	247	12	,	,	PUNCT
aji-135	247	13	demonstrating	demonstrate	VERB
aji-135	247	14	positive	positive	ADJ
aji-135	247	15	results	result	NOUN
aji-135	247	16	for	for	ADP
aji-135	247	17	some	some	PRON
aji-135	247	18	of	of	ADP
aji-135	247	19	them	they	PRON
aji-135	247	20	.	.	PUNCT
aji-135	248	1	our	our	PRON
aji-135	248	2	clinical	clinical	ADJ
aji-135	248	3	experience	experience	NOUN
aji-135	248	4	suggests	suggest	VERB
aji-135	248	5	that	that	SCONJ
aji-135	248	6	reactive	reactive	ADJ
aji-135	248	7	allergic	allergic	ADJ
aji-135	248	8	patients	patient	NOUN
aji-135	248	9	may	may	AUX
aji-135	248	10	impair	impair	VERB
aji-135	248	11	their	their	PRON
aji-135	248	12	symptoms	symptom	NOUN
aji-135	248	13	by	by	ADP
aji-135	248	14	an	an	DET
aji-135	248	15	additional	additional	ADJ
aji-135	248	16	immunoreactivity	immunoreactivity	NOUN
aji-135	248	17	against	against	ADP
aji-135	248	18	pegs	peg	NOUN
aji-135	248	19	.	.	PUNCT
aji-135	249	1	this	this	DET
aji-135	249	2	preliminary	preliminary	ADJ
aji-135	249	3	retrospective	retrospective	ADJ
aji-135	249	4	survey	survey	NOUN
aji-135	249	5	demonstrated	demonstrate	VERB
aji-135	249	6	an	an	DET
aji-135	249	7	extensive	extensive	ADJ
aji-135	249	8	range	range	NOUN
aji-135	249	9	of	of	ADP
aji-135	249	10	results	result	NOUN
aji-135	249	11	from	from	ADP
aji-135	249	12	the	the	DET
aji-135	249	13	ttp	ttp	NOUN
aji-135	249	14	and	and	CCONJ
aji-135	249	15	the	the	DET
aji-135	249	16	ex	ex	X
aji-135	249	17	vivo	vivo	NOUN
aji-135	249	18	challenge	challenge	NOUN
aji-135	249	19	test	test	NOUN
aji-135	249	20	monitored	monitor	VERB
aji-135	249	21	by	by	ADP
aji-135	249	22	lait	lait	NOUN
aji-135	249	23	against	against	ADP
aji-135	249	24	pegs	peg	NOUN
aji-135	249	25	in	in	ADP
aji-135	249	26	two	two	NUM
aji-135	249	27	cohorts	cohort	NOUN
aji-135	249	28	of	of	ADP
aji-135	249	29	patients	patient	NOUN
aji-135	249	30	with	with	ADP
aji-135	249	31	various	various	ADJ
aji-135	249	32	allergic	allergic	ADJ
aji-135	249	33	symptoms	symptom	NOUN
aji-135	249	34	.	.	PUNCT
aji-135	250	1	the	the	DET
aji-135	250	2	preliminary	preliminary	ADJ
aji-135	250	3	results	result	NOUN
aji-135	250	4	support	support	VERB
aji-135	250	5	that	that	SCONJ
aji-135	250	6	the	the	DET
aji-135	250	7	ttp	ttp	NOUN
aji-135	250	8	and	and	CCONJ
aji-135	250	9	lait	lait	NOUN
aji-135	250	10	performed	perform	VERB
aji-135	250	11	with	with	ADP
aji-135	250	12	1	1	NUM
aji-135	250	13	mg	mg	NUM
aji-135	250	14	/	/	SYM
aji-135	251	1	ml	ml	NOUN
aji-135	251	2	pegs	peg	NOUN
aji-135	251	3	4000	4000	NUM
aji-135	251	4	solution	solution	NOUN
aji-135	251	5	may	may	AUX
aji-135	251	6	discriminate	discriminate	VERB
aji-135	251	7	diverse	diverse	ADJ
aji-135	251	8	degrees	degree	NOUN
aji-135	251	9	of	of	ADP
aji-135	251	10	in	in	ADP
aji-135	251	11	vitro	vitro	X
aji-135	251	12	and	and	CCONJ
aji-135	251	13	ex	ex	PRON
aji-135	251	14	vivo	vivo	NOUN
aji-135	251	15	immunoreactivity	immunoreactivity	NOUN
aji-135	251	16	in	in	ADP
aji-135	251	17	patients	patient	NOUN
aji-135	251	18	suffering	suffer	VERB
aji-135	251	19	from	from	ADP
aji-135	251	20	diversified	diversified	ADJ
aji-135	251	21	allergic	allergic	ADJ
aji-135	251	22	phenotypes	phenotype	NOUN
aji-135	251	23	.	.	PUNCT
aji-135	252	1	it	it	PRON
aji-135	252	2	is	be	AUX
aji-135	252	3	worth	worth	ADJ
aji-135	252	4	carrying	carry	VERB
aji-135	252	5	out	out	ADP
aji-135	252	6	more	more	ADV
aji-135	252	7	in	in	ADP
aji-135	252	8	-	-	PUNCT
aji-135	252	9	depth	depth	NOUN
aji-135	252	10	studies	study	NOUN
aji-135	252	11	to	to	PART
aji-135	252	12	evaluate	evaluate	VERB
aji-135	252	13	the	the	DET
aji-135	252	14	usefulness	usefulness	NOUN
aji-135	252	15	of	of	ADP
aji-135	252	16	ttp	ttp	NOUN
aji-135	252	17	and	and	CCONJ
aji-135	252	18	lait	lait	NOUN
aji-135	252	19	in	in	ADP
aji-135	252	20	endotyping	endotype	VERB
aji-135	252	21	non	non	PROPN
aji-135	252	22	–	–	PUNCT
aji-135	252	23	ige	ige	ADJ
aji-135	252	24	-	-	PUNCT
aji-135	252	25	mediated	mediate	VERB
aji-135	252	26	hypersensitivity	hypersensitivity	NOUN
aji-135	252	27	to	to	ADP
aji-135	252	28	pegs	peg	NOUN
aji-135	252	29	.	.	PUNCT
aji-135	253	1	5	5	X
aji-135	253	2	.	.	X
aji-135	253	3	conclusion	conclusion	NOUN
aji-135	253	4	our	our	PRON
aji-135	253	5	society	society	NOUN
aji-135	253	6	is	be	AUX
aji-135	253	7	now	now	ADV
aji-135	253	8	flooded	flood	VERB
aji-135	253	9	with	with	ADP
aji-135	253	10	chemical	chemical	ADJ
aji-135	253	11	derivatives	derivative	NOUN
aji-135	253	12	through	through	ADP
aji-135	253	13	industrialized	industrialize	VERB
aji-135	253	14	foods	food	NOUN
aji-135	253	15	,	,	PUNCT
aji-135	253	16	cosmetics	cosmetic	NOUN
aji-135	253	17	,	,	PUNCT
aji-135	253	18	cleansing	cleansing	NOUN
aji-135	253	19	products	product	NOUN
aji-135	253	20	,	,	PUNCT
aji-135	253	21	and	and	CCONJ
aji-135	253	22	medicines	medicine	NOUN
aji-135	253	23	producing	produce	VERB
aji-135	253	24	unknown	unknown	ADJ
aji-135	253	25	immunoreactivity	immunoreactivity	NOUN
aji-135	254	1	[	[	X
aji-135	254	2	71	71	NUM
aji-135	254	3	]	]	PUNCT
aji-135	254	4	.	.	PUNCT
aji-135	255	1	our	our	PRON
aji-135	255	2	preliminary	preliminary	ADJ
aji-135	255	3	results	result	NOUN
aji-135	255	4	show	show	VERB
aji-135	255	5	that	that	SCONJ
aji-135	255	6	the	the	DET
aji-135	255	7	lait	lait	NOUN
aji-135	255	8	and	and	CCONJ
aji-135	255	9	ttp	ttp	PROPN
aji-135	255	10	may	may	AUX
aji-135	255	11	differentiate	differentiate	VERB
aji-135	255	12	diverse	diverse	ADJ
aji-135	255	13	degrees	degree	NOUN
aji-135	255	14	of	of	ADP
aji-135	255	15	immunoreactivity	immunoreactivity	NOUN
aji-135	255	16	against	against	ADP
aji-135	255	17	pegs	peg	NOUN
aji-135	255	18	in	in	ADP
aji-135	255	19	patients	patient	NOUN
aji-135	255	20	clinically	clinically	ADV
aji-135	255	21	diagnosed	diagnose	VERB
aji-135	255	22	with	with	ADP
aji-135	255	23	non	non	ADJ
aji-135	255	24	–	–	PUNCT
aji-135	255	25	ige	ige	ADJ
aji-135	255	26	-	-	PUNCT
aji-135	255	27	mediated	mediate	VERB
aji-135	255	28	allergies	allergy	NOUN
aji-135	255	29	.	.	PUNCT
aji-135	256	1	this	this	DET
aji-135	256	2	methodology	methodology	NOUN
aji-135	256	3	can	can	AUX
aji-135	256	4	provide	provide	VERB
aji-135	256	5	a	a	DET
aji-135	256	6	socioeconomic	socioeconomic	ADJ
aji-135	256	7	impact	impact	NOUN
aji-135	256	8	since	since	SCONJ
aji-135	256	9	the	the	DET
aji-135	256	10	technology	technology	NOUN
aji-135	256	11	to	to	PART
aji-135	256	12	perform	perform	VERB
aji-135	256	13	tial	tial	ADJ
aji-135	256	14	and	and	CCONJ
aji-135	256	15	ttp	ttp	NOUN
aji-135	256	16	is	be	AUX
aji-135	256	17	inexpensive	inexpensive	ADJ
aji-135	256	18	and	and	CCONJ
aji-135	256	19	can	can	AUX
aji-135	256	20	be	be	AUX
aji-135	256	21	achieved	achieve	VERB
aji-135	256	22	in	in	ADP
aji-135	256	23	a	a	DET
aji-135	256	24	single	single	ADJ
aji-135	256	25	lab	lab	NOUN
aji-135	256	26	room	room	NOUN
aji-135	256	27	attached	attach	VERB
aji-135	256	28	to	to	ADP
aji-135	256	29	the	the	DET
aji-135	256	30	clinical	clinical	ADJ
aji-135	256	31	facility	facility	NOUN
aji-135	256	32	with	with	ADP
aji-135	256	33	minimum	minimum	ADJ
aji-135	256	34	laboratory	laboratory	NOUN
aji-135	256	35	equipment	equipment	NOUN
aji-135	256	36	.	.	PUNCT
aji-135	257	1	however	however	ADV
aji-135	257	2	,	,	PUNCT
aji-135	257	3	the	the	DET
aji-135	257	4	propaedeutic	propaedeutic	ADJ
aji-135	257	5	meaning	meaning	NOUN
aji-135	257	6	of	of	ADP
aji-135	257	7	these	these	DET
aji-135	257	8	results	result	NOUN
aji-135	257	9	and	and	CCONJ
aji-135	257	10	the	the	DET
aji-135	257	11	possibility	possibility	NOUN
aji-135	257	12	of	of	ADP
aji-135	257	13	interferents	interferent	NOUN
aji-135	257	14	must	must	AUX
aji-135	257	15	be	be	AUX
aji-135	257	16	better	well	ADV
aji-135	257	17	established	establish	VERB
aji-135	257	18	[	[	PUNCT
aji-135	257	19	72	72	NUM
aji-135	257	20	]	]	PUNCT
aji-135	257	21	.	.	PUNCT
aji-135	258	1	studies	study	NOUN
aji-135	258	2	designed	design	VERB
aji-135	258	3	to	to	PART
aji-135	258	4	establish	establish	VERB
aji-135	258	5	diagnostic	diagnostic	ADJ
aji-135	258	6	cutoffs	cutoff	NOUN
aji-135	258	7	focused	focus	VERB
aji-135	258	8	on	on	ADP
aji-135	258	9	the	the	DET
aji-135	258	10	quality	quality	NOUN
aji-135	258	11	-	-	PUNCT
aji-135	258	12	by	by	ADP
aji-135	258	13	-	-	PUNCT
aji-135	258	14	design	design	NOUN
aji-135	258	15	approach	approach	NOUN
aji-135	258	16	with	with	ADP
aji-135	258	17	prospective	prospective	ADJ
aji-135	258	18	larger	large	ADJ
aji-135	258	19	double	double	ADJ
aji-135	258	20	-	-	PUNCT
aji-135	258	21	blind	blind	ADJ
aji-135	258	22	cohorts	cohort	NOUN
aji-135	258	23	need	need	VERB
aji-135	258	24	to	to	PART
aji-135	258	25	evaluate	evaluate	VERB
aji-135	258	26	the	the	DET
aji-135	258	27	potential	potential	ADJ
aji-135	258	28	contribution	contribution	NOUN
aji-135	258	29	of	of	ADP
aji-135	258	30	lait	lait	NOUN
aji-135	258	31	and	and	CCONJ
aji-135	258	32	ttp	ttp	NOUN
aji-135	258	33	for	for	ADP
aji-135	258	34	endotyping	endotype	VERB
aji-135	258	35	immunoreactivity	immunoreactivity	NOUN
aji-135	258	36	in	in	ADP
aji-135	258	37	patients	patient	NOUN
aji-135	258	38	suspected	suspect	VERB
aji-135	258	39	of	of	ADP
aji-135	258	40	symptomatic	symptomatic	ADJ
aji-135	258	41	hypersensitivity	hypersensitivity	NOUN
aji-135	258	42	against	against	ADP
aji-135	258	43	pegs	peg	NOUN
aji-135	258	44	[	[	X
aji-135	258	45	73,74	73,74	NOUN
aji-135	258	46	]	]	PUNCT
aji-135	258	47	.	.	PUNCT
aji-135	259	1	6	6	X
aji-135	259	2	.	.	X
aji-135	259	3	limitations	limitation	NOUN
aji-135	259	4	this	this	DET
aji-135	259	5	study	study	NOUN
aji-135	259	6	is	be	AUX
aji-135	259	7	a	a	DET
aji-135	259	8	retrospective	retrospective	ADJ
aji-135	259	9	analysis	analysis	NOUN
aji-135	259	10	of	of	ADP
aji-135	259	11	data	datum	NOUN
aji-135	259	12	collected	collect	VERB
aji-135	259	13	over	over	ADP
aji-135	259	14	six	six	NUM
aji-135	259	15	years	year	NOUN
aji-135	259	16	.	.	PUNCT
aji-135	260	1	there	there	PRON
aji-135	260	2	was	be	VERB
aji-135	260	3	no	no	DET
aji-135	260	4	protocol	protocol	NOUN
aji-135	260	5	research	research	NOUN
aji-135	260	6	,	,	PUNCT
aji-135	260	7	and	and	CCONJ
aji-135	260	8	the	the	DET
aji-135	260	9	subject	subject	NOUN
aji-135	260	10	’s	’s	PART
aji-135	260	11	data	datum	NOUN
aji-135	260	12	were	be	AUX
aji-135	260	13	limited	limit	VERB
aji-135	260	14	to	to	ADP
aji-135	260	15	the	the	DET
aji-135	260	16	essentials	essential	NOUN
aji-135	260	17	available	available	ADJ
aji-135	260	18	on	on	ADP
aji-135	260	19	our	our	PRON
aji-135	260	20	electronic	electronic	ADJ
aji-135	260	21	sheets	sheet	NOUN
aji-135	260	22	.	.	PUNCT
aji-135	261	1	therefore	therefore	ADV
aji-135	261	2	,	,	PUNCT
aji-135	261	3	we	we	PRON
aji-135	261	4	could	could	AUX
aji-135	261	5	not	not	PART
aji-135	261	6	establish	establish	VERB
aji-135	261	7	a	a	DET
aji-135	261	8	crosscomparison	crosscomparison	NOUN
aji-135	261	9	between	between	ADP
aji-135	261	10	positive	positive	ADJ
aji-135	261	11	and	and	CCONJ
aji-135	261	12	negative	negative	ADJ
aji-135	261	13	controls	control	NOUN
aji-135	261	14	to	to	PART
aji-135	261	15	validate	validate	VERB
aji-135	261	16	the	the	DET
aji-135	261	17	results	result	NOUN
aji-135	261	18	.	.	PUNCT
aji-135	262	1	the	the	DET
aji-135	262	2	number	number	NOUN
aji-135	262	3	of	of	ADP
aji-135	262	4	subjects	subject	NOUN
aji-135	262	5	is	be	AUX
aji-135	262	6	appropriate	appropriate	ADJ
aji-135	262	7	for	for	ADP
aji-135	262	8	a	a	DET
aji-135	262	9	preliminary	preliminary	ADJ
aji-135	262	10	study	study	NOUN
aji-135	262	11	;	;	PUNCT
aji-135	262	12	however	however	ADV
aji-135	262	13	,	,	PUNCT
aji-135	262	14	future	future	ADJ
aji-135	262	15	studies	study	NOUN
aji-135	262	16	must	must	AUX
aji-135	262	17	be	be	AUX
aji-135	262	18	more	more	ADV
aji-135	262	19	comprehensive	comprehensive	ADJ
aji-135	262	20	and	and	CCONJ
aji-135	262	21	include	include	VERB
aji-135	262	22	patients	patient	NOUN
aji-135	262	23	’	'	PUNCT
aji-135	262	24	follow	follow	VERB
aji-135	262	25	-	-	PUNCT
aji-135	262	26	up	up	ADP
aji-135	262	27	information	information	NOUN
aji-135	262	28	.	.	PUNCT
aji-135	263	1	the	the	DET
aji-135	263	2	lack	lack	NOUN
aji-135	263	3	of	of	ADP
aji-135	263	4	a	a	DET
aji-135	263	5	research	research	NOUN
aji-135	263	6	protocol	protocol	NOUN
aji-135	263	7	implies	imply	VERB
aji-135	263	8	the	the	DET
aji-135	263	9	possibility	possibility	NOUN
aji-135	263	10	of	of	ADP
aji-135	263	11	a	a	DET
aji-135	263	12	bias	bias	NOUN
aji-135	263	13	produced	produce	VERB
aji-135	263	14	by	by	ADP
aji-135	263	15	the	the	DET
aji-135	263	16	physician	physician	NOUN
aji-135	263	17	’s	’s	PART
aji-135	263	18	point	point	NOUN
aji-135	263	19	of	of	ADP
aji-135	263	20	view	view	NOUN
aji-135	263	21	,	,	PUNCT
aji-135	263	22	which	which	PRON
aji-135	263	23	indicated	indicate	VERB
aji-135	263	24	the	the	DET
aji-135	263	25	exam	exam	NOUN
aji-135	263	26	(	(	PUNCT
aji-135	263	27	ceo	ceo	NOUN
aji-135	263	28	)	)	PUNCT
aji-135	263	29	based	base	VERB
aji-135	263	30	on	on	ADP
aji-135	263	31	a	a	DET
aji-135	263	32	clinical	clinical	ADJ
aji-135	263	33	suspicion	suspicion	NOUN
aji-135	263	34	led	lead	VERB
aji-135	263	35	by	by	ADP
aji-135	263	36	the	the	DET
aji-135	263	37	anamnesis	anamnesis	NOUN
aji-135	263	38	,	,	PUNCT
aji-135	263	39	physical	physical	ADJ
aji-135	263	40	examination	examination	NOUN
aji-135	263	41	,	,	PUNCT
aji-135	263	42	and	and	CCONJ
aji-135	263	43	in	in	ADP
aji-135	263	44	vivo	vivo	ADJ
aji-135	263	45	provocation	provocation	NOUN
aji-135	263	46	tests	test	NOUN
aji-135	263	47	.	.	PUNCT
aji-135	264	1	the	the	DET
aji-135	264	2	study	study	NOUN
aji-135	264	3	lost	lose	VERB
aji-135	264	4	many	many	ADJ
aji-135	264	5	of	of	ADP
aji-135	264	6	these	these	DET
aji-135	264	7	patients	patient	NOUN
aji-135	264	8	to	to	PART
aji-135	264	9	follow	follow	VERB
aji-135	264	10	-	-	PUNCT
aji-135	264	11	up	up	NOUN
aji-135	264	12	,	,	PUNCT
aji-135	264	13	so	so	ADV
aji-135	264	14	assuring	assure	VERB
aji-135	264	15	the	the	DET
aji-135	264	16	relationship	relationship	NOUN
aji-135	264	17	between	between	ADP
aji-135	264	18	the	the	DET
aji-135	264	19	immunoassays	immunoassay	NOUN
aji-135	264	20	’	'	PUNCT
aji-135	264	21	results	result	NOUN
aji-135	264	22	and	and	CCONJ
aji-135	264	23	the	the	DET
aji-135	264	24	patient	patient	NOUN
aji-135	264	25	’s	’s	PART
aji-135	264	26	clinical	clinical	ADJ
aji-135	264	27	outcome	outcome	NOUN
aji-135	264	28	is	be	AUX
aji-135	264	29	impossible	impossible	ADJ
aji-135	264	30	.	.	PUNCT
aji-135	265	1	disclaimer	disclaimer	NOUN
aji-135	265	2	(	(	PUNCT
aji-135	265	3	artificial	artificial	ADJ
aji-135	265	4	intelligence	intelligence	NOUN
aji-135	265	5	)	)	PUNCT
aji-135	265	6	authors	author	NOUN
aji-135	265	7	hereby	hereby	ADV
aji-135	265	8	declare	declare	VERB
aji-135	265	9	that	that	SCONJ
aji-135	265	10	no	no	DET
aji-135	265	11	generative	generative	NOUN
aji-135	265	12	ai	ai	VERB
aji-135	265	13	technologies	technology	NOUN
aji-135	265	14	such	such	ADJ
aji-135	265	15	as	as	ADP
aji-135	265	16	large	large	ADJ
aji-135	265	17	language	language	NOUN
aji-135	265	18	models	model	NOUN
aji-135	265	19	(	(	PUNCT
aji-135	265	20	chatgpt	chatgpt	NOUN
aji-135	265	21	,	,	PUNCT
aji-135	265	22	copilot	copilot	NOUN
aji-135	265	23	,	,	PUNCT
aji-135	265	24	etc	etc	X
aji-135	265	25	)	)	PUNCT
aji-135	265	26	and	and	CCONJ
aji-135	265	27	text	text	NOUN
aji-135	265	28	-	-	PUNCT
aji-135	265	29	to	to	ADP
aji-135	265	30	-	-	PUNCT
aji-135	265	31	image	image	NOUN
aji-135	265	32	generators	generator	NOUN
aji-135	265	33	have	have	AUX
aji-135	265	34	been	be	AUX
aji-135	265	35	used	use	VERB
aji-135	265	36	during	during	ADP
aji-135	265	37	the	the	DET
aji-135	265	38	writing	writing	NOUN
aji-135	265	39	or	or	CCONJ
aji-135	265	40	editing	editing	NOUN
aji-135	265	41	of	of	ADP
aji-135	265	42	manuscripts	manuscript	NOUN
aji-135	265	43	.	.	PUNCT
aji-135	266	1	consent	consent	NOUN
aji-135	266	2	it	it	PRON
aji-135	266	3	is	be	AUX
aji-135	266	4	not	not	PART
aji-135	266	5	applicable	applicable	ADJ
aji-135	266	6	.	.	PUNCT
aji-135	267	1	ethical	ethical	ADJ
aji-135	267	2	approval	approval	NOUN
aji-135	267	3	the	the	DET
aji-135	267	4	authors	author	NOUN
aji-135	267	5	have	have	AUX
aji-135	267	6	collected	collect	VERB
aji-135	267	7	and	and	CCONJ
aji-135	267	8	preserved	preserve	VERB
aji-135	267	9	written	write	VERB
aji-135	267	10	ethical	ethical	ADJ
aji-135	267	11	approval	approval	NOUN
aji-135	267	12	per	per	ADP
aji-135	267	13	international	international	ADJ
aji-135	267	14	standards	standard	NOUN
aji-135	267	15	.	.	PUNCT
aji-135	268	1	olivier	olivier	PROPN
aji-135	268	2	et	et	PROPN
aji-135	268	3	al	al	PROPN
aji-135	268	4	.	.	PROPN
aji-135	268	5	;	;	PUNCT
aji-135	268	6	asian	asian	PROPN
aji-135	268	7	j.	j.	PROPN
aji-135	268	8	immunol	immunol	PROPN
aji-135	268	9	.	.	PROPN
aji-135	268	10	,	,	PUNCT
aji-135	268	11	vol	vol	NOUN
aji-135	268	12	.	.	PROPN
aji-135	269	1	7	7	NUM
aji-135	269	2	,	,	PUNCT
aji-135	269	3	no	no	INTJ
aji-135	269	4	.	.	NOUN
aji-135	269	5	1	1	NUM
aji-135	269	6	,	,	PUNCT
aji-135	269	7	pp	pp	ADJ
aji-135	269	8	.	.	PUNCT
aji-135	270	1	100	100	NUM
aji-135	270	2	-	-	SYM
aji-135	270	3	111	111	NUM
aji-135	270	4	,	,	PUNCT
aji-135	270	5	2024	2024	NUM
aji-135	270	6	;	;	PUNCT
aji-135	270	7	article	article	NOUN
aji-135	270	8	no.aji.119914	no.aji.119914	PROPN
aji-135	270	9	107	107	NUM
aji-135	270	10	acknowledgements	acknowledgement	NOUN
aji-135	270	11	the	the	DET
aji-135	270	12	instituto	instituto	PROPN
aji-135	270	13	alergoimuno	alergoimuno	PROPN
aji-135	270	14	de	de	PROPN
aji-135	270	15	americana	americana	PROPN
aji-135	270	16	funded	fund	VERB
aji-135	270	17	this	this	DET
aji-135	270	18	work	work	NOUN
aji-135	270	19	.	.	PUNCT
aji-135	271	1	we	we	PRON
aji-135	271	2	want	want	VERB
aji-135	271	3	to	to	PART
aji-135	271	4	thank	thank	VERB
aji-135	271	5	our	our	PRON
aji-135	271	6	new	new	ADJ
aji-135	271	7	laboratory	laboratory	NOUN
aji-135	271	8	technician	technician	NOUN
aji-135	271	9	,	,	PUNCT
aji-135	271	10	alessandra	alessandra	PROPN
aji-135	271	11	vieira	vieira	PROPN
aji-135	271	12	de	de	PROPN
aji-135	271	13	oliveira	oliveira	PROPN
aji-135	271	14	,	,	PUNCT
aji-135	271	15	for	for	ADP
aji-135	271	16	participating	participate	VERB
aji-135	271	17	in	in	ADP
aji-135	271	18	the	the	DET
aji-135	271	19	exams	exam	NOUN
aji-135	271	20	.	.	PUNCT
aji-135	272	1	competing	compete	VERB
aji-135	272	2	interests	interest	NOUN
aji-135	272	3	authors	author	NOUN
aji-135	272	4	have	have	AUX
aji-135	272	5	declared	declare	VERB
aji-135	272	6	that	that	SCONJ
aji-135	272	7	no	no	DET
aji-135	272	8	competing	compete	VERB
aji-135	272	9	interests	interest	NOUN
aji-135	272	10	exist	exist	VERB
aji-135	272	11	.	.	PUNCT
aji-135	273	1	references	reference	NOUN
aji-135	273	2	1	1	NUM
aji-135	273	3	.	.	PUNCT
aji-135	273	4	ravve	ravve	VERB
aji-135	273	5	a.	a.	NOUN
aji-135	273	6	principles	principle	NOUN
aji-135	273	7	of	of	ADP
aji-135	273	8	polymer	polymer	NOUN
aji-135	273	9	chemistry	chemistry	NOUN
aji-135	273	10	third	third	PROPN
aji-135	273	11	edition	edition	PROPN
aji-135	273	12	.	.	PUNCT
aji-135	274	1	springer	springer	PROPN
aji-135	274	2	,	,	PUNCT
aji-135	274	3	new	new	PROPN
aji-135	274	4	york	york	PROPN
aji-135	274	5	.	.	PUNCT
aji-135	275	1	2012;1	2012;1	NUM
aji-135	275	2	.	.	PUNCT
aji-135	276	1	2	2	NUM
aji-135	276	2	.	.	X
aji-135	276	3	jang	jang	PROPN
aji-135	276	4	hj	hj	PROPN
aji-135	276	5	,	,	PUNCT
aji-135	276	6	shin	shin	PROPN
aji-135	276	7	cy	cy	PROPN
aji-135	276	8	,	,	PUNCT
aji-135	276	9	kim	kim	PROPN
aji-135	276	10	kb	kb	PROPN
aji-135	276	11	.	.	PUNCT
aji-135	277	1	safety	safety	NOUN
aji-135	277	2	evaluation	evaluation	NOUN
aji-135	277	3	of	of	ADP
aji-135	277	4	polyethylene	polyethylene	NOUN
aji-135	277	5	glycol	glycol	NOUN
aji-135	277	6	(	(	PUNCT
aji-135	277	7	peg	peg	NOUN
aji-135	277	8	)	)	PUNCT
aji-135	277	9	compounds	compound	NOUN
aji-135	277	10	for	for	ADP
aji-135	277	11	cosmetic	cosmetic	ADJ
aji-135	277	12	use	use	NOUN
aji-135	277	13	.	.	PUNCT
aji-135	278	1	toxicol	toxicol	PROPN
aji-135	278	2	res	re	NOUN
aji-135	278	3	.	.	PUNCT
aji-135	279	1	2015;31(2):105	2015;31(2):105	NUM
aji-135	279	2	-	-	SYM
aji-135	279	3	36	36	NUM
aji-135	279	4	.	.	PUNCT
aji-135	280	1	3	3	X
aji-135	280	2	.	.	X
aji-135	280	3	expert	expert	PROPN
aji-135	280	4	committee	committee	PROPN
aji-135	280	5	on	on	ADP
aji-135	280	6	food	food	NOUN
aji-135	280	7	additives	additive	NOUN
aji-135	280	8	.	.	PUNCT
aji-135	281	1	evaluation	evaluation	NOUN
aji-135	281	2	of	of	ADP
aji-135	281	3	certain	certain	ADJ
aji-135	281	4	food	food	NOUN
aji-135	281	5	additives	additive	NOUN
aji-135	281	6	.	.	PUNCT
aji-135	282	1	twenty	twenty	NUM
aji-135	282	2	-	-	PUNCT
aji-135	282	3	third	third	NOUN
aji-135	282	4	report	report	NOUN
aji-135	282	5	of	of	ADP
aji-135	282	6	the	the	DET
aji-135	282	7	joint	joint	ADJ
aji-135	282	8	fao	fao	NOUN
aji-135	282	9	/	/	SYM
aji-135	282	10	who	who	PRON
aji-135	282	11	in	in	ADP
aji-135	282	12	world	world	NOUN
aji-135	282	13	health	health	PROPN
aji-135	282	14	organization	organization	PROPN
aji-135	282	15	technical	technical	PROPN
aji-135	282	16	report	report	PROPN
aji-135	282	17	series	series	NOUN
aji-135	282	18	.	.	PUNCT
aji-135	283	1	geneve	geneve	NOUN
aji-135	283	2	.	.	PUNCT
aji-135	284	1	1980	1980	NUM
aji-135	284	2	;	;	PUNCT
aji-135	285	1	648:17	648:17	NUM
aji-135	285	2	-	-	SYM
aji-135	285	3	18	18	NUM
aji-135	285	4	.	.	NOUN
aji-135	285	5	4	4	NUM
aji-135	285	6	.	.	X
aji-135	285	7	younes	younes	PROPN
aji-135	285	8	m	m	PROPN
aji-135	285	9	,	,	PUNCT
aji-135	285	10	aggett	aggett	NOUN
aji-135	285	11	p	p	X
aji-135	285	12	,	,	PUNCT
aji-135	285	13	aguilar	aguilar	PROPN
aji-135	285	14	f	f	PROPN
aji-135	285	15	,	,	PUNCT
aji-135	285	16	crebelli	crebelli	PROPN
aji-135	285	17	r	r	NOUN
aji-135	285	18	,	,	PUNCT
aji-135	285	19	dusemund	dusemund	NOUN
aji-135	285	20	b	b	NUM
aji-135	285	21	,	,	PUNCT
aji-135	285	22	filipič	filipič	PROPN
aji-135	285	23	m	m	PROPN
aji-135	285	24	,	,	PUNCT
aji-135	285	25	et	et	PROPN
aji-135	285	26	al	al	PROPN
aji-135	285	27	.	.	PROPN
aji-135	285	28	refined	refined	ADJ
aji-135	285	29	exposure	exposure	NOUN
aji-135	285	30	assessment	assessment	NOUN
aji-135	285	31	of	of	ADP
aji-135	285	32	polyethylene	polyethylene	NOUN
aji-135	285	33	glycol	glycol	NOUN
aji-135	285	34	(	(	PUNCT
aji-135	285	35	e	e	NOUN
aji-135	285	36	1521	1521	NUM
aji-135	285	37	)	)	PUNCT
aji-135	285	38	from	from	ADP
aji-135	285	39	its	its	PRON
aji-135	285	40	use	use	NOUN
aji-135	285	41	as	as	ADP
aji-135	285	42	a	a	DET
aji-135	285	43	food	food	NOUN
aji-135	285	44	additive	additive	NOUN
aji-135	285	45	.	.	PUNCT
aji-135	286	1	efsa	efsa	PROPN
aji-135	286	2	journal	journal	PROPN
aji-135	286	3	.	.	PUNCT
aji-135	287	1	european	european	ADJ
aji-135	287	2	food	food	PROPN
aji-135	287	3	safety	safety	NOUN
aji-135	287	4	authority	authority	NOUN
aji-135	287	5	.	.	PUNCT
aji-135	288	1	2018;16(6):e05293	2018;16(6):e05293	NUM
aji-135	288	2	.	.	NOUN
aji-135	289	1	5	5	NUM
aji-135	289	2	.	.	X
aji-135	290	1	cox	cox	PROPN
aji-135	290	2	s	s	PROPN
aji-135	290	3	,	,	PUNCT
aji-135	290	4	sandall	sandall	ADV
aji-135	290	5	a	a	PRON
aji-135	290	6	,	,	PUNCT
aji-135	290	7	smith	smith	PROPN
aji-135	290	8	l	l	PROPN
aji-135	290	9	,	,	PUNCT
aji-135	290	10	rossi	rossi	PROPN
aji-135	290	11	m	m	PROPN
aji-135	290	12	,	,	PUNCT
aji-135	290	13	whelan	whelan	PROPN
aji-135	290	14	k.	k.	PROPN
aji-135	290	15	food	food	PROPN
aji-135	290	16	additive	additive	NOUN
aji-135	290	17	emulsifiers	emulsifier	NOUN
aji-135	290	18	:	:	PUNCT
aji-135	290	19	a	a	DET
aji-135	290	20	review	review	NOUN
aji-135	290	21	of	of	ADP
aji-135	290	22	their	their	PRON
aji-135	290	23	role	role	NOUN
aji-135	290	24	in	in	ADP
aji-135	290	25	foods	food	NOUN
aji-135	290	26	,	,	PUNCT
aji-135	290	27	legislation	legislation	NOUN
aji-135	290	28	and	and	CCONJ
aji-135	290	29	classifications	classification	NOUN
aji-135	290	30	,	,	PUNCT
aji-135	290	31	presence	presence	NOUN
aji-135	290	32	in	in	ADP
aji-135	290	33	food	food	NOUN
aji-135	290	34	supply	supply	NOUN
aji-135	290	35	,	,	PUNCT
aji-135	290	36	dietary	dietary	ADJ
aji-135	290	37	exposure	exposure	NOUN
aji-135	290	38	,	,	PUNCT
aji-135	290	39	and	and	CCONJ
aji-135	290	40	safety	safety	NOUN
aji-135	290	41	assessment	assessment	NOUN
aji-135	290	42	.	.	PUNCT
aji-135	291	1	nutr	nutr	PROPN
aji-135	291	2	rev	rev	PROPN
aji-135	291	3	.	.	PROPN
aji-135	291	4	2021:79(6):726	2021:79(6):726	NUM
aji-135	291	5	-	-	SYM
aji-135	291	6	741	741	NUM
aji-135	291	7	.	.	PUNCT
aji-135	292	1	6	6	NUM
aji-135	292	2	.	.	X
aji-135	292	3	bancil	bancil	PROPN
aji-135	292	4	as	as	ADP
aji-135	292	5	,	,	PUNCT
aji-135	292	6	sandall	sandall	PROPN
aji-135	292	7	am	am	PROPN
aji-135	292	8	,	,	PUNCT
aji-135	292	9	rossi	rossi	PROPN
aji-135	292	10	m	m	PROPN
aji-135	292	11	,	,	PUNCT
aji-135	292	12	chassaing	chassae	VERB
aji-135	292	13	b	b	NUM
aji-135	292	14	,	,	PUNCT
aji-135	292	15	lindsay	lindsay	PROPN
aji-135	292	16	jo	jo	PROPN
aji-135	292	17	,	,	PUNCT
aji-135	292	18	whelan	whelan	PROPN
aji-135	292	19	k.	k.	PROPN
aji-135	292	20	food	food	PROPN
aji-135	292	21	additive	additive	ADJ
aji-135	292	22	emulsifiers	emulsifier	NOUN
aji-135	292	23	and	and	CCONJ
aji-135	292	24	their	their	PRON
aji-135	292	25	impact	impact	NOUN
aji-135	292	26	on	on	ADP
aji-135	292	27	gut	gut	NOUN
aji-135	292	28	microbiome	microbiome	NOUN
aji-135	292	29	,	,	PUNCT
aji-135	292	30	permeability	permeability	NOUN
aji-135	292	31	,	,	PUNCT
aji-135	292	32	and	and	CCONJ
aji-135	292	33	inflammation	inflammation	NOUN
aji-135	292	34	:	:	PUNCT
aji-135	292	35	mechanistic	mechanistic	ADJ
aji-135	292	36	insights	insight	NOUN
aji-135	292	37	in	in	ADP
aji-135	292	38	inflammatory	inflammatory	ADJ
aji-135	292	39	bowel	bowel	NOUN
aji-135	292	40	disease	disease	NOUN
aji-135	292	41	.	.	PUNCT
aji-135	293	1	journal	journal	PROPN
aji-135	293	2	of	of	ADP
aji-135	293	3	crohn	crohn	PROPN
aji-135	293	4	's	's	PART
aji-135	293	5	&	&	CCONJ
aji-135	293	6	colitis	colitis	NOUN
aji-135	293	7	.	.	PUNCT
aji-135	294	1	2021;15(6):1068	2021;15(6):1068	NUM
aji-135	294	2	-	-	SYM
aji-135	294	3	1079	1079	NUM
aji-135	294	4	.	.	PUNCT
aji-135	295	1	7	7	X
aji-135	295	2	.	.	X
aji-135	295	3	olivier	olivier	PROPN
aji-135	295	4	ce	ce	AUX
aji-135	295	5	.	.	PROPN
aji-135	295	6	considering	consider	VERB
aji-135	295	7	intestinal	intestinal	ADJ
aji-135	295	8	permeability	permeability	NOUN
aji-135	295	9	and	and	CCONJ
aji-135	295	10	immune	immune	ADJ
aji-135	295	11	metabolism	metabolism	NOUN
aji-135	295	12	in	in	ADP
aji-135	295	13	the	the	DET
aji-135	295	14	treatment	treatment	NOUN
aji-135	295	15	of	of	ADP
aji-135	295	16	food	food	NOUN
aji-135	295	17	allergies	allergy	NOUN
aji-135	295	18	.	.	PUNCT
aji-135	296	1	eur	eur	PROPN
aji-135	296	2	j	j	PROPN
aji-135	296	3	clin	clin	PROPN
aji-135	296	4	med	med	PROPN
aji-135	296	5	.	.	PUNCT
aji-135	297	1	2022;3(3):13	2022;3(3):13	NUM
aji-135	297	2	-	-	SYM
aji-135	297	3	18	18	NUM
aji-135	297	4	.	.	NOUN
aji-135	297	5	8	8	NUM
aji-135	297	6	.	.	PUNCT
aji-135	298	1	castellanos	castellanos	PROPN
aji-135	298	2	ij	ij	PROPN
aji-135	298	3	,	,	PUNCT
aji-135	298	4	crespo	crespo	PROPN
aji-135	298	5	r	r	PROPN
aji-135	298	6	,	,	PUNCT
aji-135	298	7	griebenow	griebenow	PROPN
aji-135	298	8	k.	k.	PROPN
aji-135	298	9	poly(ethylene	poly(ethylene	PROPN
aji-135	298	10	glycol	glycol	NOUN
aji-135	298	11	)	)	PUNCT
aji-135	298	12	as	as	ADP
aji-135	298	13	stabilizer	stabilizer	NOUN
aji-135	298	14	and	and	CCONJ
aji-135	298	15	emulsifying	emulsifying	NOUN
aji-135	298	16	agent	agent	NOUN
aji-135	298	17	:	:	PUNCT
aji-135	298	18	a	a	DET
aji-135	298	19	novel	novel	ADJ
aji-135	298	20	stabilization	stabilization	NOUN
aji-135	298	21	approach	approach	NOUN
aji-135	298	22	preventing	prevent	VERB
aji-135	298	23	aggregation	aggregation	NOUN
aji-135	298	24	and	and	CCONJ
aji-135	298	25	inactivation	inactivation	NOUN
aji-135	298	26	of	of	ADP
aji-135	298	27	proteins	protein	NOUN
aji-135	298	28	upon	upon	SCONJ
aji-135	298	29	encapsulation	encapsulation	NOUN
aji-135	298	30	in	in	ADP
aji-135	298	31	bioerodible	bioerodible	ADJ
aji-135	298	32	polyester	polyester	NOUN
aji-135	298	33	microspheres	microsphere	NOUN
aji-135	298	34	.	.	PUNCT
aji-135	299	1	j	j	PROPN
aji-135	299	2	controlled	control	VERB
aji-135	299	3	release	release	NOUN
aji-135	299	4	.	.	PUNCT
aji-135	300	1	2003;88(1):135	2003;88(1):135	PROPN
aji-135	300	2	-	-	SYM
aji-135	300	3	45	45	NUM
aji-135	300	4	.	.	NOUN
aji-135	300	5	9	9	NUM
aji-135	300	6	.	.	PUNCT
aji-135	300	7	jokerst	jokerst	PROPN
aji-135	300	8	jv	jv	PROPN
aji-135	300	9	,	,	PUNCT
aji-135	300	10	lobovkina	lobovkina	PROPN
aji-135	300	11	t	t	PROPN
aji-135	300	12	,	,	PUNCT
aji-135	300	13	zare	zare	PROPN
aji-135	300	14	rn	rn	PROPN
aji-135	300	15	,	,	PUNCT
aji-135	300	16	gambhir	gambhir	PROPN
aji-135	300	17	ss	ss	PROPN
aji-135	300	18	.	.	PROPN
aji-135	300	19	nanoparticle	nanoparticle	NOUN
aji-135	300	20	pegylation	pegylation	NOUN
aji-135	300	21	for	for	ADP
aji-135	300	22	imaging	imaging	NOUN
aji-135	300	23	and	and	CCONJ
aji-135	300	24	therapy	therapy	NOUN
aji-135	300	25	.	.	PUNCT
aji-135	301	1	nanomedicine	nanomedicine	PROPN
aji-135	301	2	(	(	PUNCT
aji-135	301	3	london	london	PROPN
aji-135	301	4	,	,	PUNCT
aji-135	301	5	england	england	PROPN
aji-135	301	6	)	)	PUNCT
aji-135	301	7	.	.	PUNCT
aji-135	302	1	2011	2011	NUM
aji-135	302	2	;	;	PUNCT
aji-135	302	3	6(4):715	6(4):715	NUM
aji-135	302	4	-	-	SYM
aji-135	302	5	28	28	NUM
aji-135	302	6	.	.	PUNCT
aji-135	303	1	10	10	NUM
aji-135	303	2	.	.	PUNCT
aji-135	304	1	veronese	veronese	PROPN
aji-135	304	2	fm	fm	PROPN
aji-135	304	3	,	,	PUNCT
aji-135	304	4	mero	mero	PROPN
aji-135	304	5	a.	a.	NOUN
aji-135	304	6	the	the	DET
aji-135	304	7	impact	impact	NOUN
aji-135	304	8	of	of	ADP
aji-135	304	9	pegylation	pegylation	NOUN
aji-135	304	10	on	on	ADP
aji-135	304	11	biological	biological	ADJ
aji-135	304	12	therapies	therapy	NOUN
aji-135	304	13	.	.	PUNCT
aji-135	305	1	biodrugs	biodrug	NOUN
aji-135	305	2	.	.	PUNCT
aji-135	306	1	2008;22(5):315	2008;22(5):315	NUM
aji-135	306	2	-	-	SYM
aji-135	306	3	29	29	NUM
aji-135	306	4	.	.	PUNCT
aji-135	306	5	11	11	NUM
aji-135	306	6	.	.	PUNCT
aji-135	307	1	tenchov	tenchov	PROPN
aji-135	307	2	r	r	PROPN
aji-135	307	3	,	,	PUNCT
aji-135	307	4	sasso	sasso	PROPN
aji-135	307	5	jm	jm	PROPN
aji-135	307	6	,	,	PUNCT
aji-135	307	7	zhou	zhou	PROPN
aji-135	307	8	qa	qa	PROPN
aji-135	307	9	.	.	PUNCT
aji-135	308	1	pegylated	pegylate	VERB
aji-135	308	2	lipid	lipid	NOUN
aji-135	308	3	nanoparticle	nanoparticle	NOUN
aji-135	308	4	formulations	formulation	NOUN
aji-135	308	5	:	:	PUNCT
aji-135	308	6	immunological	immunological	ADJ
aji-135	308	7	safety	safety	NOUN
aji-135	308	8	and	and	CCONJ
aji-135	308	9	efficiency	efficiency	NOUN
aji-135	308	10	perspective	perspective	NOUN
aji-135	308	11	.	.	PUNCT
aji-135	309	1	bioconjugate	bioconjugate	NOUN
aji-135	309	2	chemistry	chemistry	NOUN
aji-135	309	3	.	.	PUNCT
aji-135	310	1	2023;34(6):941	2023;34(6):941	NUM
aji-135	310	2	-	-	PUNCT
aji-135	310	3	960	960	NUM
aji-135	310	4	.	.	PUNCT
aji-135	310	5	12	12	NUM
aji-135	310	6	.	.	PUNCT
aji-135	310	7	klibanov	klibanov	PROPN
aji-135	310	8	al	al	PROPN
aji-135	310	9	,	,	PUNCT
aji-135	310	10	maruyama	maruyama	PROPN
aji-135	310	11	k	k	NOUN
aji-135	310	12	,	,	PUNCT
aji-135	310	13	torchilin	torchilin	PROPN
aji-135	310	14	vp	vp	PROPN
aji-135	310	15	,	,	PUNCT
aji-135	310	16	huang	huang	PROPN
aji-135	310	17	l.	l.	PROPN
aji-135	310	18	amphipathic	amphipathic	PROPN
aji-135	310	19	polyethyleneglycols	polyethyleneglycol	NOUN
aji-135	310	20	effectively	effectively	ADV
aji-135	310	21	prolong	prolong	VERB
aji-135	310	22	the	the	DET
aji-135	310	23	circulation	circulation	NOUN
aji-135	310	24	time	time	NOUN
aji-135	310	25	of	of	ADP
aji-135	310	26	liposomes	liposome	NOUN
aji-135	310	27	.	.	PUNCT
aji-135	311	1	febs	febs	PROPN
aji-135	311	2	lett	lett	PROPN
aji-135	311	3	.	.	PUNCT
aji-135	312	1	1990;268(1	1990;268(1	NUM
aji-135	312	2	)	)	PUNCT
aji-135	312	3	:	:	PUNCT
aji-135	312	4	235	235	NUM
aji-135	312	5	-	-	SYM
aji-135	312	6	7	7	NUM
aji-135	312	7	.	.	NOUN
aji-135	312	8	13	13	NUM
aji-135	312	9	.	.	PUNCT
aji-135	313	1	ibrahim	ibrahim	PROPN
aji-135	313	2	m	m	PROPN
aji-135	313	3	,	,	PUNCT
aji-135	313	4	ramadan	ramadan	PROPN
aji-135	313	5	e	e	PROPN
aji-135	313	6	,	,	PUNCT
aji-135	313	7	elsadek	elsadek	PROPN
aji-135	313	8	ne	ne	PROPN
aji-135	313	9	,	,	PUNCT
aji-135	313	10	emam	emam	PROPN
aji-135	313	11	se	se	PROPN
aji-135	313	12	,	,	PUNCT
aji-135	313	13	shimizu	shimizu	PROPN
aji-135	313	14	t	t	PROPN
aji-135	313	15	,	,	PUNCT
aji-135	313	16	ando	ando	PROPN
aji-135	313	17	h	h	PROPN
aji-135	313	18	,	,	PUNCT
aji-135	313	19	et	et	PROPN
aji-135	313	20	al	al	PROPN
aji-135	313	21	.	.	PUNCT
aji-135	313	22	polyethylene	polyethylene	NOUN
aji-135	313	23	glycol	glycol	NOUN
aji-135	313	24	(	(	PUNCT
aji-135	313	25	peg	peg	NOUN
aji-135	313	26	):	):	PUNCT
aji-135	313	27	the	the	DET
aji-135	313	28	nature	nature	NOUN
aji-135	313	29	,	,	PUNCT
aji-135	313	30	immunogenicity	immunogenicity	NOUN
aji-135	313	31	,	,	PUNCT
aji-135	313	32	and	and	CCONJ
aji-135	313	33	role	role	NOUN
aji-135	313	34	in	in	ADP
aji-135	313	35	the	the	DET
aji-135	313	36	hypersensitivity	hypersensitivity	NOUN
aji-135	313	37	of	of	ADP
aji-135	313	38	pegylated	pegylated	ADJ
aji-135	313	39	products	product	NOUN
aji-135	313	40	.	.	PUNCT
aji-135	314	1	j	j	PROPN
aji-135	314	2	controlled	control	VERB
aji-135	314	3	release	release	NOUN
aji-135	314	4	.	.	PUNCT
aji-135	315	1	2022;351:215	2022;351:215	NUM
aji-135	315	2	-	-	SYM
aji-135	315	3	230	230	NUM
aji-135	315	4	.	.	PUNCT
aji-135	316	1	14	14	NUM
aji-135	316	2	.	.	PUNCT
aji-135	317	1	koppen	koppen	PROPN
aji-135	317	2	ijn	ijn	PROPN
aji-135	317	3	,	,	PUNCT
aji-135	317	4	broekaert	broekaert	ADP
aji-135	318	1	ij	ij	NOUN
aji-135	318	2	,	,	PUNCT
aji-135	318	3	wilschanski	wilschanski	PROPN
aji-135	318	4	m	m	PROPN
aji-135	318	5	,	,	PUNCT
aji-135	318	6	papadopoulou	papadopoulou	PROPN
aji-135	318	7	a	a	NOUN
aji-135	318	8	,	,	PUNCT
aji-135	319	1	ribes	ribe	NOUN
aji-135	319	2	-	-	PUNCT
aji-135	319	3	koninckx	koninckx	NOUN
aji-135	319	4	c	c	PROPN
aji-135	319	5	,	,	PUNCT
aji-135	319	6	thapar	thapar	PROPN
aji-135	319	7	n	n	CCONJ
aji-135	319	8	,	,	PUNCT
aji-135	319	9	et	et	PROPN
aji-135	319	10	al	al	PROPN
aji-135	319	11	.	.	PUNCT
aji-135	319	12	role	role	NOUN
aji-135	319	13	of	of	ADP
aji-135	319	14	polyethylene	polyethylene	NOUN
aji-135	319	15	glycol	glycol	NOUN
aji-135	319	16	in	in	ADP
aji-135	319	17	the	the	DET
aji-135	319	18	treatment	treatment	NOUN
aji-135	319	19	of	of	ADP
aji-135	319	20	functional	functional	ADJ
aji-135	319	21	constipation	constipation	NOUN
aji-135	319	22	in	in	ADP
aji-135	319	23	children	child	NOUN
aji-135	319	24	.	.	PUNCT
aji-135	320	1	j	j	PROPN
aji-135	320	2	ped	ped	PROPN
aji-135	320	3	gastroenterol	gastroenterol	PROPN
aji-135	320	4	nutr	nutr	PROPN
aji-135	320	5	.	.	PUNCT
aji-135	321	1	2017;65(4):361	2017;65(4):361	PROPN
aji-135	321	2	-	-	PUNCT
aji-135	321	3	363	363	NUM
aji-135	321	4	.	.	PUNCT
aji-135	321	5	15	15	NUM
aji-135	321	6	.	.	PUNCT
aji-135	322	1	corazziari	corazziari	PROPN
aji-135	322	2	e	e	PROPN
aji-135	322	3	,	,	PUNCT
aji-135	322	4	badiali	badiali	VERB
aji-135	322	5	d	d	NOUN
aji-135	322	6	,	,	PUNCT
aji-135	322	7	bazzocchi	bazzocchi	NOUN
aji-135	322	8	g	g	NOUN
aji-135	322	9	,	,	PUNCT
aji-135	322	10	bassotti	bassotti	NOUN
aji-135	322	11	g	g	NOUN
aji-135	322	12	,	,	PUNCT
aji-135	322	13	roselli	roselli	VERB
aji-135	322	14	p	p	NOUN
aji-135	322	15	,	,	PUNCT
aji-135	322	16	mastropaolo	mastropaolo	NOUN
aji-135	322	17	g	g	NOUN
aji-135	322	18	,	,	PUNCT
aji-135	322	19	et	et	PROPN
aji-135	322	20	al	al	PROPN
aji-135	322	21	.	.	PUNCT
aji-135	323	1	long	long	ADJ
aji-135	323	2	term	term	NOUN
aji-135	323	3	efficacy	efficacy	NOUN
aji-135	323	4	,	,	PUNCT
aji-135	323	5	safety	safety	NOUN
aji-135	323	6	,	,	PUNCT
aji-135	323	7	and	and	CCONJ
aji-135	323	8	tolerability	tolerability	NOUN
aji-135	323	9	of	of	ADP
aji-135	323	10	low	low	ADJ
aji-135	323	11	daily	daily	ADJ
aji-135	323	12	doses	dose	NOUN
aji-135	323	13	of	of	ADP
aji-135	323	14	isosmotic	isosmotic	ADJ
aji-135	323	15	polyethylene	polyethylene	NOUN
aji-135	323	16	glycol	glycol	NOUN
aji-135	323	17	electrolyte	electrolyte	NOUN
aji-135	323	18	balanced	balanced	ADJ
aji-135	323	19	solution	solution	NOUN
aji-135	323	20	(	(	PUNCT
aji-135	323	21	pmf-100	pmf-100	NOUN
aji-135	323	22	)	)	PUNCT
aji-135	323	23	in	in	ADP
aji-135	323	24	the	the	DET
aji-135	323	25	treatment	treatment	NOUN
aji-135	323	26	of	of	ADP
aji-135	323	27	functional	functional	ADJ
aji-135	323	28	chronic	chronic	ADJ
aji-135	323	29	constipation	constipation	NOUN
aji-135	323	30	.	.	PUNCT
aji-135	324	1	gut	gut	VERB
aji-135	324	2	.	.	PUNCT
aji-135	325	1	2000	2000	NUM
aji-135	325	2	;	;	PUNCT
aji-135	326	1	46(4):522	46(4):522	PROPN
aji-135	326	2	-	-	SYM
aji-135	326	3	6	6	NUM
aji-135	326	4	.	.	NOUN
aji-135	326	5	16	16	NUM
aji-135	326	6	.	.	PUNCT
aji-135	327	1	expert	expert	NOUN
aji-135	327	2	panel	panel	PROPN
aji-135	327	3	cosmetic	cosmetic	ADJ
aji-135	327	4	ingredient	ingredient	NOUN
aji-135	327	5	review	review	NOUN
aji-135	327	6	.	.	PUNCT
aji-135	328	1	pegs	peg	NOUN
aji-135	328	2	.	.	PUNCT
aji-135	329	1	https://www.cirsafety.org/sites/default/files/115_final_peg	https://www.cirsafety.org/sites/default/files/115_final_peg	PROPN
aji-135	329	2	s.pdf	s.pdf	PROPN
aji-135	329	3	(	(	PUNCT
aji-135	329	4	accessed	access	VERB
aji-135	329	5	april	april	PROPN
aji-135	329	6	06	06	NUM
aji-135	329	7	,	,	PUNCT
aji-135	329	8	2024	2024	NUM
aji-135	329	9	)	)	PUNCT
aji-135	329	10	.	.	PUNCT
aji-135	330	1	17	17	NUM
aji-135	330	2	.	.	PUNCT
aji-135	330	3	fruijtier	fruijti	ADJ
aji-135	330	4	-	-	PUNCT
aji-135	330	5	pölloth	pölloth	PROPN
aji-135	330	6	c.	c.	NOUN
aji-135	330	7	safety	safety	NOUN
aji-135	330	8	assessment	assessment	NOUN
aji-135	330	9	on	on	ADP
aji-135	330	10	polyethylene	polyethylene	NOUN
aji-135	330	11	glycols	glycol	NOUN
aji-135	330	12	(	(	PUNCT
aji-135	330	13	pegs	peg	NOUN
aji-135	330	14	)	)	PUNCT
aji-135	330	15	and	and	CCONJ
aji-135	330	16	their	their	PRON
aji-135	330	17	derivatives	derivative	NOUN
aji-135	330	18	as	as	SCONJ
aji-135	330	19	used	use	VERB
aji-135	330	20	in	in	ADP
aji-135	330	21	cosmetic	cosmetic	ADJ
aji-135	330	22	products	product	NOUN
aji-135	330	23	.	.	PUNCT
aji-135	331	1	toxicol	toxicol	PROPN
aji-135	331	2	.	.	PUNCT
aji-135	332	1	2005;214(1	2005;214(1	NOUN
aji-135	332	2	-	-	PUNCT
aji-135	332	3	2):1	2):1	NUM
aji-135	332	4	-	-	SYM
aji-135	332	5	38	38	NUM
aji-135	332	6	.	.	PUNCT
aji-135	333	1	18	18	NUM
aji-135	333	2	.	.	PUNCT
aji-135	333	3	bruns	bruns	PROPN
aji-135	333	4	de	de	PROPN
aji-135	333	5	,	,	PUNCT
aji-135	333	6	herold	herold	PROPN
aji-135	333	7	da	da	NOUN
aji-135	333	8	,	,	PUNCT
aji-135	333	9	rodeheaver	rodeheaver	NOUN
aji-135	333	10	gt	gt	PROPN
aji-135	333	11	,	,	PUNCT
aji-135	333	12	edlich	edlich	X
aji-135	333	13	rf	rf	NOUN
aji-135	333	14	.	.	PROPN
aji-135	333	15	polyethylene	polyethylene	NOUN
aji-135	333	16	glycol	glycol	NOUN
aji-135	333	17	intoxication	intoxication	NOUN
aji-135	333	18	in	in	ADP
aji-135	333	19	burn	burn	NOUN
aji-135	333	20	patients	patient	NOUN
aji-135	333	21	.	.	PUNCT
aji-135	334	1	burns	burn	NOUN
aji-135	334	2	incl	incl	PROPN
aji-135	334	3	therm	therm	PROPN
aji-135	334	4	inj	inj	NOUN
aji-135	334	5	.	.	PROPN
aji-135	335	1	1982;9(1):49	1982;9(1):49	NUM
aji-135	335	2	-	-	SYM
aji-135	335	3	52	52	NUM
aji-135	335	4	.	.	NOUN
aji-135	336	1	19	19	NUM
aji-135	336	2	.	.	PUNCT
aji-135	336	3	inoue	inoue	PROPN
aji-135	336	4	h	h	PROPN
aji-135	336	5	,	,	PUNCT
aji-135	336	6	yoshikawa	yoshikawa	PROPN
aji-135	336	7	h	h	PROPN
aji-135	336	8	,	,	PUNCT
aji-135	336	9	haraura	haraura	NOUN
aji-135	336	10	h	h	NOUN
aji-135	336	11	,	,	PUNCT
aji-135	336	12	eguchi	eguchi	PROPN
aji-135	336	13	t	t	PROPN
aji-135	336	14	,	,	PUNCT
aji-135	336	15	kawano	kawano	PROPN
aji-135	336	16	y.	y.	PROPN
aji-135	336	17	polyethylene	polyethylene	NOUN
aji-135	336	18	glycol	glycol	NOUN
aji-135	336	19	allergy	allergy	NOUN
aji-135	336	20	olivier	olivier	NOUN
aji-135	336	21	et	et	PROPN
aji-135	336	22	al	al	PROPN
aji-135	336	23	.	.	PROPN
aji-135	336	24	;	;	PUNCT
aji-135	336	25	asian	asian	PROPN
aji-135	336	26	j.	j.	PROPN
aji-135	336	27	immunol	immunol	PROPN
aji-135	336	28	.	.	PROPN
aji-135	336	29	,	,	PUNCT
aji-135	336	30	vol	vol	NOUN
aji-135	336	31	.	.	PROPN
aji-135	336	32	7	7	NUM
aji-135	336	33	,	,	PUNCT
aji-135	336	34	no	no	INTJ
aji-135	336	35	.	.	NOUN
aji-135	336	36	1	1	NUM
aji-135	336	37	,	,	PUNCT
aji-135	336	38	pp	pp	ADJ
aji-135	336	39	.	.	PUNCT
aji-135	337	1	100	100	NUM
aji-135	337	2	-	-	SYM
aji-135	337	3	111	111	NUM
aji-135	337	4	,	,	PUNCT
aji-135	337	5	2024	2024	NUM
aji-135	337	6	;	;	PUNCT
aji-135	337	7	article	article	NOUN
aji-135	337	8	no.aji.119914	no.aji.119914	PROPN
aji-135	337	9	108	108	NUM
aji-135	337	10	caused	cause	VERB
aji-135	337	11	by	by	ADP
aji-135	337	12	a	a	DET
aji-135	337	13	diazepam	diazepam	NOUN
aji-135	337	14	suppository	suppository	NOUN
aji-135	337	15	.	.	PUNCT
aji-135	338	1	pediatr	pediatr	PROPN
aji-135	338	2	int	int	NOUN
aji-135	338	3	.	.	PUNCT
aji-135	339	1	2023;65(1):e15402	2023;65(1):e15402	NUM
aji-135	339	2	.	.	NOUN
aji-135	339	3	20	20	NUM
aji-135	339	4	.	.	PUNCT
aji-135	340	1	caballero	caballero	PROPN
aji-135	340	2	ml	ml	PROPN
aji-135	340	3	,	,	PUNCT
aji-135	340	4	krantz	krantz	PROPN
aji-135	340	5	ms	ms	PROPN
aji-135	340	6	,	,	PUNCT
aji-135	340	7	quirce	quirce	NOUN
aji-135	340	8	s	s	PROPN
aji-135	340	9	,	,	PUNCT
aji-135	340	10	phillips	phillips	PROPN
aji-135	340	11	ej	ej	PROPN
aji-135	340	12	,	,	PUNCT
aji-135	340	13	stone	stone	PROPN
aji-135	340	14	-	-	PUNCT
aji-135	340	15	jr	jr	PROPN
aji-135	340	16	ca	ca	PROPN
aji-135	340	17	.	.	PUNCT
aji-135	341	1	hidden	hide	VERB
aji-135	341	2	dangers	danger	NOUN
aji-135	341	3	:	:	PUNCT
aji-135	341	4	recognizing	recognize	VERB
aji-135	341	5	excipients	excipient	NOUN
aji-135	341	6	as	as	ADP
aji-135	341	7	potential	potential	ADJ
aji-135	341	8	causes	cause	NOUN
aji-135	341	9	of	of	ADP
aji-135	341	10	drug	drug	NOUN
aji-135	341	11	and	and	CCONJ
aji-135	341	12	vaccine	vaccine	NOUN
aji-135	341	13	hypersensitivity	hypersensitivity	NOUN
aji-135	341	14	reactions	reaction	NOUN
aji-135	341	15	.	.	PUNCT
aji-135	342	1	j	j	PROPN
aji-135	342	2	allergy	allergy	PROPN
aji-135	342	3	clin	clin	PROPN
aji-135	342	4	immunol	immunol	PROPN
aji-135	342	5	pract	pract	PROPN
aji-135	342	6	.	.	PUNCT
aji-135	343	1	2021;9(8):2968	2021;9(8):2968	NUM
aji-135	343	2	-	-	SYM
aji-135	343	3	2982	2982	NUM
aji-135	343	4	.	.	PUNCT
aji-135	344	1	21	21	NUM
aji-135	344	2	.	.	X
aji-135	344	3	habran	habran	PROPN
aji-135	344	4	m	m	PROPN
aji-135	344	5	,	,	PUNCT
aji-135	344	6	vandebotermet	vandebotermet	PROPN
aji-135	344	7	m	m	PROPN
aji-135	344	8	,	,	PUNCT
aji-135	344	9	schrijvers	schrijver	VERB
aji-135	344	10	r.	r.	NOUN
aji-135	344	11	polyethylene	polyethylene	NOUN
aji-135	344	12	glycol	glycol	NOUN
aji-135	344	13	allergy	allergy	NOUN
aji-135	344	14	and	and	CCONJ
aji-135	344	15	immediate	immediate	ADJ
aji-135	344	16	-	-	PUNCT
aji-135	344	17	type	type	NOUN
aji-135	344	18	hypersensitivity	hypersensitivity	NOUN
aji-135	344	19	reaction	reaction	NOUN
aji-135	344	20	to	to	ADP
aji-135	344	21	covid-19	covid-19	PROPN
aji-135	344	22	vaccination	vaccination	NOUN
aji-135	344	23	:	:	PUNCT
aji-135	344	24	case	case	NOUN
aji-135	344	25	report	report	NOUN
aji-135	344	26	.	.	PUNCT
aji-135	345	1	j	j	PROPN
aji-135	345	2	investig	investig	NOUN
aji-135	345	3	allergol	allergol	PROPN
aji-135	345	4	clin	clin	PROPN
aji-135	345	5	immunol	immunol	NOUN
aji-135	345	6	.	.	PUNCT
aji-135	346	1	2022;32(3):234	2022;32(3):234	NUM
aji-135	346	2	-	-	PUNCT
aji-135	346	3	235	235	NUM
aji-135	346	4	.	.	PUNCT
aji-135	346	5	22	22	NUM
aji-135	346	6	.	.	PUNCT
aji-135	347	1	cabanillas	cabanillas	PROPN
aji-135	347	2	b	b	PROPN
aji-135	347	3	,	,	PUNCT
aji-135	347	4	akdis	akdis	PROPN
aji-135	347	5	ca	ca	NOUN
aji-135	347	6	,	,	PUNCT
aji-135	347	7	novak	novak	PROPN
aji-135	347	8	n.	n.	PROPN
aji-135	347	9	allergic	allergic	ADJ
aji-135	347	10	reactions	reaction	NOUN
aji-135	347	11	to	to	ADP
aji-135	347	12	the	the	DET
aji-135	347	13	first	first	ADJ
aji-135	347	14	covid	covid	PROPN
aji-135	347	15	19	19	NUM
aji-135	347	16	vaccine	vaccine	NOUN
aji-135	347	17	:	:	PUNCT
aji-135	347	18	a	a	DET
aji-135	347	19	potential	potential	ADJ
aji-135	347	20	role	role	NOUN
aji-135	347	21	of	of	ADP
aji-135	347	22	polyethylene	polyethylene	NOUN
aji-135	347	23	glycol	glycol	NOUN
aji-135	347	24	?	?	PUNCT
aji-135	348	1	allergy	allergy	NOUN
aji-135	348	2	.	.	PUNCT
aji-135	349	1	2021;76(6	2021;76(6	NUM
aji-135	349	2	):	):	PUNCT
aji-135	349	3	1617	1617	NUM
aji-135	349	4	-	-	SYM
aji-135	349	5	1618	1618	NUM
aji-135	349	6	.	.	PUNCT
aji-135	350	1	23	23	NUM
aji-135	350	2	.	.	PUNCT
aji-135	351	1	ieven	ieven	PROPN
aji-135	351	2	t	t	PROPN
aji-135	351	3	,	,	PUNCT
aji-135	351	4	coorevits	coorevit	NOUN
aji-135	351	5	l	l	NOUN
aji-135	351	6	,	,	PUNCT
aji-135	351	7	vandebotermet	vandebotermet	PROPN
aji-135	351	8	m	m	PROPN
aji-135	351	9	,	,	PUNCT
aji-135	351	10	tuyls	tuyls	PROPN
aji-135	351	11	s	s	PROPN
aji-135	351	12	,	,	PUNCT
aji-135	351	13	vanneste	vanneste	ADJ
aji-135	351	14	h	h	NOUN
aji-135	351	15	,	,	PUNCT
aji-135	351	16	santy	santy	PROPN
aji-135	351	17	l	l	NOUN
aji-135	351	18	,	,	PUNCT
aji-135	351	19	et	et	PROPN
aji-135	351	20	al	al	PROPN
aji-135	351	21	.	.	PUNCT
aji-135	352	1	endotyping	endotype	VERB
aji-135	352	2	of	of	ADP
aji-135	352	3	ige	ige	NOUN
aji-135	352	4	-	-	PUNCT
aji-135	352	5	mediated	mediate	VERB
aji-135	352	6	polyethylene	polyethylene	NOUN
aji-135	352	7	glycol	glycol	NOUN
aji-135	352	8	and/or	and/or	CCONJ
aji-135	352	9	polysorbate	polysorbate	NOUN
aji-135	352	10	80	80	NUM
aji-135	352	11	allergy	allergy	NOUN
aji-135	352	12	.	.	PUNCT
aji-135	353	1	j	j	PROPN
aji-135	353	2	allergy	allergy	PROPN
aji-135	353	3	clin	clin	PROPN
aji-135	353	4	immunol	immunol	PROPN
aji-135	353	5	pract	pract	PROPN
aji-135	353	6	.	.	PUNCT
aji-135	354	1	2023;11(10):3146	2023;11(10):3146	NUM
aji-135	354	2	-	-	SYM
aji-135	354	3	3160	3160	NUM
aji-135	354	4	.	.	PUNCT
aji-135	355	1	24	24	NUM
aji-135	355	2	.	.	PUNCT
aji-135	356	1	shi	shi	PROPN
aji-135	356	2	d	d	PROPN
aji-135	356	3	,	,	PUNCT
aji-135	356	4	beasock	beasock	NOUN
aji-135	356	5	d	d	NOUN
aji-135	356	6	,	,	PUNCT
aji-135	356	7	fessler	fessler	NOUN
aji-135	356	8	a	a	NOUN
aji-135	356	9	,	,	PUNCT
aji-135	356	10	szebeni	szebeni	PROPN
aji-135	356	11	j	j	PROPN
aji-135	356	12	,	,	PUNCT
aji-135	356	13	ljubimova	ljubimova	PROPN
aji-135	356	14	jy	jy	PROPN
aji-135	356	15	,	,	PUNCT
aji-135	356	16	afonin	afonin	PROPN
aji-135	356	17	ka	ka	PROPN
aji-135	356	18	,	,	PUNCT
aji-135	356	19	dobrovolskaia	dobrovolskaia	PROPN
aji-135	356	20	ma	ma	PROPN
aji-135	356	21	.	.	PROPN
aji-135	356	22	to	to	PART
aji-135	356	23	pegylate	pegylate	VERB
aji-135	356	24	or	or	CCONJ
aji-135	356	25	not	not	PART
aji-135	356	26	to	to	PART
aji-135	356	27	pegylate	pegylate	VERB
aji-135	356	28	:	:	PUNCT
aji-135	356	29	immunological	immunological	ADJ
aji-135	356	30	properties	property	NOUN
aji-135	356	31	of	of	ADP
aji-135	356	32	nanomedicine	nanomedicine	NOUN
aji-135	356	33	’s	’s	PART
aji-135	356	34	most	most	ADV
aji-135	356	35	popular	popular	ADJ
aji-135	356	36	component	component	NOUN
aji-135	356	37	,	,	PUNCT
aji-135	356	38	polyethylene	polyethylene	NOUN
aji-135	356	39	glycol	glycol	NOUN
aji-135	356	40	and	and	CCONJ
aji-135	356	41	its	its	PRON
aji-135	356	42	alternatives	alternative	NOUN
aji-135	356	43	.	.	PUNCT
aji-135	357	1	advanced	advanced	ADJ
aji-135	357	2	drug	drug	NOUN
aji-135	357	3	delivery	delivery	NOUN
aji-135	357	4	reviews	review	NOUN
aji-135	357	5	.	.	PUNCT
aji-135	358	1	2022;180:114079	2022;180:114079	NUM
aji-135	358	2	.	.	PUNCT
aji-135	359	1	25	25	NUM
aji-135	359	2	.	.	PUNCT
aji-135	360	1	giavina	giavina	PROPN
aji-135	360	2	-	-	PUNCT
aji-135	360	3	bianchi	bianchi	PROPN
aji-135	360	4	p	p	NOUN
aji-135	360	5	,	,	PUNCT
aji-135	360	6	kalil	kalil	PROPN
aji-135	360	7	j.	j.	PROPN
aji-135	360	8	polyethylene	polyethylene	PROPN
aji-135	360	9	glycol	glycol	NOUN
aji-135	360	10	is	be	AUX
aji-135	360	11	a	a	DET
aji-135	360	12	cause	cause	NOUN
aji-135	360	13	of	of	ADP
aji-135	360	14	ige	ige	NOUN
aji-135	360	15	-	-	PUNCT
aji-135	360	16	mediated	mediate	VERB
aji-135	360	17	anaphylaxis	anaphylaxis	ADJ
aji-135	360	18	.	.	PUNCT
aji-135	361	1	j	j	PROPN
aji-135	361	2	allergy	allergy	PROPN
aji-135	361	3	clin	clin	PROPN
aji-135	361	4	immunol	immunol	PROPN
aji-135	361	5	pract	pract	PROPN
aji-135	361	6	.	.	PUNCT
aji-135	362	1	2019:7(6):1874	2019:7(6):1874	NUM
aji-135	362	2	-	-	PUNCT
aji-135	362	3	1875	1875	NUM
aji-135	362	4	.	.	PUNCT
aji-135	363	1	26	26	NUM
aji-135	363	2	.	.	PUNCT
aji-135	364	1	kelso	kelso	PROPN
aji-135	364	2	jm	jm	PROPN
aji-135	364	3	.	.	PROPN
aji-135	364	4	ige	ige	PROPN
aji-135	364	5	-	-	PUNCT
aji-135	364	6	mediated	mediate	VERB
aji-135	364	7	allergy	allergy	NOUN
aji-135	364	8	to	to	ADP
aji-135	364	9	polyethylene	polyethylene	NOUN
aji-135	364	10	glycol	glycol	NOUN
aji-135	364	11	(	(	PUNCT
aji-135	364	12	peg	peg	NOUN
aji-135	364	13	)	)	PUNCT
aji-135	364	14	as	as	ADP
aji-135	364	15	a	a	DET
aji-135	364	16	cause	cause	NOUN
aji-135	364	17	of	of	ADP
aji-135	364	18	anaphylaxis	anaphylaxis	NOUN
aji-135	364	19	to	to	ADP
aji-135	364	20	mrna	mrna	PROPN
aji-135	364	21	covid-19	covid-19	PROPN
aji-135	364	22	vaccines	vaccine	NOUN
aji-135	364	23	.	.	PUNCT
aji-135	365	1	clin	clin	PROPN
aji-135	365	2	exp	exp	NOUN
aji-135	365	3	allergy	allergy	PROPN
aji-135	365	4	.	.	PUNCT
aji-135	366	1	2022;52(1):1011	2022;52(1):1011	NUM
aji-135	366	2	.	.	PUNCT
aji-135	367	1	27	27	NUM
aji-135	367	2	.	.	PUNCT
aji-135	368	1	brockow	brockow	PROPN
aji-135	368	2	k	k	PROPN
aji-135	368	3	,	,	PUNCT
aji-135	368	4	mathes	mathes	PROPN
aji-135	368	5	s	s	PROPN
aji-135	368	6	,	,	PUNCT
aji-135	368	7	fischer	fischer	PROPN
aji-135	368	8	j	j	PROPN
aji-135	368	9	,	,	PUNCT
aji-135	368	10	volc	volc	PROPN
aji-135	368	11	s	s	PROPN
aji-135	368	12	,	,	PUNCT
aji-135	368	13	darsow	darsow	PROPN
aji-135	368	14	u	u	NOUN
aji-135	368	15	,	,	PUNCT
aji-135	368	16	eberlein	eberlein	PROPN
aji-135	368	17	b.	b.	PROPN
aji-135	368	18	et	et	PROPN
aji-135	368	19	al	al	PROPN
aji-135	368	20	.	.	PROPN
aji-135	368	21	experience	experience	NOUN
aji-135	368	22	with	with	ADP
aji-135	368	23	polyethylene	polyethylene	NOUN
aji-135	368	24	glycol	glycol	NOUN
aji-135	368	25	allergy	allergy	NOUN
aji-135	368	26	-	-	PUNCT
aji-135	368	27	guided	guide	VERB
aji-135	368	28	risk	risk	NOUN
aji-135	368	29	management	management	NOUN
aji-135	368	30	for	for	ADP
aji-135	368	31	covid-19	covid-19	PROPN
aji-135	368	32	vaccine	vaccine	NOUN
aji-135	368	33	anaphylaxis	anaphylaxis	ADJ
aji-135	368	34	.	.	PUNCT
aji-135	369	1	allergy	allergy	NOUN
aji-135	369	2	.	.	PUNCT
aji-135	370	1	2022:77(7):22002210	2022:77(7):22002210	NUM
aji-135	370	2	.	.	PUNCT
aji-135	371	1	28	28	NUM
aji-135	371	2	.	.	PUNCT
aji-135	372	1	chiang	chiang	PROPN
aji-135	372	2	v	v	PROPN
aji-135	372	3	,	,	PUNCT
aji-135	372	4	kan	kan	PROPN
aji-135	372	5	a	a	PROPN
aji-135	372	6	,	,	PUNCT
aji-135	372	7	yeung	yeung	PROPN
aji-135	372	8	h	h	PROPN
aji-135	372	9	,	,	PUNCT
aji-135	372	10	au	au	ADJ
aji-135	372	11	e	e	PROPN
aji-135	372	12	,	,	PUNCT
aji-135	372	13	lau	lau	PROPN
aji-135	372	14	cs	cs	PROPN
aji-135	372	15	,	,	PUNCT
aji-135	372	16	li	li	PROPN
aji-135	372	17	ph	ph	PROPN
aji-135	372	18	.	.	PROPN
aji-135	372	19	polyethylene	polyethylene	NOUN
aji-135	372	20	glycol	glycol	NOUN
aji-135	372	21	allergy	allergy	NOUN
aji-135	372	22	:	:	PUNCT
aji-135	372	23	risks	risk	NOUN
aji-135	372	24	of	of	ADP
aji-135	372	25	skin	skin	NOUN
aji-135	372	26	testing	testing	NOUN
aji-135	372	27	and	and	CCONJ
aji-135	372	28	complement	complement	NOUN
aji-135	372	29	-	-	PUNCT
aji-135	372	30	mediated	mediate	VERB
aji-135	372	31	anaphylaxis	anaphylaxis	ADJ
aji-135	372	32	.	.	PUNCT
aji-135	373	1	j	j	PROPN
aji-135	373	2	investig	investig	NOUN
aji-135	373	3	allergol	allergol	PROPN
aji-135	373	4	clin	clin	PROPN
aji-135	373	5	immunol	immunol	NOUN
aji-135	373	6	.	.	PUNCT
aji-135	374	1	2023;33(1):71	2023;33(1):71	PROPN
aji-135	374	2	-	-	PUNCT
aji-135	374	3	73	73	NUM
aji-135	374	4	.	.	PUNCT
aji-135	375	1	29	29	NUM
aji-135	375	2	.	.	PUNCT
aji-135	376	1	olivier	olivier	PROPN
aji-135	376	2	ce	ce	PROPN
aji-135	376	3	,	,	PUNCT
aji-135	376	4	argentão	argentão	PROPN
aji-135	376	5	dgp	dgp	NOUN
aji-135	376	6	,	,	PUNCT
aji-135	376	7	santos	santos	PROPN
aji-135	376	8	rapg	rapg	PROPN
aji-135	376	9	,	,	PUNCT
aji-135	376	10	silva	silva	PROPN
aji-135	376	11	md	md	PROPN
aji-135	376	12	,	,	PUNCT
aji-135	376	13	lima	lima	PROPN
aji-135	376	14	rps	rps	PROPN
aji-135	376	15	,	,	PUNCT
aji-135	376	16	zollner	zollner	NOUN
aji-135	376	17	rl	rl	PROPN
aji-135	376	18	.	.	PROPN
aji-135	376	19	skin	skin	PROPN
aji-135	376	20	scrape	scrape	PROPN
aji-135	376	21	test	test	NOUN
aji-135	376	22	:	:	PUNCT
aji-135	376	23	an	an	DET
aji-135	376	24	inexpensive	inexpensive	ADJ
aji-135	376	25	and	and	CCONJ
aji-135	376	26	painless	painless	ADJ
aji-135	376	27	skin	skin	NOUN
aji-135	376	28	test	test	NOUN
aji-135	376	29	for	for	ADP
aji-135	376	30	recognition	recognition	NOUN
aji-135	376	31	of	of	ADP
aji-135	376	32	immediate	immediate	ADJ
aji-135	376	33	hypersensitivity	hypersensitivity	NOUN
aji-135	376	34	in	in	ADP
aji-135	376	35	children	child	NOUN
aji-135	376	36	and	and	CCONJ
aji-135	376	37	adults	adult	NOUN
aji-135	376	38	.	.	PUNCT
aji-135	377	1	the	the	DET
aji-135	377	2	open	open	ADJ
aji-135	377	3	allergy	allergy	NOUN
aji-135	377	4	journal	journal	PROPN
aji-135	377	5	.	.	PUNCT
aji-135	378	1	2013;6:9	2013;6:9	NUM
aji-135	378	2	-	-	SYM
aji-135	378	3	17	17	NUM
aji-135	378	4	.	.	PUNCT
aji-135	379	1	30	30	NUM
aji-135	379	2	.	.	PUNCT
aji-135	380	1	zhou	zhou	PROPN
aji-135	380	2	zh	zh	PROPN
aji-135	380	3	,	,	PUNCT
aji-135	380	4	stone	stone	NOUN
aji-135	380	5	-	-	PUNCT
aji-135	380	6	jr	jr	PROPN
aji-135	380	7	ca	ca	PROPN
aji-135	380	8	,	,	PUNCT
aji-135	380	9	jakubovic	jakubovic	PROPN
aji-135	380	10	b	b	PROPN
aji-135	380	11	,	,	PUNCT
aji-135	380	12	phillips	phillips	PROPN
aji-135	380	13	ej	ej	PROPN
aji-135	380	14	,	,	PUNCT
aji-135	380	15	sussman	sussman	NOUN
aji-135	380	16	g	g	PROPN
aji-135	380	17	,	,	PUNCT
aji-135	380	18	park	park	PROPN
aji-135	380	19	j	j	PROPN
aji-135	380	20	,	,	PUNCT
aji-135	381	1	et	et	PROPN
aji-135	381	2	al	al	PROPN
aji-135	381	3	.	.	PROPN
aji-135	381	4	antipeg	antipeg	PROPN
aji-135	381	5	ige	ige	PROPN
aji-135	381	6	in	in	ADP
aji-135	381	7	anaphylaxis	anaphylaxis	NOUN
aji-135	381	8	associated	associate	VERB
aji-135	381	9	with	with	ADP
aji-135	381	10	polyethylene	polyethylene	NOUN
aji-135	381	11	glycol	glycol	NOUN
aji-135	381	12	.	.	PUNCT
aji-135	382	1	j	j	PROPN
aji-135	382	2	allergy	allergy	PROPN
aji-135	382	3	clin	clin	PROPN
aji-135	382	4	immunol	immunol	PROPN
aji-135	382	5	pract	pract	PROPN
aji-135	382	6	.	.	PUNCT
aji-135	383	1	2021;9(4):1731	2021;9(4):1731	NOUN
aji-135	383	2	-	-	PUNCT
aji-135	383	3	1733.e3	1733.e3	NUM
aji-135	383	4	.	.	PUNCT
aji-135	384	1	31	31	NUM
aji-135	384	2	.	.	PUNCT
aji-135	385	1	klimek	klimek	PROPN
aji-135	385	2	l	l	PROPN
aji-135	385	3	,	,	PUNCT
aji-135	385	4	novak	novak	PROPN
aji-135	385	5	n	n	CCONJ
aji-135	385	6	,	,	PUNCT
aji-135	385	7	cabanillas	cabanillas	PROPN
aji-135	385	8	b	b	PROPN
aji-135	385	9	,	,	PUNCT
aji-135	385	10	jutel	jutel	PROPN
aji-135	385	11	m	m	PRON
aji-135	385	12	,	,	PUNCT
aji-135	385	13	bousquet	bousquet	PROPN
aji-135	385	14	j	j	PROPN
aji-135	385	15	,	,	PUNCT
aji-135	385	16	akdis	akdis	PROPN
aji-135	385	17	ca	ca	NOUN
aji-135	385	18	.	.	PUNCT
aji-135	386	1	allergenic	allergenic	ADJ
aji-135	386	2	components	component	NOUN
aji-135	386	3	of	of	ADP
aji-135	386	4	the	the	DET
aji-135	386	5	mrna-1273	mrna-1273	ADJ
aji-135	386	6	vaccine	vaccine	NOUN
aji-135	386	7	for	for	ADP
aji-135	386	8	covid-19	covid-19	PROPN
aji-135	386	9	:	:	PUNCT
aji-135	386	10	possible	possible	ADJ
aji-135	386	11	involvement	involvement	NOUN
aji-135	386	12	of	of	ADP
aji-135	386	13	polyethylene	polyethylene	NOUN
aji-135	386	14	glycol	glycol	NOUN
aji-135	386	15	and	and	CCONJ
aji-135	386	16	igg	igg	PROPN
aji-135	386	17	-	-	PUNCT
aji-135	386	18	mediated	mediate	VERB
aji-135	386	19	complement	complement	NOUN
aji-135	386	20	activation	activation	NOUN
aji-135	386	21	.	.	PUNCT
aji-135	387	1	allergy	allergy	NOUN
aji-135	387	2	.	.	PUNCT
aji-135	388	1	2021;76(11):3307	2021;76(11):3307	NUM
aji-135	388	2	-	-	SYM
aji-135	388	3	3313	3313	NUM
aji-135	388	4	.	.	PUNCT
aji-135	389	1	32	32	NUM
aji-135	389	2	.	.	PUNCT
aji-135	389	3	freire	freire	PROPN
aji-135	389	4	-	-	PUNCT
aji-135	389	5	haddad	haddad	PROPN
aji-135	389	6	h	h	PROPN
aji-135	389	7	,	,	PUNCT
aji-135	389	8	burke	burke	PROPN
aji-135	389	9	ja	ja	PROPN
aji-135	389	10	,	,	PUNCT
aji-135	389	11	scott	scott	PROPN
aji-135	389	12	ea	ea	PROPN
aji-135	389	13	,	,	PUNCT
aji-135	389	14	ameer	ameer	PROPN
aji-135	389	15	ga	ga	PROPN
aji-135	389	16	.	.	PROPN
aji-135	389	17	clinical	clinical	ADJ
aji-135	389	18	relevance	relevance	NOUN
aji-135	389	19	of	of	ADP
aji-135	389	20	preexisting	preexist	VERB
aji-135	389	21	and	and	CCONJ
aji-135	389	22	treatment	treatment	NOUN
aji-135	389	23	-	-	PUNCT
aji-135	389	24	induced	induce	VERB
aji-135	389	25	anti	anti	ADJ
aji-135	389	26	-	-	ADJ
aji-135	389	27	poly	poly	ADJ
aji-135	389	28	(	(	PUNCT
aji-135	389	29	ethylene	ethylene	NOUN
aji-135	389	30	glycol	glycol	NOUN
aji-135	389	31	)	)	PUNCT
aji-135	389	32	antibodies	antibodie	VERB
aji-135	389	33	.	.	PUNCT
aji-135	390	1	regener	regener	PROPN
aji-135	390	2	engineer	engineer	PROPN
aji-135	390	3	transl	transl	PROPN
aji-135	390	4	med	me	VERB
aji-135	390	5	.	.	PUNCT
aji-135	390	6	2022	2022	NUM
aji-135	390	7	;	;	PUNCT
aji-135	390	8	8(1):32	8(1):32	NUM
aji-135	390	9	-	-	PUNCT
aji-135	390	10	42	42	NUM
aji-135	390	11	.	.	PUNCT
aji-135	391	1	33	33	NUM
aji-135	391	2	.	.	PUNCT
aji-135	392	1	gaballa	gaballa	PROPN
aji-135	392	2	sa	sa	PROPN
aji-135	392	3	,	,	PUNCT
aji-135	392	4	shimizu	shimizu	PROPN
aji-135	392	5	t	t	PROPN
aji-135	392	6	,	,	PUNCT
aji-135	392	7	takata	takata	NOUN
aji-135	392	8	h	h	NOUN
aji-135	392	9	,	,	PUNCT
aji-135	392	10	ando	ando	PROPN
aji-135	392	11	h	h	PROPN
aji-135	392	12	,	,	PUNCT
aji-135	392	13	ibrahim	ibrahim	PROPN
aji-135	392	14	m	m	PROPN
aji-135	392	15	,	,	PUNCT
aji-135	392	16	emam	emam	PROPN
aji-135	392	17	se	se	PROPN
aji-135	392	18	,	,	PUNCT
aji-135	392	19	et	et	PROPN
aji-135	392	20	al	al	PROPN
aji-135	392	21	.	.	PROPN
aji-135	392	22	impact	impact	NOUN
aji-135	392	23	of	of	ADP
aji-135	392	24	antipeg	antipeg	NOUN
aji-135	392	25	igm	igm	PROPN
aji-135	392	26	induced	induce	VERB
aji-135	392	27	via	via	ADP
aji-135	392	28	the	the	DET
aji-135	392	29	topical	topical	ADJ
aji-135	392	30	application	application	NOUN
aji-135	392	31	of	of	ADP
aji-135	392	32	a	a	DET
aji-135	392	33	cosmetic	cosmetic	ADJ
aji-135	392	34	product	product	NOUN
aji-135	392	35	containing	contain	VERB
aji-135	392	36	peg	peg	NOUN
aji-135	392	37	derivatives	derivative	NOUN
aji-135	392	38	on	on	ADP
aji-135	392	39	the	the	DET
aji-135	392	40	antitumor	antitumor	PROPN
aji-135	392	41	effects	effect	NOUN
aji-135	392	42	of	of	ADP
aji-135	392	43	pegylated	pegylated	ADJ
aji-135	392	44	liposomal	liposomal	ADJ
aji-135	392	45	antitumor	antitumor	PROPN
aji-135	392	46	drug	drug	NOUN
aji-135	392	47	formulations	formulation	NOUN
aji-135	392	48	in	in	ADP
aji-135	392	49	mice	mouse	NOUN
aji-135	392	50	.	.	PUNCT
aji-135	393	1	mol	mol	ADP
aji-135	393	2	pharm	pharm	PROPN
aji-135	393	3	.	.	PUNCT
aji-135	393	4	2024	2024	NUM
aji-135	394	1	;	;	PUNCT
aji-135	394	2	21(2):622	21(2):622	X
aji-135	394	3	-	-	NOUN
aji-135	394	4	632	632	NUM
aji-135	394	5	.	.	PUNCT
aji-135	394	6	34	34	NUM
aji-135	394	7	.	.	PUNCT
aji-135	394	8	ju	ju	PROPN
aji-135	394	9	y	y	PROPN
aji-135	394	10	,	,	PUNCT
aji-135	394	11	lee	lee	PROPN
aji-135	394	12	ws	ws	PROPN
aji-135	394	13	,	,	PUNCT
aji-135	394	14	pilkington	pilkington	PROPN
aji-135	394	15	eh	eh	INTJ
aji-135	394	16	,	,	PUNCT
aji-135	394	17	kelly	kelly	PROPN
aji-135	394	18	hg	hg	PROPN
aji-135	394	19	,	,	PUNCT
aji-135	394	20	li	li	PROPN
aji-135	394	21	s	s	PROPN
aji-135	394	22	,	,	PUNCT
aji-135	394	23	selva	selva	PROPN
aji-135	394	24	kj	kj	PROPN
aji-135	394	25	,	,	PUNCT
aji-135	394	26	et	et	PROPN
aji-135	394	27	al	al	PROPN
aji-135	394	28	.	.	PUNCT
aji-135	395	1	anti	anti	ADJ
aji-135	395	2	-	-	ADJ
aji-135	395	3	peg	peg	ADJ
aji-135	395	4	antibodies	antibody	NOUN
aji-135	395	5	boosted	boost	VERB
aji-135	395	6	in	in	ADP
aji-135	395	7	humans	human	NOUN
aji-135	395	8	by	by	ADP
aji-135	395	9	sars	sar	NOUN
aji-135	395	10	-	-	PUNCT
aji-135	395	11	cov-2	cov-2	NOUN
aji-135	395	12	lipid	lipid	NOUN
aji-135	395	13	nanoparticle	nanoparticle	NOUN
aji-135	395	14	mrna	mrna	PROPN
aji-135	395	15	vaccine	vaccine	PROPN
aji-135	395	16	.	.	PUNCT
aji-135	396	1	acs	acs	PROPN
aji-135	396	2	nano	nano	PROPN
aji-135	396	3	.	.	PUNCT
aji-135	397	1	2022;16(8):11769	2022;16(8):11769	NUM
aji-135	397	2	-	-	SYM
aji-135	397	3	11780	11780	NUM
aji-135	397	4	.	.	PUNCT
aji-135	398	1	35	35	NUM
aji-135	398	2	.	.	PUNCT
aji-135	399	1	rogozina	rogozina	PROPN
aji-135	399	2	o	o	NOUN
aji-135	399	3	,	,	PUNCT
aji-135	399	4	ruiz	ruiz	NOUN
aji-135	399	5	-	-	PUNCT
aji-135	399	6	fernández	fernández	PROPN
aji-135	399	7	c	c	NOUN
aji-135	399	8	,	,	PUNCT
aji-135	399	9	martínlópez	martínlópez	NOUN
aji-135	399	10	s	s	PROPN
aji-135	399	11	,	,	PUNCT
aji-135	399	12	akatbach	akatbach	NOUN
aji-135	399	13	-	-	PUNCT
aji-135	399	14	bousaid	bousaid	VERB
aji-135	399	15	i	i	PROPN
aji-135	399	16	,	,	PUNCT
aji-135	399	17	gonzálezmuñoz	gonzálezmuñoz	PROPN
aji-135	399	18	m	m	PROPN
aji-135	399	19	,	,	PUNCT
aji-135	399	20	ramírez	ramírez	PROPN
aji-135	399	21	e.	e.	PROPN
aji-135	399	22	organ	organ	PROPN
aji-135	399	23	-	-	PUNCT
aji-135	399	24	specific	specific	ADJ
aji-135	399	25	immune	immune	NOUN
aji-135	399	26	-	-	PUNCT
aji-135	399	27	mediated	mediate	VERB
aji-135	399	28	reactions	reaction	NOUN
aji-135	399	29	to	to	PART
aji-135	399	30	polyethylene	polyethylene	VERB
aji-135	399	31	glycol	glycol	NOUN
aji-135	399	32	and	and	CCONJ
aji-135	399	33	polysorbate	polysorbate	NOUN
aji-135	399	34	excipients	excipient	NOUN
aji-135	399	35	:	:	PUNCT
aji-135	399	36	three	three	NUM
aji-135	399	37	case	case	NOUN
aji-135	399	38	reports	report	VERB
aji-135	399	39	.	.	PUNCT
aji-135	400	1	front	front	ADJ
aji-135	400	2	pharmacol	pharmacol	PROPN
aji-135	400	3	.	.	PUNCT
aji-135	401	1	2023;14:1293294	2023;14:1293294	NUM
aji-135	401	2	.	.	X
aji-135	402	1	36	36	NUM
aji-135	402	2	.	.	PUNCT
aji-135	403	1	kuratsuji	kuratsuji	PROPN
aji-135	403	2	t.	t.	PROPN
aji-135	403	3	studies	study	NOUN
aji-135	403	4	on	on	ADP
aji-135	403	5	leukocyte	leukocyte	ADJ
aji-135	403	6	adherence	adherence	NOUN
aji-135	403	7	inhibition	inhibition	NOUN
aji-135	403	8	test	test	NOUN
aji-135	403	9	.	.	PUNCT
aji-135	404	1	part	part	PROPN
aji-135	404	2	ii	ii	PROPN
aji-135	404	3	.	.	PUNCT
aji-135	405	1	clinical	clinical	ADJ
aji-135	405	2	applications	application	NOUN
aji-135	405	3	of	of	ADP
aji-135	405	4	lai	lai	PROPN
aji-135	405	5	test	test	PROPN
aji-135	405	6	to	to	PART
aji-135	405	7	detect	detect	VERB
aji-135	405	8	delayed	delay	VERB
aji-135	405	9	type	type	NOUN
aji-135	405	10	hypersensitivity	hypersensitivity	NOUN
aji-135	405	11	in	in	ADP
aji-135	405	12	infants	infant	NOUN
aji-135	405	13	and	and	CCONJ
aji-135	405	14	children	child	NOUN
aji-135	405	15	.	.	PUNCT
aji-135	406	1	keio	keio	PROPN
aji-135	406	2	j	j	PROPN
aji-135	406	3	med	med	PROPN
aji-135	406	4	.	.	PUNCT
aji-135	407	1	1981;30(2):65	1981;30(2):65	NUM
aji-135	407	2	-	-	SYM
aji-135	407	3	9	9	NUM
aji-135	407	4	.	.	NOUN
aji-135	407	5	37	37	NUM
aji-135	407	6	.	.	PUNCT
aji-135	408	1	olivier	olivier	PROPN
aji-135	408	2	ce	ce	PROPN
aji-135	408	3	,	,	PUNCT
aji-135	408	4	pinto	pinto	NOUN
aji-135	408	5	dg	dg	PROPN
aji-135	408	6	,	,	PUNCT
aji-135	408	7	teixeira	teixeira	PROPN
aji-135	408	8	apm	apm	PROPN
aji-135	408	9	,	,	PUNCT
aji-135	408	10	santana	santana	PROPN
aji-135	408	11	jls	jls	PROPN
aji-135	408	12	,	,	PUNCT
aji-135	408	13	santos	santos	PROPN
aji-135	408	14	rapgs	rapgs	PROPN
aji-135	408	15	,	,	PUNCT
aji-135	408	16	lima	lima	PROPN
aji-135	408	17	rps	rps	PROPN
aji-135	408	18	,	,	PUNCT
aji-135	408	19	et	et	PROPN
aji-135	408	20	al	al	PROPN
aji-135	408	21	.	.	PUNCT
aji-135	409	1	evaluating	evaluate	VERB
aji-135	409	2	non	non	ADJ
aji-135	409	3	-	-	ADJ
aji-135	409	4	ige	ige	ADJ
aji-135	409	5	-	-	PUNCT
aji-135	409	6	mediated	mediate	VERB
aji-135	409	7	allergens	allergen	NOUN
aji-135	409	8	’	'	PUNCT
aji-135	409	9	immunoreactivity	immunoreactivity	NOUN
aji-135	409	10	in	in	ADP
aji-135	409	11	patients	patient	NOUN
aji-135	409	12	with	with	ADP
aji-135	409	13	“	"	PUNCT
aji-135	409	14	intrinsic	intrinsic	ADJ
aji-135	409	15	”	"	PUNCT
aji-135	409	16	persistent	persistent	ADJ
aji-135	409	17	rhinitis	rhinitis	NOUN
aji-135	409	18	with	with	ADP
aji-135	409	19	help	help	NOUN
aji-135	409	20	of	of	ADP
aji-135	409	21	the	the	DET
aji-135	409	22	leukocyte	leukocyte	NOUN
aji-135	409	23	adherence	adherence	NOUN
aji-135	409	24	inhibition	inhibition	NOUN
aji-135	409	25	test	test	NOUN
aji-135	409	26	.	.	PUNCT
aji-135	410	1	eur	eur	PROPN
aji-135	410	2	j	j	PROPN
aji-135	410	3	med	med	PROPN
aji-135	410	4	health	health	PROPN
aji-135	410	5	sci	sci	PROPN
aji-135	410	6	.	.	PUNCT
aji-135	411	1	2023;5(1):17	2023;5(1):17	NUM
aji-135	411	2	-	-	SYM
aji-135	411	3	22	22	NUM
aji-135	411	4	.	.	PUNCT
aji-135	412	1	38	38	NUM
aji-135	412	2	.	.	PUNCT
aji-135	413	1	olivier	olivier	PROPN
aji-135	413	2	ce	ce	PROPN
aji-135	413	3	,	,	PUNCT
aji-135	413	4	pinto	pinto	NOUN
aji-135	413	5	dg	dg	PROPN
aji-135	413	6	,	,	PUNCT
aji-135	413	7	teixeira	teixeira	PROPN
aji-135	413	8	apm	apm	PROPN
aji-135	413	9	,	,	PUNCT
aji-135	413	10	santana	santana	PROPN
aji-135	413	11	jls	jls	PROPN
aji-135	413	12	,	,	PUNCT
aji-135	413	13	santos	santos	PROPN
aji-135	413	14	rapgs	rapgs	PROPN
aji-135	413	15	,	,	PUNCT
aji-135	413	16	lima	lima	PROPN
aji-135	413	17	rps	rps	PROPN
aji-135	413	18	,	,	PUNCT
aji-135	413	19	olivier	olivier	PROPN
aji-135	413	20	et	et	PROPN
aji-135	413	21	al	al	PROPN
aji-135	413	22	.	.	PROPN
aji-135	413	23	;	;	PUNCT
aji-135	413	24	asian	asian	PROPN
aji-135	413	25	j.	j.	PROPN
aji-135	413	26	immunol	immunol	PROPN
aji-135	413	27	.	.	PROPN
aji-135	413	28	,	,	PUNCT
aji-135	413	29	vol	vol	NOUN
aji-135	413	30	.	.	PROPN
aji-135	414	1	7	7	NUM
aji-135	414	2	,	,	PUNCT
aji-135	414	3	no	no	INTJ
aji-135	414	4	.	.	NOUN
aji-135	414	5	1	1	NUM
aji-135	414	6	,	,	PUNCT
aji-135	414	7	pp	pp	ADJ
aji-135	414	8	.	.	PUNCT
aji-135	415	1	100	100	NUM
aji-135	415	2	-	-	SYM
aji-135	415	3	111	111	NUM
aji-135	415	4	,	,	PUNCT
aji-135	415	5	2024	2024	NUM
aji-135	415	6	;	;	PUNCT
aji-135	416	1	article	article	NOUN
aji-135	416	2	no.aji.119914	no.aji.119914	PROPN
aji-135	416	3	109	109	NUM
aji-135	416	4	et	et	NOUN
aji-135	416	5	al	al	PROPN
aji-135	416	6	.	.	PROPN
aji-135	416	7	evaluating	evaluate	VERB
aji-135	416	8	non	non	ADJ
aji-135	416	9	-	-	ADJ
aji-135	416	10	ige	ige	ADJ
aji-135	416	11	-	-	PUNCT
aji-135	416	12	mediated	mediate	VERB
aji-135	416	13	allergens	allergen	NOUN
aji-135	416	14	’	'	PUNCT
aji-135	416	15	immunoreactivity	immunoreactivity	NOUN
aji-135	416	16	in	in	ADP
aji-135	416	17	patients	patient	NOUN
aji-135	416	18	formerly	formerly	ADV
aji-135	416	19	classified	classify	VERB
aji-135	416	20	as	as	ADP
aji-135	416	21	“	"	PUNCT
aji-135	416	22	intrinsic	intrinsic	ADJ
aji-135	416	23	”	"	PUNCT
aji-135	416	24	asthmatics	asthmatic	NOUN
aji-135	416	25	with	with	ADP
aji-135	416	26	help	help	NOUN
aji-135	416	27	of	of	ADP
aji-135	416	28	the	the	DET
aji-135	416	29	leukocyte	leukocyte	NOUN
aji-135	416	30	adherence	adherence	NOUN
aji-135	416	31	inhibition	inhibition	NOUN
aji-135	416	32	test	test	NOUN
aji-135	416	33	.	.	PUNCT
aji-135	417	1	eur	eur	PROPN
aji-135	417	2	j	j	PROPN
aji-135	417	3	clin	clin	PROPN
aji-135	417	4	med	med	PROPN
aji-135	417	5	.	.	PUNCT
aji-135	417	6	2023	2023	NUM
aji-135	417	7	;	;	PUNCT
aji-135	417	8	4(2):1	4(2):1	PROPN
aji-135	417	9	-	-	SYM
aji-135	417	10	7	7	NUM
aji-135	417	11	.	.	NOUN
aji-135	417	12	39	39	NUM
aji-135	417	13	.	.	PUNCT
aji-135	418	1	olivier	olivier	PROPN
aji-135	418	2	ce	ce	PROPN
aji-135	418	3	,	,	PUNCT
aji-135	418	4	pinto	pinto	NOUN
aji-135	418	5	dg	dg	PROPN
aji-135	418	6	,	,	PUNCT
aji-135	418	7	teixeira	teixeira	PROPN
aji-135	418	8	apm	apm	PROPN
aji-135	418	9	,	,	PUNCT
aji-135	418	10	santana	santana	PROPN
aji-135	418	11	jls	jls	PROPN
aji-135	418	12	,	,	PUNCT
aji-135	418	13	santos	santos	PROPN
aji-135	418	14	rapgs	rapgs	PROPN
aji-135	418	15	,	,	PUNCT
aji-135	418	16	lima	lima	PROPN
aji-135	418	17	rps	rps	PROPN
aji-135	418	18	,	,	PUNCT
aji-135	418	19	et	et	PROPN
aji-135	418	20	al	al	PROPN
aji-135	418	21	.	.	PROPN
aji-135	418	22	contribution	contribution	NOUN
aji-135	418	23	of	of	ADP
aji-135	418	24	the	the	DET
aji-135	418	25	leukocyte	leukocyte	NOUN
aji-135	418	26	adherence	adherence	NOUN
aji-135	418	27	inhibition	inhibition	NOUN
aji-135	418	28	test	test	NOUN
aji-135	418	29	to	to	ADP
aji-135	418	30	the	the	DET
aji-135	418	31	diagnosis	diagnosis	NOUN
aji-135	418	32	of	of	ADP
aji-135	418	33	innate	innate	ADJ
aji-135	418	34	non	non	ADJ
aji-135	418	35	–	–	PUNCT
aji-135	418	36	ige	ige	ADJ
aji-135	418	37	-	-	PUNCT
aji-135	418	38	mediated	mediate	VERB
aji-135	418	39	immunoreactivity	immunoreactivity	NOUN
aji-135	418	40	against	against	ADP
aji-135	418	41	alternaria	alternaria	PROPN
aji-135	418	42	alternata	alternata	PROPN
aji-135	418	43	.	.	PUNCT
aji-135	419	1	asian	asian	PROPN
aji-135	419	2	j	j	PROPN
aji-135	419	3	immunol	immunol	PROPN
aji-135	419	4	2023;6(1):243251	2023;6(1):243251	NUM
aji-135	419	5	.	.	PUNCT
aji-135	420	1	40	40	NUM
aji-135	420	2	.	.	PUNCT
aji-135	421	1	olivier	olivier	PROPN
aji-135	421	2	ce	ce	PROPN
aji-135	421	3	,	,	PUNCT
aji-135	421	4	pinto	pinto	NOUN
aji-135	421	5	dg	dg	PROPN
aji-135	421	6	,	,	PUNCT
aji-135	421	7	teixeira	teixeira	PROPN
aji-135	421	8	apm	apm	PROPN
aji-135	421	9	,	,	PUNCT
aji-135	421	10	santana	santana	PROPN
aji-135	421	11	jls	jls	PROPN
aji-135	421	12	,	,	PUNCT
aji-135	421	13	santos	santos	PROPN
aji-135	421	14	rapgs	rapgs	PROPN
aji-135	421	15	,	,	PUNCT
aji-135	421	16	lima	lima	PROPN
aji-135	421	17	rps	rps	PROPN
aji-135	421	18	.	.	PUNCT
aji-135	422	1	contribution	contribution	NOUN
aji-135	422	2	of	of	ADP
aji-135	422	3	the	the	DET
aji-135	422	4	leukocyte	leukocyte	NOUN
aji-135	422	5	adherence	adherence	NOUN
aji-135	422	6	inhibition	inhibition	NOUN
aji-135	422	7	test	test	NOUN
aji-135	422	8	to	to	ADP
aji-135	422	9	the	the	DET
aji-135	422	10	diagnosis	diagnosis	NOUN
aji-135	422	11	of	of	ADP
aji-135	422	12	innate	innate	ADJ
aji-135	422	13	non	non	ADJ
aji-135	422	14	–	–	PUNCT
aji-135	422	15	ige	ige	ADJ
aji-135	422	16	-	-	PUNCT
aji-135	422	17	mediated	mediate	VERB
aji-135	422	18	immunoreactivity	immunoreactivity	NOUN
aji-135	422	19	against	against	ADP
aji-135	422	20	saccharomyces	saccharomyce	NOUN
aji-135	422	21	cerevisiae	cerevisiae	NOUN
aji-135	422	22	.	.	PUNCT
aji-135	423	1	asian	asian	PROPN
aji-135	423	2	j	j	PROPN
aji-135	423	3	immunol	immunol	NOUN
aji-135	423	4	.	.	PUNCT
aji-135	424	1	2023;6(1):234	2023;6(1):234	NUM
aji-135	424	2	-	-	SYM
aji-135	424	3	241	241	NUM
aji-135	424	4	.	.	PROPN
aji-135	424	5	41	41	NUM
aji-135	424	6	.	.	PUNCT
aji-135	425	1	olivier	olivier	PROPN
aji-135	425	2	ce	ce	PROPN
aji-135	425	3	,	,	PUNCT
aji-135	425	4	pinto	pinto	NOUN
aji-135	425	5	dg	dg	PROPN
aji-135	425	6	,	,	PUNCT
aji-135	425	7	teixeira	teixeira	PROPN
aji-135	425	8	apm	apm	PROPN
aji-135	425	9	,	,	PUNCT
aji-135	425	10	santana	santana	PROPN
aji-135	425	11	jls	jls	PROPN
aji-135	425	12	,	,	PUNCT
aji-135	425	13	santos	santos	PROPN
aji-135	425	14	rapgs	rapgs	PROPN
aji-135	425	15	,	,	PUNCT
aji-135	425	16	lima	lima	PROPN
aji-135	425	17	rps	rps	PROPN
aji-135	425	18	,	,	PUNCT
aji-135	425	19	et	et	PROPN
aji-135	425	20	al	al	PROPN
aji-135	425	21	.	.	PROPN
aji-135	425	22	contribution	contribution	NOUN
aji-135	425	23	of	of	ADP
aji-135	425	24	the	the	DET
aji-135	425	25	leukocyte	leukocyte	NOUN
aji-135	425	26	adherence	adherence	NOUN
aji-135	425	27	inhibition	inhibition	NOUN
aji-135	425	28	test	test	NOUN
aji-135	425	29	to	to	ADP
aji-135	425	30	the	the	DET
aji-135	425	31	diagnosis	diagnosis	NOUN
aji-135	425	32	of	of	ADP
aji-135	425	33	non	non	ADJ
aji-135	425	34	–	–	PUNCT
aji-135	425	35	ige	ige	ADJ
aji-135	425	36	-	-	PUNCT
aji-135	425	37	mediated	mediate	VERB
aji-135	425	38	immunoreactivity	immunoreactivity	NOUN
aji-135	425	39	against	against	ADP
aji-135	425	40	candida	candida	NOUN
aji-135	425	41	albicans	albican	NOUN
aji-135	425	42	in	in	ADP
aji-135	425	43	patients	patient	NOUN
aji-135	425	44	with	with	ADP
aji-135	425	45	atopic	atopic	NOUN
aji-135	425	46	dermatitis	dermatitis	NOUN
aji-135	425	47	.	.	PUNCT
aji-135	426	1	asian	asian	PROPN
aji-135	426	2	j	j	PROPN
aji-135	426	3	immunol	immunol	NOUN
aji-135	426	4	.	.	PUNCT
aji-135	427	1	2023;6(1):268	2023;6(1):268	NUM
aji-135	427	2	-	-	SYM
aji-135	427	3	276	276	NUM
aji-135	427	4	.	.	PUNCT
aji-135	428	1	42	42	NUM
aji-135	428	2	.	.	PUNCT
aji-135	429	1	olivier	olivier	PROPN
aji-135	429	2	ce	ce	PROPN
aji-135	429	3	,	,	PUNCT
aji-135	429	4	pinto	pinto	NOUN
aji-135	429	5	dg	dg	PROPN
aji-135	429	6	,	,	PUNCT
aji-135	429	7	teixeira	teixeira	PROPN
aji-135	429	8	apm	apm	PROPN
aji-135	429	9	,	,	PUNCT
aji-135	429	10	santana	santana	PROPN
aji-135	429	11	jls	jls	PROPN
aji-135	429	12	,	,	PUNCT
aji-135	429	13	santos	santos	PROPN
aji-135	429	14	rapgs	rapgs	PROPN
aji-135	429	15	,	,	PUNCT
aji-135	429	16	lima	lima	PROPN
aji-135	429	17	rps	rps	PROPN
aji-135	429	18	,	,	PUNCT
aji-135	429	19	et	et	PROPN
aji-135	429	20	al	al	PROPN
aji-135	429	21	.	.	PROPN
aji-135	429	22	contribution	contribution	NOUN
aji-135	429	23	of	of	ADP
aji-135	429	24	the	the	DET
aji-135	429	25	leukocyte	leukocyte	NOUN
aji-135	429	26	adherence	adherence	NOUN
aji-135	429	27	inhibition	inhibition	NOUN
aji-135	429	28	test	test	NOUN
aji-135	429	29	in	in	ADP
aji-135	429	30	diagnosing	diagnose	VERB
aji-135	429	31	non	non	ADJ
aji-135	429	32	–	–	PUNCT
aji-135	429	33	ige	ige	ADJ
aji-135	429	34	-	-	PUNCT
aji-135	429	35	mediated	mediate	VERB
aji-135	429	36	immunoreactivity	immunoreactivity	NOUN
aji-135	429	37	against	against	ADP
aji-135	429	38	aspergillus	aspergillus	NOUN
aji-135	429	39	fumigatus	fumigatus	NOUN
aji-135	429	40	in	in	ADP
aji-135	429	41	patients	patient	NOUN
aji-135	429	42	with	with	ADP
aji-135	429	43	allergic	allergic	ADJ
aji-135	429	44	rhinitis	rhinitis	NOUN
aji-135	429	45	and	and	CCONJ
aji-135	429	46	asthma	asthma	NOUN
aji-135	429	47	.	.	PUNCT
aji-135	430	1	asian	asian	PROPN
aji-135	430	2	j	j	PROPN
aji-135	430	3	immunol	immunol	NOUN
aji-135	430	4	.	.	PUNCT
aji-135	431	1	2024;7(1):12	2024;7(1):12	NUM
aji-135	431	2	-	-	SYM
aji-135	431	3	20	20	NUM
aji-135	431	4	.	.	PUNCT
aji-135	431	5	43	43	NUM
aji-135	431	6	.	.	PUNCT
aji-135	432	1	olivier	olivier	PROPN
aji-135	432	2	ce	ce	PROPN
aji-135	432	3	,	,	PUNCT
aji-135	432	4	lima	lima	PROPN
aji-135	432	5	rps	rps	PROPN
aji-135	432	6	,	,	PUNCT
aji-135	432	7	pinto	pinto	NOUN
aji-135	432	8	dg	dg	NOUN
aji-135	432	9	,	,	PUNCT
aji-135	432	10	santos	santos	PROPN
aji-135	432	11	rapg	rapg	PROPN
aji-135	432	12	,	,	PUNCT
aji-135	432	13	silva	silva	PROPN
aji-135	432	14	gkm	gkm	PROPN
aji-135	432	15	,	,	PUNCT
aji-135	432	16	lorena	lorena	PROPN
aji-135	432	17	sls	sls	PROPN
aji-135	432	18	,	,	PUNCT
aji-135	432	19	et	et	PROPN
aji-135	432	20	al	al	PROPN
aji-135	432	21	.	.	PROPN
aji-135	433	1	in	in	ADP
aji-135	433	2	search	search	NOUN
aji-135	433	3	of	of	ADP
aji-135	433	4	a	a	DET
aji-135	433	5	tolerance	tolerance	NOUN
aji-135	433	6	-	-	PUNCT
aji-135	433	7	induction	induction	NOUN
aji-135	433	8	strategy	strategy	NOUN
aji-135	433	9	for	for	ADP
aji-135	433	10	cow	cow	NOUN
aji-135	433	11	’s	’s	PART
aji-135	433	12	milk	milk	NOUN
aji-135	433	13	allergies	allergy	NOUN
aji-135	433	14	:	:	PUNCT
aji-135	433	15	significant	significant	ADJ
aji-135	433	16	reduction	reduction	NOUN
aji-135	433	17	of	of	ADP
aji-135	433	18	beta	beta	NOUN
aji-135	433	19	-	-	PUNCT
aji-135	433	20	lactoglobulin	lactoglobulin	NOUN
aji-135	433	21	allergenicity	allergenicity	NOUN
aji-135	433	22	via	via	ADP
aji-135	433	23	transglutaminase	transglutaminase	NOUN
aji-135	433	24	/	/	SYM
aji-135	433	25	cysteine	cysteine	NOUN
aji-135	433	26	polymerization	polymerization	NOUN
aji-135	433	27	.	.	PUNCT
aji-135	434	1	clinics	clinic	NOUN
aji-135	434	2	.	.	PUNCT
aji-135	435	1	2012;67(10):1171	2012;67(10):1171	NUM
aji-135	435	2	-	-	SYM
aji-135	435	3	1179	1179	NUM
aji-135	435	4	.	.	PUNCT
aji-135	436	1	44	44	NUM
aji-135	436	2	.	.	PUNCT
aji-135	437	1	olivier	olivier	PROPN
aji-135	437	2	ce	ce	PROPN
aji-135	437	3	,	,	PUNCT
aji-135	437	4	santos	santos	PROPN
aji-135	437	5	rapg	rapg	PROPN
aji-135	437	6	,	,	PUNCT
aji-135	437	7	lima	lima	PROPN
aji-135	437	8	rps	rps	PROPN
aji-135	437	9	,	,	PUNCT
aji-135	437	10	argentão	argentão	ADJ
aji-135	437	11	dgp	dgp	NOUN
aji-135	437	12	,	,	PUNCT
aji-135	437	13	silva	silva	NOUN
aji-135	437	14	gkm	gkm	PROPN
aji-135	437	15	,	,	PUNCT
aji-135	437	16	silva	silva	PROPN
aji-135	437	17	md	md	PROPN
aji-135	437	18	.	.	PUNCT
aji-135	438	1	a	a	DET
aji-135	438	2	novel	novel	ADJ
aji-135	438	3	utility	utility	NOUN
aji-135	438	4	for	for	ADP
aji-135	438	5	an	an	DET
aji-135	438	6	old	old	ADJ
aji-135	438	7	method	method	NOUN
aji-135	438	8	:	:	PUNCT
aji-135	438	9	the	the	DET
aji-135	438	10	leukocyte	leukocyte	NOUN
aji-135	438	11	adherence	adherence	NOUN
aji-135	438	12	inhibition	inhibition	NOUN
aji-135	438	13	test	test	NOUN
aji-135	438	14	is	be	AUX
aji-135	438	15	an	an	DET
aji-135	438	16	easy	easy	ADJ
aji-135	438	17	way	way	NOUN
aji-135	438	18	to	to	PART
aji-135	438	19	detect	detect	VERB
aji-135	438	20	the	the	DET
aji-135	438	21	immunoreactive	immunoreactive	ADJ
aji-135	438	22	interference	interference	NOUN
aji-135	438	23	of	of	ADP
aji-135	438	24	the	the	DET
aji-135	438	25	collection	collection	NOUN
aji-135	438	26	tube	tube	NOUN
aji-135	438	27	anticoagulant	anticoagulant	NOUN
aji-135	438	28	on	on	ADP
aji-135	438	29	cellular	cellular	ADJ
aji-135	438	30	immunoassays	immunoassay	NOUN
aji-135	438	31	.	.	PUNCT
aji-135	439	1	journal	journal	NOUN
aji-135	439	2	of	of	ADP
aji-135	439	3	cell	cell	NOUN
aji-135	439	4	adhesion	adhesion	NOUN
aji-135	439	5	;	;	PUNCT
aji-135	439	6	2014	2014	NUM
aji-135	439	7	;	;	PUNCT
aji-135	439	8	article	article	NOUN
aji-135	439	9	i	i	PROPN
aji-135	439	10	d	d	PROPN
aji-135	439	11	860427	860427	NUM
aji-135	439	12	(	(	PUNCT
aji-135	439	13	http://dx.doi.org/10.1155/2014/860427):16	http://dx.doi.org/10.1155/2014/860427):16	NOUN
aji-135	439	14	.	.	NOUN
aji-135	439	15	45	45	NUM
aji-135	439	16	.	.	PUNCT
aji-135	440	1	olivier	olivier	PROPN
aji-135	440	2	ce	ce	PROPN
aji-135	440	3	,	,	PUNCT
aji-135	440	4	pinto	pinto	NOUN
aji-135	440	5	dg	dg	PROPN
aji-135	440	6	,	,	PUNCT
aji-135	440	7	lima	lima	PROPN
aji-135	440	8	rps	rps	PROPN
aji-135	440	9	,	,	PUNCT
aji-135	440	10	silva	silva	PROPN
aji-135	440	11	md	md	PROPN
aji-135	440	12	,	,	PUNCT
aji-135	440	13	santos	santos	PROPN
aji-135	440	14	rapg	rapg	PROPN
aji-135	440	15	,	,	PUNCT
aji-135	440	16	teixeira	teixeira	PROPN
aji-135	440	17	apm	apm	PROPN
aji-135	440	18	,	,	PUNCT
aji-135	440	19	et	et	PROPN
aji-135	440	20	al	al	PROPN
aji-135	440	21	.	.	PROPN
aji-135	440	22	assessment	assessment	NOUN
aji-135	440	23	of	of	ADP
aji-135	440	24	immunoreactivity	immunoreactivity	NOUN
aji-135	440	25	against	against	ADP
aji-135	440	26	therapeutic	therapeutic	ADJ
aji-135	440	27	options	option	NOUN
aji-135	440	28	employing	employ	VERB
aji-135	440	29	the	the	DET
aji-135	440	30	leukocyte	leukocyte	NOUN
aji-135	440	31	adherence	adherence	NOUN
aji-135	440	32	inhibition	inhibition	NOUN
aji-135	440	33	test	test	NOUN
aji-135	440	34	as	as	ADP
aji-135	440	35	a	a	DET
aji-135	440	36	tool	tool	NOUN
aji-135	440	37	for	for	ADP
aji-135	440	38	precision	precision	NOUN
aji-135	440	39	medicine	medicine	NOUN
aji-135	440	40	.	.	PUNCT
aji-135	441	1	eur	eur	PROPN
aji-135	441	2	j	j	PROPN
aji-135	441	3	clin	clin	PROPN
aji-135	441	4	med	med	PROPN
aji-135	441	5	.	.	PUNCT
aji-135	442	1	2021;2(3):40	2021;2(3):40	NUM
aji-135	442	2	-	-	SYM
aji-135	442	3	45	45	NUM
aji-135	442	4	.	.	NOUN
aji-135	443	1	46	46	NUM
aji-135	443	2	.	.	PUNCT
aji-135	444	1	olivier	olivier	PROPN
aji-135	444	2	ce	ce	PROPN
aji-135	444	3	,	,	PUNCT
aji-135	444	4	pinto	pinto	NOUN
aji-135	444	5	dg	dg	PROPN
aji-135	444	6	,	,	PUNCT
aji-135	444	7	santos	santos	PROPN
aji-135	444	8	rapg	rapg	PROPN
aji-135	444	9	,	,	PUNCT
aji-135	444	10	lima	lima	PROPN
aji-135	444	11	rps	rps	PROPN
aji-135	444	12	.	.	PUNCT
aji-135	444	13	dextran	dextran	PROPN
aji-135	444	14	’s	’s	PART
aji-135	444	15	interference	interference	NOUN
aji-135	444	16	over	over	ADP
aji-135	444	17	the	the	DET
aji-135	444	18	leukocyte	leukocyte	NOUN
aji-135	444	19	adherence	adherence	NOUN
aji-135	444	20	inhibition	inhibition	NOUN
aji-135	444	21	test	test	NOUN
aji-135	444	22	.	.	PUNCT
aji-135	445	1	academia	academia	PROPN
aji-135	445	2	letter	letter	PROPN
aji-135	445	3	.	.	PUNCT
aji-135	446	1	2021	2021	NUM
aji-135	446	2	;	;	PUNCT
aji-135	447	1	article	article	NOUN
aji-135	447	2	number	number	NOUN
aji-135	447	3	3792	3792	NUM
aji-135	447	4	.	.	PUNCT
aji-135	448	1	47	47	NUM
aji-135	448	2	.	.	PUNCT
aji-135	449	1	olivier	olivier	PROPN
aji-135	449	2	ce	ce	PROPN
aji-135	449	3	,	,	PUNCT
aji-135	449	4	pinto	pinto	NOUN
aji-135	449	5	dg	dg	PROPN
aji-135	449	6	,	,	PUNCT
aji-135	449	7	teixeira	teixeira	PROPN
aji-135	449	8	apm	apm	PROPN
aji-135	449	9	,	,	PUNCT
aji-135	449	10	santana	santana	PROPN
aji-135	449	11	jls	jls	PROPN
aji-135	449	12	,	,	PUNCT
aji-135	449	13	santos	santos	PROPN
aji-135	449	14	rapgs	rapgs	PROPN
aji-135	449	15	,	,	PUNCT
aji-135	449	16	lima	lima	PROPN
aji-135	449	17	rps	rps	PROPN
aji-135	449	18	.	.	PUNCT
aji-135	450	1	immunoreactivity	immunoreactivity	NOUN
aji-135	450	2	against	against	ADP
aji-135	450	3	dermatophagoides	dermatophagoide	NOUN
aji-135	450	4	pteronyssinus	pteronyssinus	NOUN
aji-135	450	5	assessed	assess	VERB
aji-135	450	6	by	by	ADP
aji-135	450	7	the	the	DET
aji-135	450	8	leukocyte	leukocyte	NOUN
aji-135	450	9	adherence	adherence	NOUN
aji-135	450	10	inhibition	inhibition	NOUN
aji-135	450	11	test	test	NOUN
aji-135	450	12	in	in	ADP
aji-135	450	13	patients	patient	NOUN
aji-135	450	14	with	with	ADP
aji-135	450	15	intrinsic	intrinsic	ADJ
aji-135	450	16	atopic	atopic	NOUN
aji-135	450	17	dermatitis	dermatitis	NOUN
aji-135	450	18	and	and	CCONJ
aji-135	450	19	correlated	correlate	VERB
aji-135	450	20	“	"	PUNCT
aji-135	450	21	intrinsic	intrinsic	ADJ
aji-135	450	22	”	"	PUNCT
aji-135	450	23	non	non	ADJ
aji-135	450	24	–	–	PUNCT
aji-135	450	25	ige	ige	ADJ
aji-135	450	26	-	-	PUNCT
aji-135	450	27	mediated	mediate	VERB
aji-135	450	28	allergic	allergic	ADJ
aji-135	450	29	conditions	condition	NOUN
aji-135	450	30	.	.	PUNCT
aji-135	451	1	eur	eur	PROPN
aji-135	451	2	j	j	PROPN
aji-135	451	3	clin	clin	PROPN
aji-135	451	4	med	me	VERB
aji-135	451	5	.	.	PUNCT
aji-135	452	1	2021;2(6):45	2021;2(6):45	NUM
aji-135	452	2	-	-	SYM
aji-135	452	3	50	50	NUM
aji-135	452	4	.	.	PUNCT
aji-135	453	1	48	48	NUM
aji-135	453	2	.	.	PUNCT
aji-135	454	1	olivier	olivier	PROPN
aji-135	454	2	ce	ce	PROPN
aji-135	454	3	,	,	PUNCT
aji-135	454	4	pinto	pinto	NOUN
aji-135	454	5	dg	dg	PROPN
aji-135	454	6	,	,	PUNCT
aji-135	454	7	teixeira	teixeira	PROPN
aji-135	454	8	apm	apm	PROPN
aji-135	454	9	,	,	PUNCT
aji-135	454	10	santana	santana	PROPN
aji-135	454	11	jls	jls	PROPN
aji-135	454	12	,	,	PUNCT
aji-135	454	13	santos	santos	PROPN
aji-135	454	14	rapgs	rapgs	PROPN
aji-135	454	15	,	,	PUNCT
aji-135	454	16	lima	lima	PROPN
aji-135	454	17	rps	rps	PROPN
aji-135	454	18	.	.	PUNCT
aji-135	455	1	contribution	contribution	NOUN
aji-135	455	2	of	of	ADP
aji-135	455	3	the	the	DET
aji-135	455	4	leukocyte	leukocyte	NOUN
aji-135	455	5	adherence	adherence	NOUN
aji-135	455	6	inhibition	inhibition	NOUN
aji-135	455	7	test	test	NOUN
aji-135	455	8	to	to	ADP
aji-135	455	9	the	the	DET
aji-135	455	10	evaluation	evaluation	NOUN
aji-135	455	11	of	of	ADP
aji-135	455	12	cellular	cellular	ADJ
aji-135	455	13	immunoreactivity	immunoreactivity	NOUN
aji-135	455	14	against	against	ADP
aji-135	455	15	latex	latex	NOUN
aji-135	455	16	extracts	extract	NOUN
aji-135	455	17	for	for	ADP
aji-135	455	18	non	non	ADJ
aji-135	455	19	—	—	PUNCT
aji-135	455	20	ige	ige	ADJ
aji-135	455	21	-	-	PUNCT
aji-135	455	22	mediated	mediate	VERB
aji-135	455	23	latex	latex	NOUN
aji-135	455	24	-	-	PUNCT
aji-135	455	25	fruit	fruit	NOUN
aji-135	455	26	-	-	PUNCT
aji-135	455	27	pollen	pollen	NOUN
aji-135	455	28	syndrome	syndrome	NOUN
aji-135	455	29	in	in	ADP
aji-135	455	30	allergic	allergic	ADJ
aji-135	455	31	candidates	candidate	NOUN
aji-135	455	32	to	to	PART
aji-135	455	33	exclusion	exclusion	VERB
aji-135	455	34	diets	diet	NOUN
aji-135	455	35	and	and	CCONJ
aji-135	455	36	allergic	allergic	ADJ
aji-135	455	37	desensitization	desensitization	NOUN
aji-135	455	38	.	.	PUNCT
aji-135	456	1	eur	eur	PROPN
aji-135	456	2	j	j	PROPN
aji-135	456	3	clin	clin	PROPN
aji-135	456	4	med	med	PROPN
aji-135	456	5	.	.	PUNCT
aji-135	456	6	2022	2022	NUM
aji-135	456	7	;	;	PUNCT
aji-135	456	8	3(1):11	3(1):11	NUM
aji-135	456	9	-	-	SYM
aji-135	456	10	17	17	NUM
aji-135	456	11	.	.	PUNCT
aji-135	457	1	49	49	NUM
aji-135	457	2	.	.	PUNCT
aji-135	458	1	olivier	olivier	PROPN
aji-135	458	2	ce	ce	PROPN
aji-135	458	3	,	,	PUNCT
aji-135	458	4	pinto	pinto	NOUN
aji-135	458	5	dg	dg	PROPN
aji-135	458	6	,	,	PUNCT
aji-135	458	7	teixeira	teixeira	PROPN
aji-135	458	8	apm	apm	PROPN
aji-135	458	9	,	,	PUNCT
aji-135	458	10	santana	santana	PROPN
aji-135	458	11	jls	jls	PROPN
aji-135	458	12	,	,	PUNCT
aji-135	458	13	santos	santos	PROPN
aji-135	458	14	rapgs	rapgs	PROPN
aji-135	458	15	,	,	PUNCT
aji-135	458	16	lima	lima	PROPN
aji-135	458	17	rps	rps	PROPN
aji-135	458	18	.	.	PUNCT
aji-135	459	1	contribution	contribution	NOUN
aji-135	459	2	of	of	ADP
aji-135	459	3	the	the	DET
aji-135	459	4	leukocyte	leukocyte	NOUN
aji-135	459	5	adherence	adherence	NOUN
aji-135	459	6	inhibition	inhibition	NOUN
aji-135	459	7	test	test	NOUN
aji-135	459	8	for	for	ADP
aji-135	459	9	the	the	DET
aji-135	459	10	evaluation	evaluation	NOUN
aji-135	459	11	of	of	ADP
aji-135	459	12	immunoreactivity	immunoreactivity	NOUN
aji-135	459	13	against	against	ADP
aji-135	459	14	gluten	gluten	ADJ
aji-135	459	15	extracts	extract	NOUN
aji-135	459	16	in	in	ADP
aji-135	459	17	non	non	ADJ
aji-135	459	18	—	—	PUNCT
aji-135	459	19	ige	ige	ADJ
aji-135	459	20	-	-	PUNCT
aji-135	459	21	mediated	mediate	VERB
aji-135	459	22	/	/	SYM
aji-135	459	23	non	non	ADJ
aji-135	459	24	-	-	ADJ
aji-135	459	25	autoimmune	autoimmune	ADJ
aji-135	459	26	gluten	gluten	NOUN
aji-135	459	27	-	-	PUNCT
aji-135	459	28	related	relate	VERB
aji-135	459	29	disorders	disorder	NOUN
aji-135	459	30	.	.	PUNCT
aji-135	460	1	eur	eur	PROPN
aji-135	460	2	j	j	PROPN
aji-135	460	3	clin	clin	PROPN
aji-135	460	4	med	med	PROPN
aji-135	460	5	.	.	PUNCT
aji-135	461	1	2022;3(2):1	2022;3(2):1	PROPN
aji-135	461	2	-	-	PUNCT
aji-135	461	3	7	7	NUM
aji-135	461	4	.	.	NOUN
aji-135	461	5	50	50	NUM
aji-135	461	6	.	.	PUNCT
aji-135	462	1	olivier	olivier	PROPN
aji-135	462	2	ce	ce	PROPN
aji-135	462	3	,	,	PUNCT
aji-135	462	4	pinto	pinto	NOUN
aji-135	462	5	dg	dg	PROPN
aji-135	462	6	,	,	PUNCT
aji-135	462	7	teixeira	teixeira	PROPN
aji-135	462	8	apm	apm	PROPN
aji-135	462	9	,	,	PUNCT
aji-135	462	10	santana	santana	PROPN
aji-135	462	11	jls	jls	PROPN
aji-135	462	12	,	,	PUNCT
aji-135	462	13	santos	santos	PROPN
aji-135	462	14	rapgs	rapgs	PROPN
aji-135	462	15	,	,	PUNCT
aji-135	462	16	lima	lima	PROPN
aji-135	462	17	rps	rps	PROPN
aji-135	462	18	.	.	PUNCT
aji-135	463	1	leukocyte	leukocyte	ADJ
aji-135	463	2	adherence	adherence	NOUN
aji-135	463	3	inhibition	inhibition	NOUN
aji-135	463	4	test	test	NOUN
aji-135	463	5	to	to	ADP
aji-135	463	6	the	the	DET
aji-135	463	7	assessment	assessment	NOUN
aji-135	463	8	of	of	ADP
aji-135	463	9	immunoreactivity	immunoreactivity	NOUN
aji-135	463	10	against	against	ADP
aji-135	463	11	cow	cow	NOUN
aji-135	463	12	’s	’s	PART
aji-135	463	13	milk	milk	NOUN
aji-135	463	14	proteins	protein	NOUN
aji-135	463	15	in	in	ADP
aji-135	463	16	non	non	ADJ
aji-135	463	17	—	—	PUNCT
aji-135	463	18	ige	ige	ADJ
aji-135	463	19	-	-	PUNCT
aji-135	463	20	mediated	mediate	VERB
aji-135	463	21	gastrointestinal	gastrointestinal	ADJ
aji-135	463	22	food	food	NOUN
aji-135	463	23	allergy	allergy	NOUN
aji-135	463	24	.	.	PUNCT
aji-135	464	1	eur	eur	PROPN
aji-135	464	2	j	j	PROPN
aji-135	464	3	clin	clin	PROPN
aji-135	464	4	med	me	VERB
aji-135	464	5	.	.	PUNCT
aji-135	465	1	2022;3(2):38	2022;3(2):38	NUM
aji-135	465	2	-	-	SYM
aji-135	465	3	43	43	NUM
aji-135	465	4	.	.	PUNCT
aji-135	466	1	51	51	NUM
aji-135	466	2	.	.	PUNCT
aji-135	467	1	olivier	olivier	PROPN
aji-135	467	2	ce	ce	PROPN
aji-135	467	3	,	,	PUNCT
aji-135	467	4	pinto	pinto	NOUN
aji-135	467	5	dg	dg	PROPN
aji-135	467	6	,	,	PUNCT
aji-135	467	7	teixeira	teixeira	PROPN
aji-135	467	8	apm	apm	PROPN
aji-135	467	9	,	,	PUNCT
aji-135	467	10	santana	santana	PROPN
aji-135	467	11	jls	jls	PROPN
aji-135	467	12	,	,	PUNCT
aji-135	467	13	santos	santos	PROPN
aji-135	467	14	rapgs	rapgs	PROPN
aji-135	467	15	,	,	PUNCT
aji-135	467	16	lima	lima	PROPN
aji-135	467	17	rps	rps	PROPN
aji-135	467	18	.	.	PUNCT
aji-135	468	1	contribution	contribution	NOUN
aji-135	468	2	of	of	ADP
aji-135	468	3	the	the	DET
aji-135	468	4	leukocyte	leukocyte	NOUN
aji-135	468	5	adherence	adherence	NOUN
aji-135	468	6	inhibition	inhibition	NOUN
aji-135	468	7	test	test	NOUN
aji-135	468	8	to	to	ADP
aji-135	468	9	the	the	DET
aji-135	468	10	diagnosis	diagnosis	NOUN
aji-135	468	11	of	of	ADP
aji-135	468	12	immunoreactivity	immunoreactivity	NOUN
aji-135	468	13	against	against	ADP
aji-135	468	14	cobalt	cobalt	NOUN
aji-135	468	15	.	.	PUNCT
aji-135	469	1	asian	asian	PROPN
aji-135	469	2	j	j	PROPN
aji-135	469	3	immunol	immunol	NOUN
aji-135	469	4	.	.	PUNCT
aji-135	470	1	2023;6(1):174	2023;6(1):174	X
aji-135	470	2	-	-	PUNCT
aji-135	470	3	184	184	NUM
aji-135	470	4	.	.	PUNCT
aji-135	471	1	52	52	NUM
aji-135	471	2	.	.	PUNCT
aji-135	472	1	olivier	olivier	PROPN
aji-135	472	2	ce	ce	PROPN
aji-135	472	3	,	,	PUNCT
aji-135	472	4	pinto	pinto	NOUN
aji-135	472	5	dg	dg	PROPN
aji-135	472	6	,	,	PUNCT
aji-135	472	7	teixeira	teixeira	PROPN
aji-135	472	8	apm	apm	PROPN
aji-135	472	9	,	,	PUNCT
aji-135	472	10	santana	santana	PROPN
aji-135	472	11	jls	jls	PROPN
aji-135	472	12	,	,	PUNCT
aji-135	472	13	santos	santos	PROPN
aji-135	472	14	rapgs	rapgs	PROPN
aji-135	472	15	,	,	PUNCT
aji-135	472	16	lima	lima	PROPN
aji-135	472	17	rps	rps	PROPN
aji-135	472	18	.	.	PUNCT
aji-135	473	1	intrinsic	intrinsic	ADJ
aji-135	473	2	atopic	atopic	NOUN
aji-135	473	3	dermatitis	dermatitis	NOUN
aji-135	473	4	:	:	PUNCT
aji-135	473	5	titration	titration	NOUN
aji-135	473	6	of	of	ADP
aji-135	473	7	precipitins	precipitin	NOUN
aji-135	473	8	in	in	ADP
aji-135	473	9	the	the	DET
aji-135	473	10	screening	screening	NOUN
aji-135	473	11	of	of	ADP
aji-135	473	12	food	food	NOUN
aji-135	473	13	allergens	allergen	NOUN
aji-135	473	14	for	for	ADP
aji-135	473	15	prescription	prescription	NOUN
aji-135	473	16	of	of	ADP
aji-135	473	17	elimination	elimination	NOUN
aji-135	473	18	diets	diet	NOUN
aji-135	473	19	and	and	CCONJ
aji-135	473	20	desensitization	desensitization	NOUN
aji-135	473	21	strategies	strategy	NOUN
aji-135	473	22	.	.	PUNCT
aji-135	474	1	eur	eur	PROPN
aji-135	474	2	j	j	PROPN
aji-135	474	3	clin	clin	PROPN
aji-135	474	4	med	me	VERB
aji-135	474	5	.	.	PUNCT
aji-135	475	1	2021.2(6):1	2021.2(6):1	NUM
aji-135	475	2	-	-	SYM
aji-135	475	3	9	9	NUM
aji-135	475	4	.	.	PUNCT
aji-135	476	1	olivier	olivier	PROPN
aji-135	476	2	et	et	PROPN
aji-135	476	3	al	al	PROPN
aji-135	476	4	.	.	PROPN
aji-135	476	5	;	;	PUNCT
aji-135	476	6	asian	asian	PROPN
aji-135	476	7	j.	j.	PROPN
aji-135	476	8	immunol	immunol	PROPN
aji-135	476	9	.	.	PROPN
aji-135	476	10	,	,	PUNCT
aji-135	476	11	vol	vol	NOUN
aji-135	476	12	.	.	PROPN
aji-135	477	1	7	7	NUM
aji-135	477	2	,	,	PUNCT
aji-135	477	3	no	no	INTJ
aji-135	477	4	.	.	NOUN
aji-135	477	5	1	1	NUM
aji-135	477	6	,	,	PUNCT
aji-135	477	7	pp	pp	ADJ
aji-135	477	8	.	.	PUNCT
aji-135	478	1	100	100	NUM
aji-135	478	2	-	-	SYM
aji-135	478	3	111	111	NUM
aji-135	478	4	,	,	PUNCT
aji-135	478	5	2024	2024	NUM
aji-135	478	6	;	;	PUNCT
aji-135	479	1	article	article	NOUN
aji-135	479	2	no.aji.119914	no.aji.119914	PROPN
aji-135	479	3	110	110	NUM
aji-135	479	4	53	53	NUM
aji-135	479	5	.	.	PUNCT
aji-135	480	1	williams	williams	PROPN
aji-135	480	2	ca	ca	PROPN
aji-135	480	3	,	,	PUNCT
aji-135	480	4	chase	chase	PROPN
aji-135	480	5	mw	mw	PROPN
aji-135	480	6	.	.	PROPN
aji-135	480	7	chapter	chapter	NOUN
aji-135	480	8	13	13	NUM
aji-135	480	9	precipitation	precipitation	NOUN
aji-135	480	10	reactions	reaction	NOUN
aji-135	480	11	.	.	PUNCT
aji-135	481	1	in	in	ADP
aji-135	481	2	reactions	reaction	NOUN
aji-135	481	3	of	of	ADP
aji-135	481	4	antibodies	antibody	NOUN
aji-135	481	5	with	with	ADP
aji-135	481	6	soluble	soluble	ADJ
aji-135	481	7	antigens	antigen	NOUN
aji-135	481	8	,	,	PUNCT
aji-135	481	9	academic	academic	ADJ
aji-135	481	10	press	press	NOUN
aji-135	481	11	.	.	PUNCT
aji-135	482	1	1971;3:1	1971;3:1	NUM
aji-135	482	2	-	-	SYM
aji-135	482	3	102	102	NUM
aji-135	482	4	.	.	PUNCT
aji-135	483	1	54	54	NUM
aji-135	483	2	.	.	PUNCT
aji-135	484	1	bruusgaard	bruusgaard	ADV
aji-135	484	2	-	-	PUNCT
aji-135	484	3	mouritsen	mouritsen	NOUN
aji-135	484	4	ma	ma	PROPN
aji-135	484	5	,	,	PUNCT
aji-135	484	6	johansen	johansen	PROPN
aji-135	484	7	jd	jd	PROPN
aji-135	484	8	,	,	PUNCT
aji-135	484	9	garvey	garvey	PROPN
aji-135	484	10	lh	lh	PROPN
aji-135	484	11	.	.	PUNCT
aji-135	485	1	clinical	clinical	ADJ
aji-135	485	2	manifestations	manifestation	NOUN
aji-135	485	3	and	and	CCONJ
aji-135	485	4	impact	impact	NOUN
aji-135	485	5	on	on	ADP
aji-135	485	6	daily	daily	ADJ
aji-135	485	7	life	life	NOUN
aji-135	485	8	of	of	ADP
aji-135	485	9	allergy	allergy	NOUN
aji-135	485	10	to	to	ADP
aji-135	485	11	polyethylene	polyethylene	NOUN
aji-135	485	12	glycol	glycol	NOUN
aji-135	485	13	(	(	PUNCT
aji-135	485	14	peg	peg	NOUN
aji-135	485	15	)	)	PUNCT
aji-135	485	16	in	in	ADP
aji-135	485	17	ten	ten	NUM
aji-135	485	18	patients	patient	NOUN
aji-135	485	19	.	.	PUNCT
aji-135	486	1	clin	clin	PROPN
aji-135	486	2	exp	exp	NOUN
aji-135	486	3	allergy	allergy	PROPN
aji-135	486	4	.	.	PUNCT
aji-135	487	1	2021;51(3):463470	2021;51(3):463470	NUM
aji-135	487	2	.	.	PUNCT
aji-135	488	1	55	55	NUM
aji-135	488	2	.	.	PUNCT
aji-135	489	1	hicks	hicks	PROPN
aji-135	489	2	ed	ed	PROPN
aji-135	489	3	,	,	PUNCT
aji-135	489	4	hall	hall	NOUN
aji-135	489	5	g	g	NOUN
aji-135	489	6	,	,	PUNCT
aji-135	489	7	hershfield	hershfield	PROPN
aji-135	489	8	ms	ms	PROPN
aji-135	489	9	,	,	PUNCT
aji-135	489	10	tarrant	tarrant	PROPN
aji-135	489	11	tk	tk	PROPN
aji-135	489	12	,	,	PUNCT
aji-135	489	13	bali	bali	PROPN
aji-135	489	14	p	p	PROPN
aji-135	489	15	,	,	PUNCT
aji-135	489	16	sleasman	sleasman	PROPN
aji-135	489	17	jw	jw	PROPN
aji-135	489	18	,	,	PUNCT
aji-135	490	1	et	et	PROPN
aji-135	490	2	al	al	PROPN
aji-135	490	3	.	.	PUNCT
aji-135	490	4	treatment	treatment	NOUN
aji-135	490	5	with	with	ADP
aji-135	490	6	elapegademase	elapegademase	NOUN
aji-135	490	7	restores	restore	VERB
aji-135	490	8	immunity	immunity	NOUN
aji-135	490	9	in	in	ADP
aji-135	490	10	infants	infant	NOUN
aji-135	490	11	with	with	ADP
aji-135	490	12	adenosine	adenosine	ADJ
aji-135	490	13	deaminase	deaminase	NOUN
aji-135	490	14	deficient	deficient	ADJ
aji-135	490	15	severe	severe	ADJ
aji-135	490	16	combined	combined	ADJ
aji-135	490	17	immunodeficiency	immunodeficiency	NOUN
aji-135	490	18	.	.	PUNCT
aji-135	491	1	j	j	PROPN
aji-135	491	2	clin	clin	PROPN
aji-135	491	3	immunol	immunol	PROPN
aji-135	491	4	.	.	PUNCT
aji-135	492	1	2024	2024	NUM
aji-135	492	2	;	;	PUNCT
aji-135	493	1	44(5):107	44(5):107	X
aji-135	493	2	.	.	PUNCT
aji-135	494	1	56	56	NUM
aji-135	494	2	.	.	PUNCT
aji-135	494	3	bento	bento	NOUN
aji-135	494	4	c	c	PROPN
aji-135	494	5	,	,	PUNCT
aji-135	494	6	katz	katz	PROPN
aji-135	494	7	m	m	PROPN
aji-135	494	8	,	,	PUNCT
aji-135	494	9	santos	santos	PROPN
aji-135	494	10	mmm	mmm	PROPN
aji-135	494	11	,	,	PUNCT
aji-135	494	12	afonso	afonso	PROPN
aji-135	494	13	cam	cam	PROPN
aji-135	494	14	.	.	PUNCT
aji-135	495	1	striving	strive	VERB
aji-135	495	2	for	for	ADP
aji-135	495	3	uniformity	uniformity	NOUN
aji-135	495	4	:	:	PUNCT
aji-135	495	5	a	a	DET
aji-135	495	6	review	review	NOUN
aji-135	495	7	on	on	ADP
aji-135	495	8	advances	advance	NOUN
aji-135	495	9	and	and	CCONJ
aji-135	495	10	challenges	challenge	NOUN
aji-135	495	11	to	to	PART
aji-135	495	12	achieve	achieve	VERB
aji-135	495	13	uniform	uniform	ADJ
aji-135	495	14	polyethylene	polyethylene	NOUN
aji-135	495	15	glycol	glycol	NOUN
aji-135	495	16	.	.	PUNCT
aji-135	496	1	org	org	ADJ
aji-135	496	2	process	process	NOUN
aji-135	496	3	res	re	NOUN
aji-135	496	4	develop	develop	VERB
aji-135	496	5	.	.	PUNCT
aji-135	497	1	2024;28(4):860890	2024;28(4):860890	NUM
aji-135	497	2	.	.	PUNCT
aji-135	498	1	57	57	NUM
aji-135	498	2	.	.	PUNCT
aji-135	499	1	kayode	kayode	PROPN
aji-135	499	2	os	os	PROPN
aji-135	499	3	,	,	PUNCT
aji-135	499	4	nakonechna	nakonechna	PROPN
aji-135	499	5	a	a	PRON
aji-135	499	6	,	,	PUNCT
aji-135	499	7	siew	siew	PROPN
aji-135	499	8	lqc	lqc	PROPN
aji-135	499	9	,	,	PUNCT
aji-135	499	10	dziadzio	dziadzio	PROPN
aji-135	499	11	m	m	PRON
aji-135	499	12	,	,	PUNCT
aji-135	499	13	kennard	kennard	PROPN
aji-135	499	14	l	l	PROPN
aji-135	499	15	,	,	PUNCT
aji-135	499	16	rutkowski	rutkowski	PROPN
aji-135	499	17	k	k	PROPN
aji-135	499	18	,	,	PUNCT
aji-135	499	19	et	et	PROPN
aji-135	499	20	al	al	PROPN
aji-135	499	21	.	.	PUNCT
aji-135	499	22	polyethylene	polyethylene	NOUN
aji-135	499	23	glycol	glycol	NOUN
aji-135	499	24	hypersensitivity	hypersensitivity	NOUN
aji-135	499	25	,	,	PUNCT
aji-135	499	26	patient	patient	ADJ
aji-135	499	27	outcomes	outcome	NOUN
aji-135	499	28	in	in	ADP
aji-135	499	29	a	a	DET
aji-135	499	30	7	7	NUM
aji-135	499	31	-	-	PUNCT
aji-135	499	32	year	year	NOUN
aji-135	499	33	retrospective	retrospective	ADJ
aji-135	499	34	study	study	NOUN
aji-135	499	35	.	.	PUNCT
aji-135	500	1	ann	ann	PROPN
aji-135	500	2	allergy	allergy	PROPN
aji-135	500	3	asthma	asthma	PROPN
aji-135	500	4	immunol	immunol	PROPN
aji-135	500	5	.	.	PUNCT
aji-135	501	1	published	publish	VERB
aji-135	501	2	online	online	ADJ
aji-135	501	3	march	march	PROPN
aji-135	501	4	30	30	NUM
aji-135	501	5	,	,	PUNCT
aji-135	501	6	2024	2024	NUM
aji-135	501	7	.	.	PUNCT
aji-135	502	1	doi	doi	NOUN
aji-135	502	2	:	:	PUNCT
aji-135	502	3	10.1016	10.1016	NUM
aji-135	502	4	/	/	SYM
aji-135	502	5	j.anai.2024.03.022	j.anai.2024.03.022	PROPN
aji-135	502	6	.	.	PROPN
aji-135	503	1	58	58	NUM
aji-135	503	2	.	.	PUNCT
aji-135	504	1	perkins	perkin	VERB
aji-135	504	2	g	g	PROPN
aji-135	504	3	,	,	PUNCT
aji-135	504	4	troelnikov	troelnikov	PROPN
aji-135	504	5	a	a	X
aji-135	504	6	,	,	PUNCT
aji-135	504	7	hissaria	hissaria	PROPN
aji-135	504	8	p.	p.	PROPN
aji-135	504	9	reply	reply	NOUN
aji-135	504	10	.	.	PUNCT
aji-135	505	1	j	j	PROPN
aji-135	505	2	allergy	allergy	PROPN
aji-135	505	3	clin	clin	PROPN
aji-135	505	4	immunol	immunol	PROPN
aji-135	505	5	.	.	PUNCT
aji-135	505	6	2021	2021	NUM
aji-135	505	7	;	;	PUNCT
aji-135	505	8	148(3):902	148(3):902	NUM
aji-135	505	9	-	-	PUNCT
aji-135	505	10	903	903	NUM
aji-135	505	11	.	.	PUNCT
aji-135	506	1	59	59	NUM
aji-135	506	2	.	.	PUNCT
aji-135	507	1	lisiecka	lisiecka	PROPN
aji-135	507	2	mz	mz	PROPN
aji-135	507	3	.	.	PROPN
aji-135	507	4	polyethylene	polyethylene	NOUN
aji-135	507	5	glycol	glycol	NOUN
aji-135	507	6	and	and	CCONJ
aji-135	507	7	immunology	immunology	NOUN
aji-135	507	8	:	:	PUNCT
aji-135	507	9	aspects	aspect	NOUN
aji-135	507	10	of	of	ADP
aji-135	507	11	allergic	allergic	ADJ
aji-135	507	12	reactions	reaction	NOUN
aji-135	507	13	and	and	CCONJ
aji-135	507	14	their	their	PRON
aji-135	507	15	mechanisms	mechanism	NOUN
aji-135	507	16	,	,	PUNCT
aji-135	507	17	as	as	ADV
aji-135	507	18	well	well	ADV
aji-135	507	19	as	as	ADP
aji-135	507	20	ways	way	NOUN
aji-135	507	21	to	to	PART
aji-135	507	22	prevent	prevent	VERB
aji-135	507	23	them	they	PRON
aji-135	507	24	in	in	ADP
aji-135	507	25	clinical	clinical	ADJ
aji-135	507	26	practice	practice	NOUN
aji-135	507	27	.	.	PUNCT
aji-135	508	1	immunol	immunol	NOUN
aji-135	508	2	res	re	NOUN
aji-135	508	3	.	.	PUNCT
aji-135	508	4	published	publish	VERB
aji-135	508	5	online	online	ADJ
aji-135	508	6	march	march	PROPN
aji-135	508	7	19	19	NUM
aji-135	508	8	,	,	PUNCT
aji-135	508	9	2024	2024	NUM
aji-135	508	10	.	.	PUNCT
aji-135	509	1	doi	doi	NOUN
aji-135	509	2	:	:	PUNCT
aji-135	509	3	10.1007	10.1007	NUM
aji-135	509	4	/	/	SYM
aji-135	509	5	s12026	s12026	PRON
aji-135	509	6	-	-	PUNCT
aji-135	509	7	024	024	NUM
aji-135	509	8	-	-	PUNCT
aji-135	509	9	09473	09473	NUM
aji-135	509	10	-	-	SYM
aji-135	509	11	w	w	PROPN
aji-135	509	12	60	60	NUM
aji-135	509	13	.	.	PUNCT
aji-135	510	1	eberlein	eberlein	PROPN
aji-135	510	2	b	b	PROPN
aji-135	510	3	,	,	PUNCT
aji-135	510	4	mathes	mathes	PROPN
aji-135	510	5	s	s	PROPN
aji-135	510	6	,	,	PUNCT
aji-135	510	7	darsow	darsow	PROPN
aji-135	510	8	u	u	PROPN
aji-135	510	9	,	,	PUNCT
aji-135	510	10	biedermann	biedermann	PROPN
aji-135	510	11	t	t	PROPN
aji-135	510	12	,	,	PUNCT
aji-135	510	13	brockow	brockow	PROPN
aji-135	510	14	k.	k.	PROPN
aji-135	510	15	allergy	allergy	PROPN
aji-135	510	16	to	to	ADP
aji-135	510	17	peg	peg	NOUN
aji-135	510	18	(	(	PUNCT
aji-135	510	19	polyethylene	polyethylene	NOUN
aji-135	510	20	glycol	glycol	NOUN
aji-135	510	21	)	)	PUNCT
aji-135	510	22	sensitivity	sensitivity	NOUN
aji-135	510	23	of	of	ADP
aji-135	510	24	basophil	basophil	NOUN
aji-135	510	25	activation	activation	NOUN
aji-135	510	26	test	test	NOUN
aji-135	510	27	with	with	ADP
aji-135	510	28	covid-19	covid-19	PROPN
aji-135	510	29	mrna	mrna	NOUN
aji-135	510	30	-	-	PUNCT
aji-135	510	31	vaccine	vaccine	NOUN
aji-135	510	32	bnt162b2	bnt162b2	PROPN
aji-135	510	33	.	.	PUNCT
aji-135	511	1	hum	hum	PROPN
aji-135	511	2	vaccin	vaccin	PROPN
aji-135	511	3	immunother	immunother	PROPN
aji-135	511	4	.	.	PUNCT
aji-135	512	1	2024;20(1):2312600	2024;20(1):2312600	NUM
aji-135	512	2	.	.	PUNCT
aji-135	513	1	61	61	NUM
aji-135	513	2	.	.	PUNCT
aji-135	514	1	perkins	perkins	PROPN
aji-135	514	2	gb	gb	PROPN
aji-135	514	3	,	,	PUNCT
aji-135	514	4	tunbridge	tunbridge	NOUN
aji-135	514	5	mj	mj	PROPN
aji-135	514	6	,	,	PUNCT
aji-135	514	7	hurtado	hurtado	PROPN
aji-135	514	8	pr	pr	NOUN
aji-135	514	9	,	,	PUNCT
aji-135	514	10	zuiani	zuiani	PROPN
aji-135	514	11	j	j	PROPN
aji-135	514	12	,	,	PUNCT
aji-135	514	13	mhatre	mhatre	PROPN
aji-135	514	14	s	s	PART
aji-135	514	15	,	,	PUNCT
aji-135	514	16	yip	yip	PROPN
aji-135	514	17	kh	kh	PROPN
aji-135	514	18	,	,	PUNCT
aji-135	514	19	et	et	PROPN
aji-135	514	20	al	al	PROPN
aji-135	514	21	.	.	PROPN
aji-135	514	22	pegylated	pegylate	VERB
aji-135	514	23	liposomes	liposome	NOUN
aji-135	514	24	for	for	ADP
aji-135	514	25	diagnosis	diagnosis	NOUN
aji-135	514	26	of	of	ADP
aji-135	514	27	polyethylene	polyethylene	NOUN
aji-135	514	28	glycol	glycol	NOUN
aji-135	514	29	allergy	allergy	NOUN
aji-135	514	30	.	.	PUNCT
aji-135	515	1	j	j	PROPN
aji-135	515	2	allergy	allergy	PROPN
aji-135	515	3	clin	clin	PROPN
aji-135	515	4	immunol	immunol	PROPN
aji-135	515	5	.	.	PUNCT
aji-135	515	6	published	publish	VERB
aji-135	515	7	online	online	ADV
aji-135	515	8	may	may	PROPN
aji-135	515	9	6	6	NUM
aji-135	515	10	,	,	PUNCT
aji-135	515	11	2024	2024	NUM
aji-135	515	12	.	.	PUNCT
aji-135	516	1	doi	doi	NOUN
aji-135	516	2	:	:	PUNCT
aji-135	516	3	10.1016	10.1016	NUM
aji-135	516	4	/	/	SYM
aji-135	516	5	j.jaci.2024.03.030	j.jaci.2024.03.030	PROPN
aji-135	516	6	62	62	NUM
aji-135	516	7	.	.	PUNCT
aji-135	517	1	tuttle	tuttle	PROPN
aji-135	517	2	kl	kl	PROPN
aji-135	517	3	,	,	PUNCT
aji-135	517	4	lynch	lynch	PROPN
aji-135	517	5	dm	dm	PROPN
aji-135	517	6	,	,	PUNCT
aji-135	517	7	marquis	marquis	PROPN
aji-135	517	8	k	k	PROPN
aji-135	517	9	,	,	PUNCT
aji-135	517	10	besz	besz	PROPN
aji-135	517	11	km	km	PROPN
aji-135	517	12	,	,	PUNCT
aji-135	517	13	matulonis	matulonis	PROPN
aji-135	517	14	ua	ua	PROPN
aji-135	517	15	,	,	PUNCT
aji-135	517	16	castells	castell	VERB
aji-135	517	17	mc	mc	PROPN
aji-135	517	18	.	.	PROPN
aji-135	518	1	phenotypes	phenotype	NOUN
aji-135	518	2	of	of	ADP
aji-135	518	3	hypersensitivity	hypersensitivity	NOUN
aji-135	518	4	reactions	reaction	NOUN
aji-135	518	5	to	to	PART
aji-135	518	6	pegylated	pegylated	ADJ
aji-135	518	7	liposomal	liposomal	ADJ
aji-135	518	8	doxorubicin	doxorubicin	PROPN
aji-135	518	9	:	:	PUNCT
aji-135	518	10	safety	safety	NOUN
aji-135	518	11	and	and	CCONJ
aji-135	518	12	efficacy	efficacy	NOUN
aji-135	518	13	of	of	ADP
aji-135	518	14	128	128	NUM
aji-135	518	15	rapid	rapid	ADJ
aji-135	518	16	desensitizations	desensitization	NOUN
aji-135	518	17	.	.	PUNCT
aji-135	519	1	j	j	PROPN
aji-135	519	2	allergy	allergy	PROPN
aji-135	519	3	clin	clin	PROPN
aji-135	519	4	immunol	immunol	PROPN
aji-135	519	5	pract	pract	PROPN
aji-135	519	6	.	.	PUNCT
aji-135	520	1	2024;12(5):13481350.e2	2024;12(5):13481350.e2	X
aji-135	520	2	.	.	PUNCT
aji-135	521	1	63	63	NUM
aji-135	521	2	.	.	PUNCT
aji-135	522	1	wells	wells	PROPN
aji-135	522	2	hg	hg	PROPN
aji-135	522	3	.	.	PUNCT
aji-135	523	1	studies	study	NOUN
aji-135	523	2	on	on	ADP
aji-135	523	3	the	the	DET
aji-135	523	4	chemistry	chemistry	NOUN
aji-135	523	5	of	of	ADP
aji-135	523	6	anaphylaxis	anaphylaxis	ADJ
aji-135	523	7	(	(	PUNCT
aji-135	523	8	iii	iii	NOUN
aji-135	523	9	)	)	PUNCT
aji-135	523	10	.	.	PUNCT
aji-135	524	1	experiments	experiment	NOUN
aji-135	524	2	with	with	ADP
aji-135	524	3	isolated	isolated	ADJ
aji-135	524	4	proteins	protein	NOUN
aji-135	524	5	,	,	PUNCT
aji-135	524	6	especially	especially	ADV
aji-135	524	7	those	those	PRON
aji-135	524	8	of	of	ADP
aji-135	524	9	the	the	DET
aji-135	524	10	hen	hen	NOUN
aji-135	524	11	’s	’s	PART
aji-135	524	12	egg	egg	NOUN
aji-135	524	13	.	.	PUNCT
aji-135	525	1	j	j	PROPN
aji-135	525	2	infec	infec	PROPN
aji-135	525	3	diseases	disease	NOUN
aji-135	525	4	.	.	PUNCT
aji-135	526	1	1911;9:147	1911;9:147	NUM
aji-135	526	2	-	-	PUNCT
aji-135	526	3	171	171	NUM
aji-135	526	4	.	.	PUNCT
aji-135	527	1	64	64	NUM
aji-135	527	2	.	.	PUNCT
aji-135	528	1	gell	gell	PROPN
aji-135	528	2	pgh	pgh	PROPN
aji-135	528	3	,	,	PUNCT
aji-135	528	4	harington	harington	PROPN
aji-135	528	5	cr	cr	PROPN
aji-135	528	6	,	,	PUNCT
aji-135	528	7	rivers	river	NOUN
aji-135	528	8	rp	rp	NOUN
aji-135	528	9	.	.	PUNCT
aji-135	529	1	the	the	DET
aji-135	529	2	antigenic	antigenic	ADJ
aji-135	529	3	function	function	NOUN
aji-135	529	4	of	of	ADP
aji-135	529	5	simple	simple	ADJ
aji-135	529	6	chemical	chemical	NOUN
aji-135	529	7	compounds	compound	NOUN
aji-135	529	8	;	;	PUNCT
aji-135	529	9	production	production	NOUN
aji-135	529	10	of	of	ADP
aji-135	529	11	precipitins	precipitin	NOUN
aji-135	529	12	in	in	ADP
aji-135	529	13	rabbits	rabbit	NOUN
aji-135	529	14	.	.	PUNCT
aji-135	530	1	briti	briti	PROPN
aji-135	530	2	j	j	PROPN
aji-135	530	3	exp	exp	NOUN
aji-135	530	4	pathol	pathol	NOUN
aji-135	530	5	.	.	PUNCT
aji-135	531	1	1946;27(5):267286	1946;27(5):267286	NUM
aji-135	531	2	.	.	PUNCT
aji-135	532	1	65	65	NUM
aji-135	532	2	.	.	PUNCT
aji-135	533	1	olivier	olivier	PROPN
aji-135	533	2	ce	ce	PROPN
aji-135	533	3	,	,	PUNCT
aji-135	533	4	lima	lima	PROPN
aji-135	533	5	rps	rps	PROPN
aji-135	533	6	,	,	PUNCT
aji-135	533	7	pinto	pinto	NOUN
aji-135	533	8	dg	dg	NOUN
aji-135	533	9	,	,	PUNCT
aji-135	533	10	santos	santos	PROPN
aji-135	533	11	rapg	rapg	VERB
aji-135	533	12	.	.	PUNCT
aji-135	534	1	the	the	DET
aji-135	534	2	plasma	plasma	NOUN
aji-135	534	3	preincubation	preincubation	NOUN
aji-135	534	4	with	with	ADP
aji-135	534	5	papain	papain	NOUN
aji-135	534	6	before	before	SCONJ
aji-135	534	7	the	the	DET
aji-135	534	8	assay	assay	NOUN
aji-135	534	9	suggests	suggest	VERB
aji-135	534	10	that	that	SCONJ
aji-135	534	11	a	a	DET
aji-135	534	12	gell	gell	NOUN
aji-135	534	13	and	and	CCONJ
aji-135	534	14	coombs	coombs	PROPN
aji-135	534	15	type	type	PROPN
aji-135	534	16	ii	ii	PROPN
aji-135	534	17	reaction	reaction	NOUN
aji-135	534	18	is	be	AUX
aji-135	534	19	been	be	AUX
aji-135	534	20	demonstrated	demonstrate	VERB
aji-135	534	21	by	by	ADP
aji-135	534	22	the	the	DET
aji-135	534	23	leukocyte	leukocyte	NOUN
aji-135	534	24	adherence	adherence	NOUN
aji-135	534	25	inhibition	inhibition	NOUN
aji-135	534	26	test	test	NOUN
aji-135	534	27	.	.	PUNCT
aji-135	535	1	biomed	biome	VERB
aji-135	535	2	j	j	PROPN
aji-135	535	3	sci	sci	PROPN
aji-135	535	4	techn	techn	PROPN
aji-135	535	5	res	re	NOUN
aji-135	535	6	.	.	PUNCT
aji-135	536	1	2021;36(3):28647	2021;36(3):28647	NUM
aji-135	536	2	-	-	SYM
aji-135	536	3	28655	28655	NUM
aji-135	536	4	.	.	PUNCT
aji-135	537	1	66	66	NUM
aji-135	537	2	.	.	PUNCT
aji-135	538	1	thomson	thomson	PROPN
aji-135	538	2	dmp	dmp	PROPN
aji-135	538	3	.	.	PROPN
aji-135	538	4	assessment	assessment	NOUN
aji-135	538	5	of	of	ADP
aji-135	538	6	immune	immune	ADJ
aji-135	538	7	status	status	NOUN
aji-135	538	8	by	by	ADP
aji-135	538	9	the	the	DET
aji-135	538	10	leukocyte	leukocyte	NOUN
aji-135	538	11	adherence	adherence	NOUN
aji-135	538	12	inhibition	inhibition	NOUN
aji-135	538	13	test	test	NOUN
aji-135	538	14	.	.	PUNCT
aji-135	539	1	academic	academic	ADJ
aji-135	539	2	press	press	NOUN
aji-135	539	3	:	:	PUNCT
aji-135	539	4	new	new	PROPN
aji-135	539	5	york	york	PROPN
aji-135	539	6	,	,	PUNCT
aji-135	539	7	1982;17,380	1982;17,380	NUM
aji-135	539	8	p.	p.	NOUN
aji-135	539	9	67	67	NUM
aji-135	539	10	.	.	PUNCT
aji-135	540	1	tong	tong	PROPN
aji-135	540	2	aw	aw	INTJ
aji-135	540	3	,	,	PUNCT
aji-135	540	4	burger	burger	PROPN
aji-135	540	5	dr	dr	PROPN
aji-135	540	6	,	,	PUNCT
aji-135	540	7	finke	finke	PROPN
aji-135	540	8	p	p	PROPN
aji-135	540	9	,	,	PUNCT
aji-135	540	10	barney	barney	PROPN
aji-135	540	11	c	c	PROPN
aji-135	540	12	,	,	PUNCT
aji-135	540	13	vandenbark	vandenbark	PROPN
aji-135	540	14	aa	aa	PROPN
aji-135	540	15	,	,	PUNCT
aji-135	540	16	vetto	vetto	PROPN
aji-135	540	17	rm	rm	PROPN
aji-135	540	18	.	.	PROPN
aji-135	541	1	assessment	assessment	NOUN
aji-135	541	2	of	of	ADP
aji-135	541	3	the	the	DET
aji-135	541	4	mechanism	mechanism	NOUN
aji-135	541	5	of	of	ADP
aji-135	541	6	the	the	DET
aji-135	541	7	leukocyte	leukocyte	NOUN
aji-135	541	8	adherence	adherence	NOUN
aji-135	541	9	inhibition	inhibition	NOUN
aji-135	541	10	test	test	NOUN
aji-135	541	11	.	.	PUNCT
aji-135	542	1	cancer	cancer	NOUN
aji-135	542	2	res	re	NOUN
aji-135	542	3	.	.	PUNCT
aji-135	543	1	1979;39(2	1979;39(2	NUM
aji-135	543	2	pt	pt	NOUN
aji-135	543	3	2):597	2):597	NUM
aji-135	543	4	-	-	SYM
aji-135	543	5	603	603	NUM
aji-135	543	6	.	.	PUNCT
aji-135	543	7	68	68	NUM
aji-135	543	8	.	.	PUNCT
aji-135	543	9	fink	fink	VERB
aji-135	543	10	a	a	PRON
aji-135	543	11	,	,	PUNCT
aji-135	543	12	heller	heller	NOUN
aji-135	543	13	l	l	PROPN
aji-135	543	14	,	,	PUNCT
aji-135	543	15	eliraz	eliraz	VERB
aji-135	543	16	a	a	PRON
aji-135	543	17	,	,	PUNCT
aji-135	543	18	weisman	weisman	PROPN
aji-135	543	19	z	z	PROPN
aji-135	543	20	,	,	PUNCT
aji-135	543	21	miskin	miskin	PROPN
aji-135	543	22	a	a	DET
aji-135	543	23	,	,	PUNCT
aji-135	543	24	schlezinger	schlezinger	NOUN
aji-135	543	25	m	m	PROPN
aji-135	543	26	,	,	PUNCT
aji-135	543	27	et	et	PROPN
aji-135	543	28	al	al	PROPN
aji-135	543	29	.	.	PROPN
aji-135	543	30	allergenspecific	allergenspecific	PROPN
aji-135	543	31	leukocyte	leukocyte	NOUN
aji-135	543	32	adherence	adherence	NOUN
aji-135	543	33	inhibition	inhibition	NOUN
aji-135	543	34	(	(	PUNCT
aji-135	543	35	lai	lai	NOUN
aji-135	543	36	)	)	PUNCT
aji-135	543	37	assay	assay	VERB
aji-135	543	38	:	:	PUNCT
aji-135	543	39	sensitivity	sensitivity	NOUN
aji-135	543	40	,	,	PUNCT
aji-135	543	41	specificity	specificity	NOUN
aji-135	543	42	and	and	CCONJ
aji-135	543	43	mechanism	mechanism	NOUN
aji-135	543	44	.	.	PUNCT
aji-135	544	1	immunol	immunol	PROPN
aji-135	544	2	lett	lett	PROPN
aji-135	544	3	.	.	PUNCT
aji-135	545	1	1987;16(1):6570	1987;16(1):6570	NOUN
aji-135	545	2	.	.	PUNCT
aji-135	546	1	69	69	NUM
aji-135	546	2	.	.	PUNCT
aji-135	547	1	halliday	halliday	PROPN
aji-135	547	2	wj	wj	PROPN
aji-135	547	3	,	,	PUNCT
aji-135	547	4	maluish	maluish	NOUN
aji-135	547	5	a	a	PRON
aji-135	547	6	,	,	PUNCT
aji-135	547	7	miller	miller	PROPN
aji-135	547	8	s.	s.	PROPN
aji-135	547	9	blocking	block	VERB
aji-135	547	10	and	and	CCONJ
aji-135	547	11	unblocking	unblocking	NOUN
aji-135	547	12	of	of	ADP
aji-135	547	13	cell	cell	NOUN
aji-135	547	14	-	-	PUNCT
aji-135	547	15	mediated	mediate	VERB
aji-135	547	16	anti	anti	ADJ
aji-135	547	17	-	-	ADJ
aji-135	547	18	tumor	tumor	ADJ
aji-135	547	19	immunity	immunity	NOUN
aji-135	547	20	in	in	ADP
aji-135	547	21	mice	mouse	NOUN
aji-135	547	22	,	,	PUNCT
aji-135	547	23	as	as	SCONJ
aji-135	547	24	detected	detect	VERB
aji-135	547	25	by	by	ADP
aji-135	547	26	the	the	DET
aji-135	547	27	leucocyte	leucocyte	PROPN
aji-135	547	28	adherence	adherence	NOUN
aji-135	547	29	inhibition	inhibition	NOUN
aji-135	547	30	test	test	NOUN
aji-135	547	31	.	.	PUNCT
aji-135	548	1	cell	cell	NOUN
aji-135	548	2	immunol	immunol	NOUN
aji-135	548	3	.	.	PUNCT
aji-135	549	1	1974;10(3):467	1974;10(3):467	NUM
aji-135	549	2	-	-	SYM
aji-135	549	3	475	475	NUM
aji-135	549	4	.	.	PUNCT
aji-135	550	1	70	70	NUM
aji-135	550	2	.	.	PUNCT
aji-135	551	1	chung	chung	PROPN
aji-135	551	2	mk	mk	PROPN
aji-135	551	3	,	,	PUNCT
aji-135	551	4	house	house	PROPN
aji-135	551	5	js	js	PROPN
aji-135	551	6	,	,	PUNCT
aji-135	551	7	akhtari	akhtari	NOUN
aji-135	551	8	fs	fs	PROPN
aji-135	551	9	,	,	PUNCT
aji-135	551	10	makris	makris	PROPN
aji-135	551	11	kc	kc	PROPN
aji-135	551	12	,	,	PUNCT
aji-135	551	13	langston	langston	PROPN
aji-135	551	14	ma	ma	PROPN
aji-135	551	15	,	,	PUNCT
aji-135	551	16	islam	islam	PROPN
aji-135	551	17	kt	kt	PROPN
aji-135	551	18	,	,	PUNCT
aji-135	551	19	et	et	PROPN
aji-135	551	20	al	al	PROPN
aji-135	551	21	.	.	PUNCT
aji-135	551	22	decoding	decode	VERB
aji-135	551	23	the	the	DET
aji-135	551	24	exposome	exposome	NOUN
aji-135	551	25	:	:	PUNCT
aji-135	551	26	data	datum	NOUN
aji-135	551	27	science	science	NOUN
aji-135	551	28	methodologies	methodology	NOUN
aji-135	551	29	and	and	CCONJ
aji-135	551	30	implications	implication	NOUN
aji-135	551	31	in	in	ADP
aji-135	551	32	exposome	exposome	NOUN
aji-135	551	33	-	-	PUNCT
aji-135	551	34	wide	wide	ADJ
aji-135	551	35	association	association	NOUN
aji-135	551	36	studies	study	NOUN
aji-135	551	37	(	(	PUNCT
aji-135	551	38	exwass	exwass	PROPN
aji-135	551	39	)	)	PUNCT
aji-135	551	40	.	.	PUNCT
aji-135	552	1	exposome	exposome	NOUN
aji-135	552	2	.	.	PUNCT
aji-135	553	1	2024;4(1	2024;4(1	NUM
aji-135	553	2	):	):	PUNCT
aji-135	553	3	osae001	osae001	PROPN
aji-135	553	4	.	.	PUNCT
aji-135	554	1	71	71	NUM
aji-135	554	2	.	.	PUNCT
aji-135	555	1	olivier	olivier	PROPN
aji-135	555	2	ce	ce	PROPN
aji-135	555	3	,	,	PUNCT
aji-135	555	4	pinto	pinto	NOUN
aji-135	555	5	dg	dg	PROPN
aji-135	555	6	,	,	PUNCT
aji-135	555	7	teixeira	teixeira	PROPN
aji-135	555	8	apm	apm	PROPN
aji-135	555	9	,	,	PUNCT
aji-135	555	10	santana	santana	PROPN
aji-135	555	11	jls	jls	PROPN
aji-135	555	12	,	,	PUNCT
aji-135	555	13	santos	santos	PROPN
aji-135	555	14	rapg	rapg	PROPN
aji-135	555	15	,	,	PUNCT
aji-135	555	16	lima	lima	PROPN
aji-135	555	17	rps	rps	PROPN
aji-135	555	18	.	.	PUNCT
aji-135	556	1	exploring	explore	VERB
aji-135	556	2	the	the	DET
aji-135	556	3	role	role	NOUN
aji-135	556	4	of	of	ADP
aji-135	556	5	leukocyte	leukocyte	NOUN
aji-135	556	6	adherence	adherence	NOUN
aji-135	556	7	inhibition	inhibition	NOUN
aji-135	556	8	test	test	NOUN
aji-135	556	9	in	in	ADP
aji-135	556	10	assessing	assess	VERB
aji-135	556	11	non	non	ADJ
aji-135	556	12	-	-	ADJ
aji-135	556	13	ige	ige	ADJ
aji-135	556	14	mediated	mediate	VERB
aji-135	556	15	immunoreactivity	immunoreactivity	NOUN
aji-135	556	16	to	to	ADP
aji-135	556	17	benzoic	benzoic	NOUN
aji-135	556	18	acid	acid	NOUN
aji-135	556	19	in	in	ADP
aji-135	556	20	allergic	allergic	ADJ
aji-135	556	21	patients	patient	NOUN
aji-135	556	22	.	.	PUNCT
aji-135	557	1	asian	asian	PROPN
aji-135	557	2	j	j	PROPN
aji-135	557	3	immunol	immunol	NOUN
aji-135	557	4	;	;	PUNCT
aji-135	558	1	2024;7(1):63	2024;7(1):63	X
aji-135	558	2	-	-	SYM
aji-135	558	3	70	70	NUM
aji-135	558	4	.	.	PUNCT
aji-135	559	1	72	72	NUM
aji-135	559	2	.	.	PUNCT
aji-135	559	3	anouar	anouar	PROPN
aji-135	559	4	s	s	PROPN
aji-135	559	5	,	,	PUNCT
aji-135	559	6	hazim	hazim	NOUN
aji-135	559	7	r	r	NOUN
aji-135	559	8	,	,	PUNCT
aji-135	559	9	brahim	brahim	PROPN
aji-135	559	10	a.	a.	NOUN
aji-135	559	11	interferences	interference	VERB
aji-135	559	12	in	in	ADP
aji-135	559	13	immunological	immunological	ADJ
aji-135	559	14	assays	assay	NOUN
aji-135	559	15	:	:	PUNCT
aji-135	559	16	causes	cause	NOUN
aji-135	559	17	,	,	PUNCT
aji-135	559	18	detection	detection	NOUN
aji-135	559	19	,	,	PUNCT
aji-135	559	20	and	and	CCONJ
aji-135	559	21	prevention	prevention	NOUN
aji-135	559	22	.	.	PUNCT
aji-135	560	1	asian	asian	PROPN
aji-135	560	2	j	j	PROPN
aji-135	560	3	immunol	immunol	NOUN
aji-135	560	4	.	.	PUNCT
aji-135	561	1	2024;7(1):71	2024;7(1):71	NUM
aji-135	561	2	-	-	SYM
aji-135	561	3	78	78	NUM
aji-135	561	4	.	.	PUNCT
aji-135	562	1	olivier	olivier	PROPN
aji-135	562	2	et	et	PROPN
aji-135	562	3	al	al	PROPN
aji-135	562	4	.	.	PROPN
aji-135	562	5	;	;	PUNCT
aji-135	562	6	asian	asian	PROPN
aji-135	562	7	j.	j.	PROPN
aji-135	562	8	immunol	immunol	PROPN
aji-135	562	9	.	.	PROPN
aji-135	562	10	,	,	PUNCT
aji-135	562	11	vol	vol	NOUN
aji-135	562	12	.	.	PROPN
aji-135	563	1	7	7	NUM
aji-135	563	2	,	,	PUNCT
aji-135	563	3	no	no	INTJ
aji-135	563	4	.	.	NOUN
aji-135	563	5	1	1	NUM
aji-135	563	6	,	,	PUNCT
aji-135	563	7	pp	pp	ADJ
aji-135	563	8	.	.	PUNCT
aji-135	564	1	100	100	NUM
aji-135	564	2	-	-	SYM
aji-135	564	3	111	111	NUM
aji-135	564	4	,	,	PUNCT
aji-135	564	5	2024	2024	NUM
aji-135	564	6	;	;	PUNCT
aji-135	565	1	article	article	NOUN
aji-135	565	2	no.aji.119914	no.aji.119914	PROPN
aji-135	565	3	111	111	NUM
aji-135	565	4	73	73	NUM
aji-135	565	5	.	.	PUNCT
aji-135	566	1	chiarentin	chiarentin	PROPN
aji-135	566	2	l	l	PROPN
aji-135	566	3	,	,	PUNCT
aji-135	566	4	gonçalves	gonçalves	PROPN
aji-135	566	5	c	c	PROPN
aji-135	566	6	,	,	PUNCT
aji-135	566	7	augusto	augusto	PROPN
aji-135	566	8	c	c	PROPN
aji-135	566	9	,	,	PUNCT
aji-135	566	10	miranda	miranda	PROPN
aji-135	566	11	m	m	PROPN
aji-135	566	12	,	,	PUNCT
aji-135	566	13	cardoso	cardoso	PROPN
aji-135	566	14	c	c	PROPN
aji-135	566	15	,	,	PUNCT
aji-135	566	16	vitorino	vitorino	PROPN
aji-135	566	17	c.	c.	PROPN
aji-135	566	18	drilling	drill	VERB
aji-135	566	19	into	into	ADP
aji-135	566	20	“	"	PUNCT
aji-135	566	21	quality	quality	NOUN
aji-135	566	22	by	by	ADP
aji-135	566	23	design	design	NOUN
aji-135	566	24	”	"	PUNCT
aji-135	566	25	approach	approach	NOUN
aji-135	566	26	for	for	ADP
aji-135	566	27	analytical	analytical	ADJ
aji-135	566	28	methods	method	NOUN
aji-135	566	29	.	.	PUNCT
aji-135	567	1	crit	crit	PROPN
aji-135	567	2	rev	rev	PROPN
aji-135	567	3	analytical	analytical	ADJ
aji-135	567	4	chem	chem	NOUN
aji-135	567	5	.	.	PUNCT
aji-135	568	1	2023;1	2023;1	NUM
aji-135	568	2	-	-	SYM
aji-135	568	3	42	42	NUM
aji-135	568	4	.	.	PUNCT
aji-135	569	1	74	74	NUM
aji-135	569	2	.	.	PUNCT
aji-135	570	1	world	world	PROPN
aji-135	570	2	medical	medical	PROPN
aji-135	570	3	association	association	PROPN
aji-135	570	4	declaration	declaration	PROPN
aji-135	570	5	of	of	ADP
aji-135	570	6	helsinki	helsinki	PROPN
aji-135	570	7	:	:	PUNCT
aji-135	570	8	ethical	ethical	ADJ
aji-135	570	9	principles	principle	NOUN
aji-135	570	10	for	for	ADP
aji-135	570	11	medical	medical	ADJ
aji-135	570	12	research	research	NOUN
aji-135	570	13	involving	involve	VERB
aji-135	570	14	human	human	ADJ
aji-135	570	15	subjects	subject	NOUN
aji-135	570	16	.	.	PUNCT
aji-135	571	1	jama	jama	NOUN
aji-135	571	2	.	.	PUNCT
aji-135	572	1	2013;310(20	2013;310(20	PROPN
aji-135	572	2	):	):	PUNCT
aji-135	572	3	2191	2191	NUM
aji-135	572	4	-	-	SYM
aji-135	572	5	4	4	NUM
aji-135	572	6	.	.	PUNCT
aji-135	572	7	disclaimer	disclaimer	ADJ
aji-135	572	8	/	/	SYM
aji-135	572	9	publisher	publisher	NOUN
aji-135	572	10	’s	’s	PART
aji-135	572	11	note	note	NOUN
aji-135	572	12	:	:	PUNCT
aji-135	572	13	the	the	DET
aji-135	572	14	statements	statement	NOUN
aji-135	572	15	,	,	PUNCT
aji-135	572	16	opinions	opinion	NOUN
aji-135	572	17	and	and	CCONJ
aji-135	572	18	data	datum	NOUN
aji-135	572	19	contained	contain	VERB
aji-135	572	20	in	in	ADP
aji-135	572	21	all	all	DET
aji-135	572	22	publications	publication	NOUN
aji-135	572	23	are	be	AUX
aji-135	572	24	solely	solely	ADV
aji-135	572	25	those	those	PRON
aji-135	572	26	of	of	ADP
aji-135	572	27	the	the	DET
aji-135	572	28	individual	individual	ADJ
aji-135	572	29	author(s	author(s	PROPN
aji-135	572	30	)	)	PUNCT
aji-135	572	31	and	and	CCONJ
aji-135	572	32	contributor(s	contributor(s	NOUN
aji-135	572	33	)	)	PUNCT
aji-135	572	34	and	and	CCONJ
aji-135	572	35	not	not	PART
aji-135	572	36	of	of	ADP
aji-135	572	37	the	the	DET
aji-135	572	38	publisher	publisher	NOUN
aji-135	572	39	and/or	and/or	CCONJ
aji-135	572	40	the	the	DET
aji-135	572	41	editor(s	editor(s	NOUN
aji-135	572	42	)	)	PUNCT
aji-135	572	43	.	.	PUNCT
aji-135	573	1	this	this	DET
aji-135	573	2	publisher	publisher	NOUN
aji-135	573	3	and/or	and/or	CCONJ
aji-135	573	4	the	the	DET
aji-135	573	5	editor(s	editor(s	NOUN
aji-135	573	6	)	)	PUNCT
aji-135	573	7	disclaim	disclaim	VERB
aji-135	573	8	responsibility	responsibility	NOUN
aji-135	573	9	for	for	ADP
aji-135	573	10	any	any	DET
aji-135	573	11	injury	injury	NOUN
aji-135	573	12	to	to	ADP
aji-135	573	13	people	people	NOUN
aji-135	573	14	or	or	CCONJ
aji-135	573	15	property	property	NOUN
aji-135	573	16	resulting	result	VERB
aji-135	573	17	from	from	ADP
aji-135	573	18	any	any	DET
aji-135	573	19	ideas	idea	NOUN
aji-135	573	20	,	,	PUNCT
aji-135	573	21	methods	method	NOUN
aji-135	573	22	,	,	PUNCT
aji-135	573	23	instructions	instruction	NOUN
aji-135	573	24	or	or	CCONJ
aji-135	573	25	products	product	NOUN
aji-135	573	26	referred	refer	VERB
aji-135	573	27	to	to	ADP
aji-135	573	28	in	in	ADP
aji-135	573	29	the	the	DET
aji-135	573	30	content	content	NOUN
aji-135	573	31	.	.	PUNCT
aji-135	574	1	_	_	PUNCT
aji-135	575	1	_	_	PUNCT
aji-135	576	1	_	_	PUNCT
aji-135	577	1	_	_	PUNCT
aji-135	578	1	_	_	PUNCT
aji-135	579	1	_	_	PUNCT
aji-135	580	1	_	_	PUNCT
aji-135	581	1	_	_	PUNCT
aji-135	582	1	_	_	PUNCT
aji-135	583	1	_	_	PUNCT
aji-135	584	1	_	_	PUNCT
aji-135	585	1	_	_	PUNCT
aji-135	586	1	_	_	PUNCT
aji-135	587	1	_	_	PUNCT
aji-135	588	1	_	_	PUNCT
aji-135	589	1	_	_	PUNCT
aji-135	590	1	_	_	PUNCT
aji-135	591	1	_	_	PUNCT
aji-135	592	1	_	_	PUNCT
aji-135	593	1	_	_	PUNCT
aji-135	594	1	_	_	PUNCT
aji-135	595	1	_	_	PUNCT
aji-135	596	1	_	_	PUNCT
aji-135	597	1	_	_	PUNCT
aji-135	598	1	_	_	PUNCT
aji-135	599	1	_	_	PUNCT
aji-135	600	1	_	_	PUNCT
aji-135	601	1	_	_	PUNCT
aji-135	602	1	_	_	PUNCT
aji-135	603	1	_	_	PUNCT
aji-135	604	1	_	_	PUNCT
aji-135	605	1	_	_	PUNCT
aji-135	606	1	_	_	PUNCT
aji-135	607	1	_	_	PUNCT
aji-135	608	1	_	_	PUNCT
aji-135	609	1	_	_	PUNCT
aji-135	610	1	_	_	PUNCT
aji-135	611	1	_	_	PUNCT
aji-135	612	1	_	_	PUNCT
aji-135	613	1	_	_	PUNCT
aji-135	614	1	_	_	PUNCT
aji-135	615	1	_	_	PUNCT
aji-135	616	1	_	_	PUNCT
aji-135	617	1	_	_	PUNCT
aji-135	618	1	_	_	PUNCT
aji-135	619	1	_	_	PUNCT
aji-135	620	1	_	_	PUNCT
aji-135	621	1	_	_	PUNCT
aji-135	622	1	_	_	PUNCT
aji-135	623	1	_	_	PUNCT
aji-135	624	1	_	_	PUNCT
aji-135	625	1	_	_	PUNCT
aji-135	626	1	_	_	PUNCT
aji-135	627	1	_	_	PUNCT
aji-135	628	1	_	_	PUNCT
aji-135	629	1	_	_	PUNCT
aji-135	630	1	_	_	PUNCT
aji-135	631	1	_	_	PUNCT
aji-135	632	1	_	_	PUNCT
aji-135	633	1	_	_	PUNCT
aji-135	634	1	_	_	PUNCT
aji-135	635	1	_	_	PUNCT
aji-135	636	1	_	_	PUNCT
aji-135	637	1	_	_	PUNCT
aji-135	638	1	_	_	PUNCT
aji-135	639	1	_	_	PUNCT
aji-135	640	1	_	_	PUNCT
aji-135	641	1	_	_	PUNCT
aji-135	642	1	_	_	PUNCT
aji-135	643	1	_	_	PUNCT
aji-135	644	1	_	_	PUNCT
aji-135	645	1	_	_	PUNCT
aji-135	646	1	_	_	PUNCT
aji-135	647	1	_	_	PUNCT
aji-135	648	1	_	_	PUNCT
aji-135	649	1	_	_	PUNCT
aji-135	650	1	_	_	PUNCT
aji-135	651	1	_	_	PUNCT
aji-135	652	1	_	_	PUNCT
aji-135	653	1	_	_	PUNCT
aji-135	654	1	_	_	PUNCT
aji-135	655	1	©	©	PRON
aji-135	655	2	copyright	copyright	NOUN
aji-135	655	3	(	(	PUNCT
aji-135	655	4	2024	2024	NUM
aji-135	655	5	):	):	PUNCT
aji-135	655	6	author(s	author(s	NOUN
aji-135	655	7	)	)	PUNCT
aji-135	655	8	.	.	PUNCT
aji-135	656	1	the	the	DET
aji-135	656	2	licensee	licensee	NOUN
aji-135	656	3	is	be	AUX
aji-135	656	4	the	the	DET
aji-135	656	5	journal	journal	PROPN
aji-135	656	6	publisher	publisher	NOUN
aji-135	656	7	.	.	PUNCT
aji-135	657	1	this	this	PRON
aji-135	657	2	is	be	AUX
aji-135	657	3	an	an	DET
aji-135	657	4	open	open	ADJ
aji-135	657	5	access	access	NOUN
aji-135	657	6	article	article	NOUN
aji-135	657	7	distributed	distribute	VERB
aji-135	657	8	under	under	ADP
aji-135	657	9	the	the	DET
aji-135	657	10	terms	term	NOUN
aji-135	657	11	of	of	ADP
aji-135	657	12	the	the	DET
aji-135	657	13	creative	creative	ADJ
aji-135	657	14	commons	common	NOUN
aji-135	657	15	attribution	attribution	NOUN
aji-135	657	16	license	license	NOUN
aji-135	657	17	(	(	PUNCT
aji-135	657	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-135	657	19	)	)	PUNCT
aji-135	657	20	,	,	PUNCT
aji-135	657	21	which	which	PRON
aji-135	657	22	permits	permit	VERB
aji-135	657	23	unrestricted	unrestricted	ADJ
aji-135	657	24	use	use	NOUN
aji-135	657	25	,	,	PUNCT
aji-135	657	26	distribution	distribution	NOUN
aji-135	657	27	,	,	PUNCT
aji-135	657	28	and	and	CCONJ
aji-135	657	29	reproduction	reproduction	NOUN
aji-135	657	30	in	in	ADP
aji-135	657	31	any	any	DET
aji-135	657	32	medium	medium	NOUN
aji-135	657	33	,	,	PUNCT
aji-135	657	34	provided	provide	VERB
aji-135	657	35	the	the	DET
aji-135	657	36	original	original	ADJ
aji-135	657	37	work	work	NOUN
aji-135	657	38	is	be	AUX
aji-135	657	39	properly	properly	ADV
aji-135	657	40	cited	cite	VERB
aji-135	657	41	.	.	PUNCT
aji-135	658	1	peer	peer	NOUN
aji-135	658	2	-	-	PUNCT
aji-135	658	3	review	review	NOUN
aji-135	658	4	history	history	NOUN
aji-135	658	5	:	:	PUNCT
aji-135	658	6	the	the	DET
aji-135	658	7	peer	peer	NOUN
aji-135	658	8	review	review	NOUN
aji-135	658	9	history	history	NOUN
aji-135	658	10	for	for	ADP
aji-135	658	11	this	this	DET
aji-135	658	12	paper	paper	NOUN
aji-135	658	13	can	can	AUX
aji-135	658	14	be	be	AUX
aji-135	658	15	accessed	access	VERB
aji-135	658	16	here	here	ADV
aji-135	658	17	:	:	PUNCT
aji-135	658	18	https://www.sdiarticle5.com/review-history/119914	https://www.sdiarticle5.com/review-history/119914	X
aji-135	658	19	https://www.sdiarticle5.com/review-history/119914	https://www.sdiarticle5.com/review-history/119914	NOUN